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Abstract 
The aim of this dissertation was to examine whether UK based weight management 
programmes promote weight loss maintenance (follow up of 12 months to assess 
effectiveness of intervention on weight loss) in adults through the process of a 
systematic review. The World Health Organisation (WHO) has described obesity as 
a “global epidemic”. Weight management comprises two phases; weight loss and 
weight loss maintenance. The latter phase is the true goal for obesity and the most 
difficult element of weight management to achieve. However much less is known 
about this as compared with the weight loss phase. There is little purpose in 
committing time and money to reducing obesity if the weight is regained. This is 
counter-productive and weight loss maintenance is essential to combat the obesity 
epidemic. Searches were made for relevant information from a variety of scientific 
online databases and journals. Seven articles met the inclusion criteria and were 
analysed in the review. All studies incorporated a multi-component (diet, exercise, 
behavior modification) intervention approach. All control and intervention groups 
reported weight loss at 12 months when compared with baseline. All groups received 
an intervention. One study reported a significant difference (P<0.05) between 
groups. Four studies reported on at least one component (diet, physical activity, 
behavior modification) however there was not enough information to conclude 
whether they complied with national guidelines (NICE CG43 and SIGN 115). High 
attrition rates and loss to follow up are problematic for each study except one. 
Analysis on an intention to treat basis was common however this is problematic and 
there are alternative methods which may be more suitable for dealing with missing 
data.  
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1 Introduction 
1.1 Obesity – General Overview 
The World Health Organisation (WHO) has described obesity as a “global epidemic” 
(http//www.who.int/). It defines it as “a condition of abnormal or excessive fat accumulation in 
adipose tissue, to the extent that health may be impaired”. WHO utilises body mass index 
(BMI) to classify overweight, underweight and obesity in adults. It calculates BMI by dividing 
an individual’s weight (kg) by height (m2).  
Table 1: The International Classification of Adult Underweight, Overweight and Obesity 
According to BMI 
Classification BMI(kg/m2) 
 Principal cut-off 
points 
Additional cut-off 
points 
Underweight <18.50 <18.50 
Severe thinness <16.00 <16.00 
Moderate thinness 16.00 - 16.99 16.00 - 16.99 
Mild thinness 17.00 - 18.49 17.00 - 18.49 
Normal range 18.50 - 24.99 18.50 - 22.99 
23.00 - 24.99 
Overweight ≥25.00 ≥25.00 
Pre-obese 25.00 - 29.99 25.00 - 27.49 
27.50 - 29.99 
Obese ≥30.00 ≥30.00 
Obese class I 30.00 - 34.99 30.00 - 32.49 
32.50 - 34.99 
Obese class II 35.00 - 39.99 35.00 - 37.49 
37.50 - 39.99 
Obese class III ≥40.00 ≥40.00 
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Source: Adapted from (WHO, 1995, WHO, 2000 ). 
Research has demonstrated several limitations of BMI measurement, for example, it cannot 
distinguish fat from muscle, bone and other lean body mass (WHO, 1995 and WHO, 2000 ). 
It can lead to misclassification among ethnic groups, in particular overestimation of African 
Americans therefore overstating the true difference in obesity between whites and African 
Americans (Burkhauser and Cawley 2008). (Ko et al (2001) recommended that BMI cut off 
values of 23 kg/m2 and 26 kg/m2 be used to define overweight and obesity respectively in 
Hong Kong Chinese. This study assessed body fat of 5153 Hong Kong Chinese by 
bioelectrical impedance. The receiver operating characteristic curve showed that the BMI 
corresponding to the conventional upper limit of normal body fat was 22.5-23.1 kg/m2 and 
the BMI corresponding to the 90 percentiles of body fat was 25.4-26.1 kg/m2. 
Despite these limitations the BMI formula has been shown to give valid estimates of body fat 
in males and females of all ages when compared to skin fold thickness measurement or 
bioelectrical impedance analysis data (Deurenberg, Westrate, Seidell, 1991). 
Many UK commercial weight loss programs use BMI to assess weight classification of 
members. Weight watchers (http://www.weightwatchers.co.uk), Slimming World 
(http://www.slimmingworld.com), and Unislim (http://www.unislim.com) provide BMI 
calculators on their websites and access to this is free of charge i.e. no membership 
required. It is non-invasive, inexpensive and easy to use by individuals and clinicians 
therefore promoting ease of comparability across populations (National Obesity 
Observatory). The National Institute for Clinical Excellence (CG43, 2006) and Scottish 
Intercollegiate Guidelines Network (Guideline 115, 2010) recommend that BMI should be 
measured in conjunction with waist circumstance when measuring overweight and obesity 
for those with BMI of less than 35 kg/m2 to refine assessment of risk of obesity-related co 
morbidities. For adults with a BMI of 35 kg/m2 or more, risks are assumed to be very high 
with any waist circumference. 
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Obesity is directly associated with cardiovascular diseases, type II diabetes and some forms 
of cancer (Bray, 2004, Xavier Pi-Sunyer, 2002). Certification of obesity as a cause of death 
in England is increasing (Duncan, Griffity, Rutter & Goldacre, 2010). The latter research 
paper found that when obesity was coded as an underlying cause of death, the most 
common other conditions mentioned were heart failure, pulmonary embolism, diabetes 
mellitus and pneumonia. When obesity was coded as a condition contributing to death, but 
not as the underlying cause, the most common underlying certified causes were chronic 
ischemic heart disease, acute myocardial infarction, chronic obstructive pulmonary disease 
and diabetes mellitus.  
The Organisation for Economic Co-operation and Development (OECD) which produced 
health data in 2011 (OECD Health Data, 2011) detail that the obesity rate among adults in 
the UK (based on actual measures of weight and height) have risen from 14% in 1991 was 
23% in 2009. The Foresight report, Tackling Obesities: Future Choices project was 
commissioned by the UK government and published in 2007 (Future Choices Project, 2007) 
(www.foresight.gov.uk). This report examined current obesity trends in the UK and assessed 
where councils can use their local leadership role to positively change obesity levels and 
create healthier environments. It predicted that if no action was taken, 60% of men, 50% of 
women and 25% of children would be obese by 2050. This report estimates the direct cost to 
the UK government to be £4.2 billion and Foresight have forecast that if the current trend 
continues this will more than double by 2050. The government responded in 2008 with a 
cross-government strategy called Healthy Weight Healthy Lives (Department of Health, 
2008). The aim of this report is to reverse obesity by ensuring that everybody is able to 
achieve and maintain a healthy weight. The initial focus is on children with an aim to reduce 
obesity to 2000 levels. The latest progress report was published in March 2010, ‘Healthy 
Weight, Healthy Lives. Two Years On’ (Department of Health, 2010). This report states that 
‘good progress is being made’. For example, child obesity in under 11’s is levelling off but 
prevalence remains high. Child obesity prevelance reduced from 17.3% in 2005 to 13.9% in 
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2008. ‘Change4Life’ was launched in January 2009. It cost £75 million and is a three year 
programme. This is a social marketing movement aimed at getting people to eat well, move 
more and live longer. More than 400,000 families have joined. In February 2010 the 
government launched Change4Life for adults. There is no progress report on this yet. 
One in four adults in the UK is obese, so successful weight management programs are 
urgently required (Truby, 2011). Weight Watchers currently claim 2 million UK members and 
Rosemary Connelly claim in excess of 700,000 UK members. There is a paucity of 
systematic reviews of commercial weight loss programs in the UK and these are required to 
summarise the research evidence in order to assess effectiveness (Wing, 2010). Weight 
management comprises two phases; weight loss and weight loss maintenance (Finer, 2001). 
The latter phase has been cited as the true goal for obesity management and the most 
difficult element of weight management to achieve but much less is known about this as 
compared with the weight loss phase. (Anderson, Vichitbandra & Kryscio, 1999).  
1.2 Obesity and Primary Care Intervention 
The cross-government strategy ‘ Healthy Weight, Healthy Lives’ ‘ (Department of Health, 
2008) identifies primary care as the first port of call for advice about weight control, creating 
a need for simple, effective interventions to be delivered by primary care teams. The 
National Institute for Health and Clinical Excellence (National Institue for Health and Clinical 
Excellence, Clinical Guideline CG43, 2006) recommend that clinical management be offered 
to obese patients by primary care physicians.  
A relevant study (Browne, Stride, Psarou, Thompson & Brewins, 2007)noted that nurses in 
primary care play a key role in managing obesity. Practice Nurses (82%) felt that lack of 
obesity management training was apparent and did not believe that organisational support 
was in place. Only nine respondents (2.3%) provided input into a group intervention for 
obesity management. This study reported that within an area of 60,000 obese adults there 
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were about 2700 (4.5%) individuals being supported and assessed within any four weeks by 
primary care. This indicates the level of activity and scale of the problem. Epstein (2005) 
conducted a qualitative study of 21 GP’s working in an inner London primary care trust 
regarding their views on treatment of obese patients. This study reported that these 
physicians felt that obesity was not within their professional domain and would resist any 
government pressure to accept obesity as part of their workload. No statistics or data was 
reported.  
The previous two studies focus on obesity management and treatment. The Foresight 
Report declares that “the distinction between prevention and treatment is important”. Aucott, 
Riddell and Smith (2011) conducted the first UK based study to assess attitudes of general 
practitioners, registrars and their trainers toward obesity prevention in adults. A postal 
questionnaire was sent to all GP registrars (GPR) and GP trainers (GPT) in Scotland of 
which there were 103 and 91 respectively. The questions included individual details, 
opinions about current obesity prevention strategies and facts about current obesity 
prevention practices.  51% responded representing 5% of Scottish GP’s. There were large 
differences in opinion between GPR’s and GPT’s as to whether primary care could and/or 
should prevent obesity. 36% GPR’s and 8% GPT’s felt that primary care can help prevent 
obesity. 37% GPR’s and 5% of GPT’s felt that primary care should prevent obesity. Despite 
the belief that obesity prevention is best supported from within primary care particularly from 
GPR’s, these GP’s did not feel that the responsibility of obesity prevention should be solely 
theirs. The fear of obesity swamping primary care is reflected by recent UK studies 
suggesting that GP’s consider obesity not to be a medical problem (Mercer & Tessier, 2001, 
Alexander et al, 2007). In addition common barriers to obesity management include limited 
training and knowledge (Terre, Hunter, Poston, Haddock & Steward, 2007, Treyzon, 2005). 
The Counterweight Project (Ross, Laws, Reckless & Lean, 2008) provided evidence of an 
effective model of weight management in primary care. This model consisted of four stages: 
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1) Audit and project development - specialist obesity dieticians were the weight 
management advisors and they facilitated programme implementations  
2) Practice training and support - the practice care nurse (PCN) was identified as the 
most suitable person to deliver the weight management intervention. They attended 
an 8 hour training programme and incorporated the appointments into appointments 
which were usually spent managing comorbid conditions. The role of the GP was to 
identify suitable patients for the intervention. 
3) Nurse led patient intervention – the PCN delivered patient education through weight 
management discussion, communication of information and the transfer of behaviour 
skills and strategies during each session. 
4) Evaluation – A patient data set was devised and included baseline weight, weight 
circumference, blood pressure, fasting lipids, glucose. This study used evidence 
based pathways which included strategies to empower clinicians and patients. 
Primary outcome measures were weight change and percentage of patients achieving >5% 
loss at 12 and 24 months. Primary care practice nurses from 65 UK general practices 
delivered interventions to 1906 patients with BMI > 30kg/m2 or > 28kg/m2. Mean weight 
change in those who attended and had data at 12 months (n=642) was -3.0kg and at 24 
months was (n=357) was -2.3kg. Among attendees at specific time-points 30.7% had 
maintained weight loss of 5% at 12 months and 31.9% at 24 months. A total of 761 (54%) of 
all 1419 patients who had been enrolled in the programme for > 12 months provided data at 
or beyond 12 months. By applying the mean change in BMI observed, to the costs of 
prescribing medications at varying BMI levels expected savings of 6.3% of prescribing costs 
for all patients and 8% of the programme cost offset in year one, increasing to 22% when 
attendance and follow up is optimal. There was no control group in this study and this 
prevents exact quantification of the Counterweight Programme achievements.  
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This is the first known study to use an evidence based approach which aims to empower 
patients. The impact on secondary outcomes such as obesity related diseases was not 
possible outside a formal heavily funded research setting. This study demonstrates that 
practice nurses can achieve and maintain clinically beneficial patient weight loss when 
weight management training is provided to them. It is important to note that one in five 
practices withdrew from the programme due to lack of resources and time and changes in 
clinical staff. It is relevant that practices were asked to incorporate this programme into 
routine clinical practices without additional funding and this may have been a significant 
barrier.  
Weight management programmes may not always be available through local general 
practice. Time for implementing the scheme and staff training together with lack of funding 
can constrain general practice participation as demonstrated by the Ross, Laws, Reckless 
and Lean (2008). Lavin et al (2006) recognise this and assessed the feasibility and benefits 
of implementing a ‘Slimming on Referral’ service using a local commercial weight 
management group by primary care. 107 patients participated and inclusion criteria included 
BMI > 30kg/m2 and age >18 years. Patients were offered free attendance at a local Slimming 
World (SW) group for 12 consecutive weeks. 91 patients (85%) patients attended a group 
with 62 completing 12 weeks. Average weight loss in participants was 5.4% (6.4% baseline 
weight). 47 patients chose to self fund for a further 12 weeks. Based on SW fees in 2004 the 
cost per patient to cover membership and 12 weeks attendance at a group was £44.50 with 
primary care trust discount. Practices estimated that each referral used 20 minutes of nurse 
and administrator time which added a notional £7 per patient when salaries were 
considered. Referral without the constraints of a research study would take less time with 
minimal data collection. This study estimated that 12 weeks of Sibutramine would cost £112 
per patient and £124 for Orlistat. This does not include a weight management programme as 
recommended by NICE (CG43, 2006). One to one treatment by a dietician would cost £55 - 
£115 per patient. Slimming World offers a practical solution where there is no in-house 
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weight management programme. This study reported that lower income people are less 
likely to access healthcare and yet experience a greater risk of obesity. This emphasises the 
importance of providing accessible free treatment for this group. More recently (Jebb et al, 
2011) conducted a randomised controlled trial comparing primary care referral to a 
commercial provider for weight loss treatment with standard care.  
772 overweight or obese patients from Australia, Germany and UK were randomly assigned 
to either 12 months standard care as defined by the national treatment guidelines of each 
country or 12 months free membership to a commercial programme (Weight Watchers) and 
followed up for 12 months. 377 participants were assigned to the commercial group and 230 
(61%) completed the 12 month assessment. 395 participants were assigned to standard 
care and 214 (54%) completed the 12 month assessment. Mean weight change at 12 
months was -5.06kg for the commercial programme versus -2.25kg for those received with 
standard care. This study demonstrates that referral by a primary health care professional to 
a commercial weight loss programme which provides regular weighing, nutrition and 
exercise advise, motivation and group support can offer a clinically useful early intervention 
for weight management in overweight and obese people that can be delivered at large scale.  
The largest audit of NHS referral to a commercial weight loss programme in the UK was 
detailed in an observational study carried out by Ahern, Olston, Asten & Jebb (2011). This 
offered Weight Watchers (WW) on Prescription by the NHS. Data was obtained from the 
WW NHS Referral Scheme database for 29,326 referral courses started after 2nd April 2007 
and ending before 6th October 2009 [90% female; median age 49 years (IQR 38 - 61 years); 
median BMI 35.1 kg/m2 (IQR 31.8 - 39.5 kg/m2).  
Participants received vouchers (funded by the PCT following referral by a healthcare 
professional) to attend 12 WW meetings. Body weight was measured at WW meetings and 
relayed to the central database. Median weight change for all referrals was -2.8 kg [IQR -5.9 
- -0.7 kg] representing -3.1% initial weight. 33% of all courses resulted in loss of ≥5% initial 
Alison Sarah Moore (0818494) MSc Nutrition Science & Exercise Studies(XN7519) 8
th
 October 2012 
Page 17 of 86 
weight. 54% of courses were completed. Median weight change for those completing a first 
course was -5.4 kg [IQR -7.8 - -3.1 kg] or -5.6% of initial weight. 57% lost ≥5% initial weight. 
These results are comparable with those of the Ross, Laws, Reckless and Lean (2008) 
(25.3% of participants lost ≥5% at 3 months, 40.2% at 6 months and 33.7% at twelve 
months) and Slimming on Referral programme (completing a 12 week course lost 5.4 kg, 
with 57% losing ≥5% baseline weight).  
Twelve weeks is a relatively brief duration and data on longer term outcomes is necessary to 
assess whether this treatment has a significant impact on long term health. Repeat referrals 
comprised a quarter of the study group and although their weight diminished they did 
achieve additional weight loss therefore longer participation may improve weight loss. This 
will have increased intervention costs for the NHS and the long term impact of this scheme 
needs to be established. 
1.3 Role of Weight Management Programs in Weight 
Management 
There is evidence to support the use of weight loss programs as an effective method for 
weight management once the client remains active in the program.  
Heshka et al (2003)compared weight loss with self-help compared with a structured 
commercial program in a randomised trial in America. Waist circumference (P = .003) and 
body mass index (P<.001) decreased more in the commercial group. The results show that 
people offered two years free use of commercial weight management program achieved a 
mean weight loss of 2.0kg. Those two twenty minute consultations with a nutritionist and 
self-help resources achieved a mean weight loss of 0.2kg at the end of two years. It is 
relevant that participants who attended 78% or more of the commercial group sessions 
maintained a mean weight loss of 5kg at the end of the two year study. It is also important to 
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note that results were obtained in a regular commercial weight loss program and not in an 
academic or research environment.  
Rock et al (2010)found that mean weight loss  7.4kg for the centre based group (pre 
packaged food, planned menu and physical activity), 6.2kg for the telephone based group 
(one to one weight loss counselling) and 2.0kg for the usual care control group (two weight 
loss counselling sessions with a dietetics professional and monthly contacts) after two years. 
It must be noted that the cost of participation was free and individuals may be reluctant to 
pay under normal circumstances for the cost of meals, counselling sessions and telephone. 
In addition the study was unblinded and this may have influenced participant’s behaviour 
and effectiveness. This research demonstrates the dependent relationship between success 
(weight loss and maintenance) with telephone one to one counselling and regular face to 
face contact. This is difficult to incorporate into medical practice given the limitation on NHS 
resources (McTigue et al, 2003). 
The figures used in the previous two studies were calculated according to intention to treat, 
using baseline observation carried forward for missing data. Although the studies were 
conducted in America both are two years in duration. There is a paucity of similar type 
studies of this time scale in the UK. 
The only non-commercially funded UK study’s to examine the efficacy of commercial weight 
loss programs are Lighten Up (Jolly et al, 2010) and BBC Trials (Truby et al, 2006). 
Lighten Up is a randomised controlled trial comparing a range of 12-week commercial and 
NHS weight reduction programmes with a comparator group who are provided with 12 
vouchers enabling free entrance to a local leisure centre. The weight reduction programmes 
are:  
(i) Weight Watchers,  
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(ii) Slimming World,  
(iii) Rosemary Conley,  
(iv) A group-based dietetics-led programme (Size Down),  
(v) General practice one-to-one counselling,  
(vi) Pharmacy-led one-to-one counselling,  
(vii) Choice of any of the 6 programmes.  
People with obesity or overweight with a co-morbid disorder are invited to take part by a 
letter from their general practitioner. The sample size is 740 participants. 
The primary outcome was weight loss at three months and secondary outcomes were weight 
loss at one year, self-reported physical activity at 3 and 12 months follow-up and percentage 
weight-loss at 3 months and one year. All programmes achieved significant weight loss from 
baseline to programme end (range 1.37 kg (general practice) to 4.43kg (Weight Watchers), 
and all except general practice and pharmacy provision resulted in significant weight loss at 
one year. Commercial services achieved significantly greater weight loss. (mean difference 
2.3 (1.3 to 3.4) kg). 
The BBC trial was a six month randomised unblinded control trial. It compared the effects of 
four commercial weight loss diets available to adults in the UK. These comprised  
 Dr Atkins' new diet revolution,  
 Slim-Fast plan,  
 Weight Watchers pure points programme, and  
 Rosemary Conley's eat yourself slim diet and fitness plan.  
Behaviour modification, a feature of all these group programs, teaches participants to control 
their environment in relation to food. Body fat and weight were reduced in all participants by 
six months. Average weight loss was 5.9 kg and average fat loss was 4.4 kg over six 
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months. This trial demonstrates that adults who are motivated to follow commercial diets for 
six months can achieve weight loss and fat loss. This study recommends that given the 
limited resources for weight management in the NHS, healthcare practitioners should 
discuss with their patients programmes known to be effective.  
1.4 Clinically Significant Weight Loss - Reduction in Obesity Related 
Diseases 
The principles of weight management are primarily to achieve clinically significant weight 
loss and secondarily to maintain weight loss (Finer, 2001). For pharmacological interventions 
effectiveness for intentional weight loss is defined as >5% of initial weight in those with 
obesity related diseases and 10% for those without co morbidity (Committee for Proprietary 
Medicinal Products, 1997) and (Food and Drug Administration, 1997).  
While studies describing an intentional weight loss of 5% or 10% will be examined and 
shown to produce clinically significant benefits it may not redefine a person from an obese 
state to a non-obese state. It is important to distinguish between intentional and unintentional 
weight loss because the causes and consequences can differ significantly (Wing & Hill, 
2001). A relevant study (French, Jeffery, Folsom, Williamson & Byers, 1995) revealed that 
women who had intentionally lost > 20 lbs were more likely to report weight losses due to 
lower calorie diets, exercise and weight loss groups, while women who had unintentionally 
lost > 20 lbs were more likely to report losses due to depression or stress. The findings of 
this study promote further research into understanding why women lose weight and it is 
necessary to examine further the relationship between body weight changes and health 
outcomes. 
(Dansinger, Gleason, Griffith, Selker, Schaefer, 2005) demonstrate that weight loss through 
commercial diets can improve cardiac related risk factors at one year. 160 patients were 
randomly assigned to one of four popular diets: 
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 Atkins,  
 Ornish,  
 Weight Watchers and  
 Zone diets.  
Mean (SD) weight loss at 1 year was 2.1 (4.8) kg for Atkins (21 [53%] of 40 participants 
completed, P = .009), 3.2 (6.0) kg for Zone (26 [65%] of 40 completed, P = .002), 3.0 (4.9) 
kg for Weight Watchers (26 [65%] of 40 completed, P < .001), and 3.3 (7.3) kg for Ornish (20 
[50%] of 40 completed, P = .007). Each diet significantly reduced the low-density 
lipoprotein/high-density lipoprotein (HDL) cholesterol ratio by approximately 10% (all P<.05), 
with no significant effects on blood pressure or glucose at 1 year. For each diet, decreasing 
levels of total/HDL cholesterol, C-reactive protein, and insulin were significantly associated 
with weight loss (mean r = 0.36, 0.37, and 0.39, respectively) with no significant difference 
between diets (P = .48, P = .57, P = .31, respectively).  
The number of participants who did not complete the study at months 2, 6, and 12 were 34 
(21%), 61 (38%), and 67 (42%), respectively. At 1 year, there was a non-significant trend 
(P = .08) toward a difference in discontinuation rates between the more extreme diets (48% 
for Atkins and 50% for Ornish) and moderate diets (35% for Zone and 35% for Weight 
Watchers). Had the participants been able to select their diet choice the adherence rates 
may have been greater as selection choice may have better facilitated such aspects as their 
personality or lifestyle. Therefore it is important to note that this study only evaluated dietary 
components. It is reported that the high discontinuation rates for Atkins and Ornish suggest 
that these diets are possibly too extreme. Practical techniques are required to reduce low 
adherence rates and perhaps offer a wider range of options to facilitate all participants. Only 
25% of the initial participants sustained a 1-year weight loss of more than 5% of initial body 
weight and approximately 10% of participants lost more than 10% of body weight. It is 
apparent that these diets assessed under clinical conditions benefit the minority of 
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individuals who can sustain a high dietary adherence level. This study concludes that poor 
sustainability and adherence rates resulted in modest weight loss and cardiac risk factor 
reductions for each diet group. However cardiac risk factor reductions were associated with 
weight loss regardless of diet type implying that adherence level rather than diet type was 
the key determinant of clinical benefits. Further investigations of the potential health benefits 
of these diets would be appropriate by studying cardiovascular outcomes. 
Sacks et al (2009) demonstrated the clinically significant benefits of weight loss through diets 
and subsequent reduction in cholesterol levels and high blood pressure. They assigned 800 
participants to one of four diets;  
 20% fat, 15% protein, and 65% carbohydrates (low-fat, average-protein);  
 20% fat, 25% protein, and 55% carbohydrates (low-fat, high-protein);  
 40% fat, 15% protein, and 45% carbohydrates (high-fat, average-protein); and  
 40% fat, 25% protein, and 35% carbohydrates (high-fat, high-protein).  
All the diets reduced risk factors for cardiovascular disease and diabetes at 6 months and 2 
years. At 2 years, the two low-fat diets and the highest-carbohydrate diet decreased low-
density lipoprotein cholesterol levels more than did the high-fat diets or the lowest-
carbohydrate diet (low-fat vs. high-fat, 5% vs. 1% [P=0.001]; highest-carbohydrate vs. 
lowest-carbohydrate, 6% vs. 1% [P=0.01]). The lowest-carbohydrate diet increased HDL 
cholesterol levels more than the highest-carbohydrate diet (9% vs. 6%, P=0.02).  
All the diets decreased triglyceride levels similarly, by 12 to 17%. All the diets except the one 
with the highest carbohydrate content decreased fasting serum insulin levels by 6 to 12%; 
the decrease was larger with the high-protein diet than with the average-protein diet (10% 
vs. 4%, P=0.07). Blood pressure decreased from baseline by 1 to 2 mm Hg, with no 
significant differences among the groups (P>0.59 for all comparisons).  
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Most of the weight loss occurred in the first 6 months. Changes from baseline differed 
among the diet groups by less than 0.5 kg of body weight and 0.5 cm of waist circumference. 
A total of 185 of the participants (23%) continued to lose weight from 6 months to 2 years; 
the mean (±SD) additional weight loss was 3.6±3.5 kg, for a mean total loss from baseline of 
9.3±8.2 kg, with no significant differences among the diet groups. At 2 years, 31% to 37% of 
the participants had lost at least 5% of their initial body weight, 14% to 15% of the 
participants in each diet group had lost at least 10% of their initial weight, and 2% to 4% had 
lost 20 kg or more (P>0.20 for the comparisons between diets). After 12 months, all groups, 
on average, slowly regained body weight. 80% of participants completed the trial and 
attendance was strongly associated with weight loss (0.2kg per session attended). 
These two studies provide evidence of the clinically significant benefits of intentional weight 
loss on obesity related risk factors. Whilst these studies have demonstrated the clinically 
significant benefits of at least 5% weight loss it must be noted that it cannot automatically be 
assumed that weight gain <5% is not clinically significant. 
1.5 Weight Loss Maintenance 
Long term weight loss maintenance has been cited as an elusive goal (Wing & Phelan, 
2005). A study by (Ulen, Hulzinga, Beech & Elasy, 2008) demonstrated that a weight loss of 
8% - 10% by six months is regained. Whilst weight loss maintenance studies detail the 
prevalence of success or failure there is a lack of consistent criteria to define this (Stevens, 
Truesdale & McClain, 2006).  Expert committees have addressed the definition of weight 
loss maintenance following weight loss.  
The Institute of Medicine (IOM) define weight loss maintenance as losing at least 5%  of 
body weight or reducing BMI by at least one unit and keeping below this minimum for at 
least a year (Institute of Medicine, National Academy of Sciences, 1995).  
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By this definition there is no limit on the amount of weight that can be regained once net 
weight loss remains below the criterion. This definition assumes that the bounds around 
which weight maintenance is placed are known. However several different methods could be 
used to choose this body weight. For example in a clinical setting weight maintenance may 
refer to maintenance of a current weight or weight after weight loss. An observational study 
may define weight maintenance as staying within set bounds of the weight at the first 
examination or around the mean weight over all examinations. 
The National Heart Lung and Blood Institute (NHLBI) clinical guidelines define successful 
weight maintenance after weight loss as a weight regain of <3kg (6.6 pounds) in two years 
and a sustained reduction of in waist circumference of at least 4cm (National Heart Lung and 
Blood Institute, 1998). This definition does not consider intentional weight loss. Although any 
weight maintenance definition will be somewhat arbitrary it should be compatible with 
national and international expert committees current recommendations and permit study 
comparison. In addition an appropriate definition of weight maintenance should include 
designated body weight under standardised conditions and avoid the use body weight 
percentages. 
Although it has been demonstrated that participants of a structured weight loss program will 
regain all of their weight loss within 3- 5 years (Stunkard, McClaren-Hume, 1959), there is 
room for optimism. Two long term research studies, National Weight Control Registry 
(Graham, Bond, Hill & Wing, 2011) and Look AHEAD study (Wadden, 2006) and have 
demonstrated evidence to the contrary.  
The National Weight Control Registry (NWCR) is the largest prospective investigation of 
long-term successful weight loss maintenance. It tracks over 10,000 weight maintainers who 
are over 18 years old, have lost at least 30lb and have kept it off for a minimum of a year 
(Bond, Phelan, Hill, Wing 2009 & Thomas, Wing, 2009). In order to maintain weight loss, 
members report engaging in high levels of physical activity, eating a low-fat, low-calorie diet, 
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eating breakfast and self-monitoring weight. A key feature here is a consistent eating pattern 
across weekdays and weekends. Although participants self-report their current weight and 
height it is required that a physician verifies this to the registry. 
Similar results were demonstrated by (Wadden et al, 2009)in a four year analysis of The 
Look AHEAD (Action for Health in Diabetes) study. This is the first randomised controlled 
trial to assess whether intentional weight loss combined with increased physical activity 
reduces cardiovascular morbidity and mortality in overweight individuals with type 2 diabetes 
(Ryan, Espeland, Foster, 2003).  
The study began in 2001 and is scheduled to conclude in 2012. A total of 5145 participants 
have been randomly assigned to a usual care condition (Diabetes Support and Education) or 
to an intensive lifestyle intervention with a goal of inducing a loss of 7% of initial weight and 
increasing physical activity to 175 min/week. Participants regained approximately 25% of 
weight losses over year 1 and year 2 and 20% between year 2 and year 3 they regained 
only 8% of weight loss between year 3 and year 4. 
These studies demonstrate that weight regain may slow down over time (2-5 years). 
The NWCR have identified factors that could possibly predict successful weight loss 
maintainers. Findings demonstrate that individuals who kept their weight off for 2 years or 
more had a greater chance of similar outcome the following year.  
Look AHEAD (Wadden et al, 2011) found that the larger the participants’ weight loss the first 
year, the larger their loss at year 4. The odds of achieving a loss ≥ 10% of initial weight at 
year 4 were 9.8 (95% CI: 6.99–13.74) times greater for participants who lost ≥ 10% at year 1 
compared to participants who lost < 5% at year 1 and 2.0 (95% CI: 1.41–2.96) times greater 
for participants who had lost 5.0 to 9.9% at year 1 compared with those who lost < 5% at 
year 1. Similar analyses revealed that the odds of achieving a loss ≥ 5% at year 4 were 9.3 
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(95% CI: 7.27–11.83) times greater for participants who lost ≥ 10% at 1 year and 2.4 (95% 
CI: 1.88–3.04) times higher for individuals who lost 5.0–9.9%, compared to participants who 
lost < 5% the first year. 
This research demonstrates that with long-term participant support, weight loss achieved 
with a behavioural intervention is not invariably followed by a return to baseline weight. 
Patient support was provided in month 1-6 with three group meetings and one individual 
session. During months 7-12 group sessions were provided every other week with a monthly 
individual session.  
Sessions were led by intervention teams that included registered dieticians, behavioural 
psychologists and exercise specialists. Successful weight loss maintenance is achievable 
however this depends on the definition criteria utilised within the study. This is important 
because it has been revealed that the true goal for obesity is weight loss maintenance and 
this is more difficult to achieve than weight loss (Fletcher, 1992). Furthermore these studies 
demonstrate that long term success increases once a specific weight loss has been 
maintained for 2-5 years. (McGuire, Wing, Klem, Lang, Hill Jo, 1999) detail that weight loss 
for ≥2 years is protective again subsequent regain and that by two years the likelihood of 
regaining 2.6kg in the coming year is only 50% and by five years the likelihood drops to 
2.7%. 
As demonstrated there is research to support the use of weight management programmes 
as an effective solution for weight management in terms of health benefits and cost to both 
UK population and UK government. NICE clinical guideline CG43 and SIGN clinical 
guideline 115 both recommend the use of multi component weight management 
programmes comprising diet, physical activity and behaviour modification. Both guidelines 
detail that if this is adhered then weight loss maintenance will follow. There is little point 
investing in change if weight is regained and obesity resumes therefore weight loss 
maintenance is a vital to combat obesity. At present there is limited information on this 
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therefore the effectiveness of weight management programmes on weight maintenance 
cannot be assessed. This systematic review will aim to assist with bridging this current gap 
in the research within the UK. Can weight loss programs promote weight loss maintenance 
(follow up of 12 months to assess effectiveness of intervention on sustained weight loss)? 
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2 Methodology 
2.1 Research Questions 
What is the effect of UK based weight management programmes on weight loss 
maintenance (follow up of 12 months to assess effectiveness of intervention on weight loss) 
for adults? 
How do weight management programmes impact on adult weight loss maintenance of 
weight when focusing on diet, physical activity and behaviour modification? 
What are the effects of withdrawal/loss to follow up on a weight management programme? 
How does this impact on statistical analysis and subsequent outcome of weight loss 
maintenance?  
The research questions will be addressed by a systematic review of all literature pertaining 
to weight loss maintenance which is achieved through a  weight management programme 
once the following inclusion criteria is met.  
Weight loss maintenance is defined as follow up at 12 months to assess the impact of 
intervention on weight loss. 
2.2 Inclusion Criteria 
This criteria was developed to assist with identification of relevant studies to help with 
answering the research questions.  
2.2.1 Population 
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Study participants UK adults (>18 years) classified as overweight or obese with BMI of >25 
kg/m2 
2.2.2 Intervention 
Weight management programme comprising of a combination of diet, physical activity and 
behaviour change strategy to influence lifestyle.  
Programmes must include a follow up of at least 12 months in order to assess the impact of 
interventions on sustained weight loss.  
The programme is delivered by the health sector, in the community or commercially. 
2.2.3 Comparators 
Normal practice (as defined by the study) 
Single-component weight management strategies 
Other structured multi component weight management studies 
2.2.4 Outcomes 
Studies are required to include a measure of weight loss and weight loss maintenance. 
Other inclusion criteria: 
English language only 
UK primary research study or review based on UK population- no meta-analysis 
All of the initial relevance criteria have to be met to be included in the study. If any of these 
criteria failed then the study was excluded.  
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As stated above all studies must clearly specify the three components to ensure they were 
multicomponent and also to ensure that they were reproducible. The following criteria were 
reviewed in each study in respect of the three components to assess eligibility: 
2.3 Research Plan 
The research plan comprised of  
 Key word search 
 Searching key databases and journals 
 Study Types 
 Quality assessment 
 Data Management 
2.3.1 Key Word Search 
Phase 1 of the search strategy involved keyword searches were conducted in order to 
produce a manageable number of search results. 
The retrieval of causation studies cited in MEDLINE can be substantially enhanced by 
selected combinations of indexing terms and text words (Wilczynski Haynes, 2003). This 
study found that combinations of terms reached peak sensitivity of 93%. Compared with the 
best single term, multiple terms increased sensitivity for sound studies by 15.5% (absolute 
increase), but with some loss of specificity when sensitivity was maximised. Combining 
terms to optimise sensitivity and specificity achieved sensitivities and specificities both above 
80%. They recommended using alternative word and terms to broaden the search. 
The medical subject heading (MeSH) subject headings include “obesity”, “weight gain”, 
“weight loss”, and “weight loss programs” (United States National Library of Medicine, 2012). 
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The keywords that were used alone or in combination are detailed in table 2.0. The search 
protocol is aimed at increasing the specificity as the process continues. 
Table 2.0. Search Terms and Synonyms 
 Key Word Synonyms 
Population Under Study Adults Age over 18 years 
Outcome of Interest Weight Loss Maintenance Weight gain/regain, obesity, 
reducing weight, overweight, 
weight loss, weight 
management, body fat, BMI 
Potential Source of 
Influence 
Weight Management 
Program 
Weight reduction program, 
diet, exercise, plan 
These keywords were then combined using Boolean search operators in order to obtain 
maximal search capacity. It allows the combination of words and phrases into a search 
statement to retrieve documents from databases. It consists of three logical operators, ‘OR’, 
‘AND’, ‘NOT’. For example within the context of this review is “weight loss maintenance AND 
diet”, “weight loss program AND weight regain”. 
The first search comprised the population under study (and/or synonyms) ‘Adults’ and the 
outcome of interest ‘weight loss maintenance’. 
This search yielded in excess of 300 articles therefore the search was refined further. 
The second search comprised the key words ‘adults’ AND ‘weight loss programme’ This 
search still yielded more than 300 articles and so the search was again refined  The third 
search used a search phrase directly related to the question i.e. ‘weight loss programme 
related to weight loss maintenance in adults’  
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2.4 Searching Key Databases and Journals 
The key databases which were reviewed included: 
 PUBMED 
 PsycInfo 
 CINAHL 
 The Cochrane Database of Systematic Reviews 
 The Cochrane Central Register of Controlled Trials (CENTRAL) 
The journals which were reviewed included: 
 Obesity management 
 Obesity research 
 The International Journal of Obesity 
 Medicine and Science in sport and exercise 
 Preventative medicine 
 Research quarterly for exercise and sport 
 British Medical Journal 
 The Lancet 
 Nutrition Journal 
 British Journal of Nutrition 
 European Journal of Clinical Nutrition 
Phase two of the search strategy involved a more detailed search on the reference lists from 
the original research papers. The bibliographies of the retrieved articles were reviewed. 
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Grey literature was sought by to obtain unpublished studies and ongoing trials by searching 
UK Clinical Research Network Portfolio controlled trials multiple register. None were found. 
The search includes: 
 International Standard Randomised Controlled Trial Number Register,  
 National Institutes of Health,  
 ClinicalTrials.gov,  
 Action Medical Research,  
 Medical Research Council,  
 NHS Health Technology Assessment,  
 Wellcome Trust,  
 UK Clinical Trials Gateway);  
 World Health Organisation,  
 International Clinical Trials Registry Platform,  
 GSK Clinical Trial Register. 
2.5 Quality Assessment 
All studies which met the inclusion criteria were subjected to a process of quality 
assessment. (Downs & Black, 1998) checklist is used to assess the methodological quality 
of randomised and non-randomised trials of health care intervention. The “Checklist for 
Measuring Quality” (Downs & Black, 1998) addresses the increasing demand for the use of 
evidence from systematic reviews and meta-analyses to support program and policy 
decisions in public health decision-making.  
This tool can be used to assess the quality of original or primary source research articles 
and to synthesise evidence from quantitative studies for public health practitioners, policy 
makers and decision-makers. The tool provides both an overall score for study quality and a 
numeric score out of a possible 28 points. The five sections include questions about:  
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 Study quality (10 items) – the overall quality of the study;  
 External validity (3 items) – the ability to generalize findings of the study;  
 Study bias (7 items) – to assess bias in the intervention and outcome measure(s);  
 Confounding and selection bias (6 items) – to determine bias from sampling or group 
assignment; and  
 Power of the study (1 items) – to determine if findings are due to chance. 
Administration of the tool can happen either within a systematic review process, or as 
a quality assessment tool for individual articles.  
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2.6 Data Management 
Data from each article was accurately recorded in a tabulated summary in Appendix 1. The 
information recorded is relevant to answering the research questions and enables 
consistency of comparability across the selected studies. 
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3 Results 
Seven studies met the inclusion criteria and these comprised three RCT’s, two cluster 
RCT’S, one pilot and one cohort (audit) study. Quality assessment was conducted using 
Downs & Black check list as described in the methodology section. A maximum score of 28 
can be obtained on this checklist. One point is attributed to 27 questions with two points for 
question five. The list was adapted for the audit and pilot study and questions 21-24 were 
omitted. This table is detailed in Appendix 2. 
The highest score of 93% was achieved by three studies. Jolly et al (2011) and Nanchahal et 
al (2012) achieved zero score for questions 14 and 24. Neither study made an attempt to 
blind study subjects to the intervention which they received (question 14). Concealment of 
the randomised intervention assignment from participants and health care staff until 
recruitment was complete and irrevocable was not done. Moore et al (2003) scored zero for 
questions 9 and 25. Loss to follow up was not described (question 9) and there was not 
adequate adjustment for confounding in the analyses from which the main findings were 
drawn (question 25). Davies et al (2007) scored 89%. Zero points were attributed to question 
14, 15 and 24. No attempt was made to blind those measuring the main outcomes of the 
intervention (question 15). Relton, Strong and Li (2011) scored 86% and achieved zero 
score for questions 10, 25, 27. Actual probability values were not reported (question 10) and 
the study did not detail the statistical power used (question 27). Ross, Laws, Reckless and 
Lean (2008) was scored 77%. Zero score was attributed to questions 9, 10, 25 and 27. A 
score of 75% was achieved by McConnon et al. Zero score was attributed to questions 8, 
10, 14, 15, 17, 24 and 25. All important adverse events that may be a consequence of the 
intervention were not reported (question 8) and it is unclear whether analysis adjusted for 
different lengths of follow up (question 17).  
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What is the effect of UK based weight management programmes on weight loss 
maintenance (follow up of 12 months to assess effectiveness of intervention on 
weight loss) for adults? 
Seven studies assess the impact of weight management programmes for a twelve month 
period. The key parameters of these studies are displayed in table 3 and table 4. 
Alison Sarah Moore (0818494) MSc Nutrition Science & Exercise Studies(XN7519) 8
th
 October 2012 
Page 38 of 86 
Table 3: Summary of results relating to research question 1(Mean Weight Change & Weight Loss) 
Study Quality 
Score 
Study 
Type 
Population Inclusion & Exclusion Criteria Mean Baseline 
Weight (kg) & 
BMI(kg/m²) 
Mean Weight (kg) & 
BMI(kg/m²) change 
from Baseline to 12 
months 
Difference 
Between 
Baseline & 12 
Months(P<0.05) 
Between Groups 
(Intervention & 
Control) 
Moore et al 
(2003) 
26(93%) Cluster 
RCT 
44 general 
practices/8
43 patients 
Inclusion 
Patient body mass index ≥ 30 kg/m
2 
Patient aged 16 to 64 years to 
Exclusion 
Staff were excluded in they worked 
in primary care but between 
practices. 
No patient exclusion criteria 
detailed 
 
Weight 
Intervention=100.8 
Control=100.2 
BMI 
Intervention = 37.0 
Control = 36.9 
Weight  
Intervention= -0.5 
Control=-0.9 
BMI 
Intervention=-0.1 
Control = -0.1 
Weight 
P=0.7 
BMI = 0.96 
McConnon 
et al (2006) 
21(75%) RCT 221 
participants 
Inclusion 
BMI >30 kg/m2 
18–65 years of age (due to body 
composition changes 
over the age of 65 years) 
Able to access the Internet at least 
once per week 
Able to read and write in English 
(for the purposesof accessing the 
site and completing questionnaires) 
Exclusion 
Pregnant or lactating women 
Women planning on becoming 
pregnant within the 
next year.Any illness or reason 
where the GP feels that the patient 
should not be taking part in a 
clinical trial. 
 
Weight 
Intervention=98.9 
Control=97.9 
BMI 
Intervention =34.5 
Control = 34.4 
Weight 
Intervention=-1.3 
Control=-1.9 
 
Weight 
 P=0.56 
BMI  
P=0.3 
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Study 
Quality 
Score 
Study 
Type 
Population Inclusion & Exclusion Criteria Mean Baseline 
Weight (kg) & 
BMI(kg/m²) 
Mean Weight (kg) & 
BMI(kg/m²) change 
from Baseline to 12 
months 
Difference 
Between 
Baseline & 12 
Months(P<0.05) 
Between Groups 
(Intervention & 
Control) 
Nanchahal 
et al (2012) 
26(93%) RCT 381 
participants 
Inclusion 
> 18 years of age  
BMI > 25kg/m² 
Attending a participating practice 
Willing to attend visits with a 
CAMWEL advisor for 12 months 
Exclusion 
Pregnancy or lactation 
Diagnosis of renal failure 
Use of a pacemaker 
Recent cancer diagnosis 
Participation in another weight 
management study 
Weight 
Intervention=93.7 
Control=90.95 
BMI 
Intervention =33.92 
Control = 33.02 
Weight 
Intervention = -2.39 
Control= -1.3 
BMI 
Not provided 
Weight  
P=0.35 
Jolly et al 
(2011) 
26(93%)  RCT 740 
participants 
Inclusion 
White Europeans and all ethnic 
groups apart from South Asians 
with no comorbidities: BMI ≥30 
White Europeans and all ethnic 
groups apart from South Asians 
with comorbidities: BMI ≥28 
South Asians with no comorbidities: 
BMI ≥25 
South Asians with comorbidities 
GP had to confirm that the patient 
had no medical contraindications 
for any of the intervention 
programmes before a letter of 
invitation was sent. 
Exclusion 
Unable to understand English or 
were pregnant 
Weight 
Intervention=93.41 
Control=93.14 
BMI 
Intervention =33.55 
Control = 33.88 
Weight 
Intervention= -2.08 
Control= - 1.08 
BMI 
Intervention = -0.69 
Control = -0.45  
Weight 
P = 0.69 
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Study Quality 
Score 
Study 
Type 
Population Inclusion & Exclusion Criteria Mean Baseline 
Weight (kg) & 
BMI(kg/m²) 
Mean Weight (kg) & 
BMI(kg/m²) change 
from Baseline to 12 
months 
Difference 
Between 
Baseline & 12 
Months(P<0.05) 
Between Groups 
(Intervention & 
Control) 
Davies et al 
(2007) 
25 
(89%) 
Cluster 
RCT 
207 general 
practices/824 
adults 
Inclusion 
Referral to study within 4 weeks of 
type 2 diagnosis & programme 
participation within 12 weeks. 
Exclusion 
None listed 
Weight 
Intervention=91.8 
Control=91.6 
BMI 
Intervention = 
32.3 
Control = 32.4 
Weight 
Intervention= -2.98 
Control= -1.86 
BMI 
Not provided  
Weight  
P = 0.027 
BMI  
Not provided 
Ross, Laws, 
Reckless & 
Lean (2008) 
17 
(77%) 
Cohort 
Study 
65 general 
practices, 
1906 patients 
Inclusion 
body mass index (BMI) ≥30 kg/m2 
or ≥28 kg/m2 with obesity-related 
comorbidities 
Exclusion 
None detailed 
Weight  
Not provided 
BMI 
All participants 
37.1. 
Weight 
Change = -2.96 
BMI 
Change = -1.08 
No control group  
39.9% of 
‘completers’ 
achieved >5% 
weight loss at 12 
months  
Relton, 
Strong & Li 
(2011) 
19 
(86%) 
Pilot 402 
participants 
Inclusion 
>BMI .22.5 kg/m
2 
Lived in NHS Eastern and Coastal 
Kent area.Obtained consent from 
GP if <21 or > 65 years, breast 
feeding a baby > 6 weeks 
old,chronic medical condition 
thatrequired regular medical 
checks, were taking prescription 
medication, or had been advised to 
eat a special diet to treat 
a medical condition. 
Exclusion 
Breast feeding a baby >6weeks old 
Weight 
101.8 
BMI 
34.6 
Weight 
Change = -4.0 
BMI 
Not provided 
No control group 
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Table 4 Summary of Results Relating to Research Question 1 (Intervention Type) 
Study Quality 
Score 
Study Type Intervention Usual Care Intervention 
Duration 
Follow Up 
Moore et al 
(2003) 
26(93%) Cluster RCT 4.5 hour training programme (3 training 
sessions) for general practitioners and practice 
nurses promoting an obesity management 
model (clinical benefit of weight loss & 
effective treatment options i.e. diet, exercise, 
behaviour change). 
Practitioners saw patients every two weeks 
until 10% weight loss and then every 1-2 
months thereafter for weight maintenance. 
Routine clinical practice 18 months 3, 12,18 
months 
 
McConnon 
et al (2006) 
21(75%) RCT Intervention website set up providing advice, 
tools & information (weight loss, exercise, 
behaviour change). 
Participants were given demonstration & 
username & password. 
Participants managed own care & asked to log 
on once a week during the trial. 
Participants were provided with personalised 
advice & motivational statements were 
generated based on self-reported progress. 
Generic emails were sent if participants did not 
visit site regularly. 
Advised to continue with usual 
approach to weight 
Given written information at 
baseline outlining information 
available within primary care. 
12 months 6, 12 
months 
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Study Quality 
Score 
Study Type Intervention Usual Care Intervention 
Duration 
Follow Up 
Nanchahal 
et al (2012) 
26(93%) RCT Structured one to one programme session 
(30mins) delivered over 14 visits by trained 
advisors. 
Participants attended sessions every fortnight 
for first 12 weeks, every 3 weeks for 12 weeks 
& monthly for next 12 weeks.  
Participants were given pedometers & hand 
outs associated with each session. 
General practitioners received NICE clinical 
guidelines on obesity 
Participants were asked to 
contact their GP to receive usual 
weight management care which 
could include referral to dietician, 
exercise on referral, ‘shape up’ 
programme, prescription of weight 
loss medication, weight loss 
surgery or no further treatment. 
General practitioners received 
NICE clinical guidelines on 
obesity 
9 months 6, 12 
months 
 
Jolly et al 
(2011) 
26(93%)  RCT Commercial Operators (weight watchers, 
slimming world, rosemary conley)-vouchers for 
12 consecutive weeks. 
Size Down Programme (NHS based 
programme led by food advisors & trained by 
dietetics department)-six sessions. Weigh in 
sessions at 9 & 12 weeks. 
General Practice/Pharmacy-12 one to one 
sessions 
Sent vouchers for 12 free 
sessions at local leisure centre. 
No appointments were made or 
advice or support given. 
3 months 3 months 
12 months 
Davies et al 
(2007) 
25(89% Cluster RCT Structured group education programme for 6 
hours delivered by 2 healthcare professional 
educators 
“Enhanced standard care” 
Control practices were provided 
with same contact time with 
healthcare professionals as 
intervention practices. 
Allowed to use these resources 
as they saw fit within their usual 
care routine. 
12 months 4,8,12 
months 
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Study Quality 
Score 
Study Type Intervention Usual Care Intervention 
Duration 
Follow Up 
Ross, Laws, 
Reckless & 
Lean (2008) 
16(73%) Cohort Study Counterweight Programme - 4 phases: 
1)Practice audit & needs assessment, 
2)practice support & training,  
3)practice nurse led intervention, 
4)evaluation 
Practice Intervention 
1 hour training for GP’s and 8 hour training for 
PN’s including review of Counterweight 
screening & treatment pathways, importance 
of raising the issue of weight with patients & 
review of benefits of 5-10% weight loss. 
Peer support to GP’s & PN’s until competency 
was achieved – usually took 6 months. 
Patient Intervention 
Individuals contemplating change or taking 
action were offered the Counterweight 
Programme.9 appointments in 12 months after 
initial screening i.e. 6 individual 
appointments(10-30 mins each) or 6 group 
sessions(1 hour each) over 3 months. 
Not Applicable 
 
24 months 6,9,12,24 
months 
Relton, 
Strong & Li 
2011 
18(82%) Pilot Plans ranged from 15lb(6.8kg) weight loss 
over 3 months to 50lb(22.7kg) weight loss over 
7 months. 
Max plan length was 13 months. 
Rewards ranged £70 to £425 per annum. 
P4P (pound for pound) credited participants 
monthly for cumulative weight loss up at a max 
target weight loss rate of 7.1lb (3.2kg) per 
month & for weight loss maintenance. 
Accumulated financial rewards plus 50% 
bonus of total max reward were given if final 
target weight loss at plan completion was 
achieved 
Not applicable Dependent 
on individual 
plan 
duration. 
Monthly 
until plan 
completion 
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All studies reported weight loss from baseline to 12 months for intervention group 
however only Davies et al reported a significant difference between groups. Whilst all 
studies incorporated weight management intervention with a combination of diet, physical 
activity and behavior change strategy to influence lifestyle as recommended by NICE and 
SIGN obesity guidelines the application varied greatly and the intervention type varied 
considerably.  
McConnon et al (2006) reported a mean weight loss of 1.9kg in the usual care group and 
a weight loss of 1.3kg in the intervention group. There was no significant difference 
between the intervention and control group weight loss from baseline to 12 Months 
(P=0.56). This study also reported that 22% of internet responders lost 5% or more of the 
baseline weight at 12 months with 18% of the usual care group losing “at least this 
amount”. It was not possible to calculate the latter figure as not enough information was 
provided in the study. Similarly Moore et al (2003) reported no significant difference in 
weight change (P=0.7) or BMI (0.96) at 12 months between groups after the intervention. 
Although the patients in the intervention group were 1kg heavier than control group at 12 
months there was no significant difference (P=0.5)  
Nanchalal et al (2012) reported that a higher proportion of the intervention group (32.7%) 
than the control group (20.4%) lost 5% or more of their baseline weight (P=0.04). In 
contrast Davies et al (2007) reported that although both groups lost weight at 12 months 
the intervention group showed a greater weight loss : -2.98kg compared with 1.86kg 
which resulted in a significant difference P=0.027 after adjusting for baseline and cluster 
effect. The modest (1.1kg) but statistically significant difference in weight loss was 
sustained to 12 months. 
Although there was no significant difference between the comparator group and the 
intervention groups (P = 0.69) at 12 months by Jolly et al it should be noted that all 
programmes except general practice and pharmacy provision resulted in significant 
weight loss at 12 months when comparing each group individually. For example there 
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was a significant difference (P=0.024) for Weight Watcher participants between baseline 
and 12 months. This study also reported that 22.4% of the intervention group and 17% of 
the comparator group achieved 5% loss in body weight at one year. 
The anticipated outcome focus by Ross, Laws, Reckless and Lean (2008) was a clinically 
meaningful weight loss of 5% or more up to 12 months. The results indicate that 
‘completers’ achieved successful weight loss with 39.9% achieving a weight loss of 5% or 
more at 12 months. The mean weight change for completers at 12 months was -4.5kg. 
Relton, Strong and Li (2011) also reported that those who remained active in the 
programme had lost significantly more weight than those who were inactive and who had 
failed to complete their plan. The overall mean weight loss for all participants was 6.4kg 
at 12 months. The estimated 12 month mean weight loss for all participants in the 
programme is 4.0kg under an assumption of return to baseline weight for those who do 
not report 12 month weights. They also reported that 69.2% of those who were active in 
the programme (25%) achieved weight loss >5%. 
How do weight management programmes impact on weight loss 
maintenance ((follow up of 12 months to assess effectiveness of 
intervention on weight loss)) focusing on effect on diet, physical activity 
and behaviour modification?  
Four studies out of seven reported on the impact of a weight loss programme in terms of at 
least one of the following; diet, physical activity or behaviour modification  at 12 months. The 
key parameters of these studies are displayed in table 5 
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Table 5: Summary of results relating to research question 2  
Study Quality 
Score 
Study Type Population Diet at 12 
Months 
Between 
Groups 
(P<0.05) 
Physical Activity 
at 12 Months 
Between Groups 
(P<0.05) 
Behaviour 
Modification 
at 12 Months 
Between 
Groups 
(P<0.05) 
McConnon et al 
(2006) 
21(75%) RCT 221 
participants 
P>0.05 P=0.6 No Data 
Nanchahal et al 
(2012) 
26(93%) RCT 381 
participants 
P=0.036 P=0.206 P=0.093 
Jolly et al (2011) 26(93%)  RCT 740 
participants 
No Data P=0.097 No data 
Davies et al 
(2007) 
25(89% Cluster RCT 207 general 
practices/ 824 
adults 
No Data P=0.81 No Data 
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The studies detailed in table 5 assessed one of the following elements of the weight 
management programme; diet, physical activity, behaviour modification. All results are self 
reported and assessment was by questionnaire. 
Two studies reported on dietary change between baseline and 12 months between groups. 
Nanchahal (2012) reported on changes in eating and activity habits by participants who lost 
5% or more of baseline weight compared with those who did not. Participants who lost 5% or 
more of baseline weight were more likely to state that they had reduced portion sizes and fat 
and sugar intake than those who did not (P=0.036). McConnon et al (2007) reported in text 
that there was no significant difference between groups at 12 months but did provide a ‘P’ 
value for this. 
All four studies reported on changes in physical activity from baseline to 12 months and no 
significant differences were reported between the groups. McConnon et al reported ‘a 
significant reduction in self-rated physical activity score over the intervention period (P=0.6) 
with a mean reduction of 0.34 in the sample’. Nanchahal reported no evidence of increasing 
physical activity levels between the groups (P=0.206). Jolly et al (2011) detail that self 
reported physical activity increased between baseline (mean=560 kcals/week) and follow up 
(mean=1552kcals/week) at 12 months in all groups. At one year follow up the mean physical 
activity reported by the intervention groups was 1502kcals/week compared with 
1899kcals/week for the comparator group however there was no significant difference 
(P=0.97). There was a significant difference (P<0.001) in physical activity (kcals/week) from 
baseline to one year for each group when compared individually. Similarly Davies et al 
(2007) used a continuous scale to measure physical activity. at baseline, four, eight and 12 
months. The participants in the intervention group showed a greater increase in physical 
activity at 12 months (P=0.81). 
One study reported on behavior modification. Nanchahal et al (2012) stated that there was 
no significant difference between groups at 12 months (P=0.093).  
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What is the effect of withdrawal/loss to follow up within a weight management 
programme on weight loss maintenance (follow up of 12 months in order to 
assess the impact of interventions on weight loss)? How is this dealt with in 
the statistical analysis and subsequent outcome? 
Six studies have statistically assessed the effect of participant withdrawal from the weight 
management programme and subsequent loss to follow up. The key parameters of these 
studies are detailed in table 6 and table 7. 
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Table 6: Summary of results relating to research question 3 (Basis of Statistical Analysis) 
Study Checklist 
Score 
Study 
Type 
Population Baseline 
Sample Size 
Intention to 
Treat (ITT) 
Baseline 
Observation 
Carried 
Forward(BOCF) 
Weight Loss at 
12 months(kg) 
Last 
Observation 
Carried 
Forward(LOCF) 
Weight Loss at 
12 months(kg) 
Adjustment 
Moore et al 
(2003) 
26(93%) Cluster 
RCT 
44 general 
practices/843 
adults 
660 adults (22 
practices 
recruiting 30 
patients each) 
Where 
Possible 
No No Withdrawl & loss to follow 
up Cluster & within cluster 
variation 
McConnon et 
al (2006) 
21(75%) RCT 221 adults 180 adults Unclear Yes –  reported 
but  no group 
data provided 
Yes -  reported 
but no group 
data provided 
Loss to Follow Up 
Loss to follup up & missing 
data 
Nanchahal et 
al (2012) 
26(93% RCT 381 adults 228 adults Yes No No Loss to Follow Up 
Missing data (Multiple 
Imputation) 
Jolly et al 
(2011) 
26(93%)  RCT 740 adults 70 adults per 
group(8 groups). 
Yes Intervention 
1.94kg 
Control 1.08kg 
Intervention 
2.83kg 
Control 1.33 
Cluster & Within Cluster 
Variation 
Loss to Follow Up & 
Missing Data 
Davies et al 
(2007) 
25(89% Cluster 
RCT 
207 general 
practices/824 
adults 
630 adult (315 
per study arm) 
Yes No No Failure to Consent & Drop 
Out Rate 
Cluster Effect 
Relton, Strong 
& Li 2011 
18(82%) Pilot 402 adults Not Provided Yes No No Adjust baseline co-variates 
Loss to follow up/Missing 
Data 
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Table 7 Summary of Results Relating to Research Question 3 (Loss to Follow Up):   
Study Assumed Loss to 
Follow Up at 12 
Months 
Actual Loss To Follow 
Up at 12 Months 
Power 
Calculation 
Basis of Calculation Mean Difference 
Detection Required at 
12 Months 
Moore et al 
(2003) 
15% Intervention 33% 
Control 33% 
80% Clinical significance of >5% or 3-5kg 
weight loss 
3-5kg 
McConnon et 
al (2006) 
22% Intervention 51% 
Control 30% 
80% Detection of 5 kg weight loss 
(approximately 5% of body weight) or 
less than 2.5 kg/m2 in BMI 
Not provided 
Nanchahal et al 
(2012) 
40% Intervention 56% 
Control 40% 
90% Clinical significance of >5%-10% weight 
loss, an average of >7%- 
6.9kg weight loss 
Jolly et al 
(2011) 
20% Intervention 39% 
Control 28% 
90% Clinical significance of >5%-10% weight 
loss 
2kg 
Davies et al 
(2007) 
20% Intervention=8% 
Control = 11% 
Not Provided Clinical significance of >5% weight loss Not Provided 
Relton, Strong 
& Li 2011 
Not provided 38% N/A Proportion of weight loss >5% or >10%. Not Provided 
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The clinical significance of >5% weight loss has been reported in five studies (table 6(b)) which 
have been incorporated into statistical analysis. In addition three studies also specified a mean 
weight difference detection required at 12 months. Moore et al (2003) required >5% weight loss 
or 3-5kg weight loss. The study design incorporated 80% power to detect a mean difference in 
weight between treatment arms of approximately 3-5kg, assuming 5% significance and a within 
practice correlation coefficient of 0.05. Nanchahal et al (2012) required a detection of 6.9kg 
mean weight difference at 12 months between the two groups with two sided statistical 
significance of 1%, power at 90% and the correlation coefficient between baseline and follow up 
values set at 0.7. Jolly et al (2011) reported that in order to detect a 2kg difference at 90% 
power and 5% significance and assumed 20% loss to follow up therefore 100 adults per group 
were recruited with an estimated 70 adults required to participate 
Assumed and actual loss to follow up (LTFU) varied considerably. Moore et al (2003) made an 
allowance of 15% which required approximately 660 patients (22 practices, 30 patients each). 
Actual LTFU up was 33% for each group. Nanchahal assumed LTFU up at 12 months of 40% 
and it was estimated that 380 participants were required. Actual LTFU was 56% for the 
intervention group and 40% for the control group. Jolly et al (2011) assumed LTFU of 20% and 
actual LTFU was 39% for intervention group and 28% for control group. In contrast Davies et al 
assumed drop out rate of 20% was greater than actual loss to follow up i.e. did not attend the 
practice (intervention=8% and control = 11%). The total number of adults recruited was 1000 in 
order to secure a necessary 630 participants (315 per arm)  
Two studies calculated last observation carried forward (LOCF) and baseline observation 
carried forward (BOCF). McConnon et al (2006) investigated differences between the groups 
using covariance analysis (ANCOVA) on weight at 12 months. This adjusted for any imbalance 
in age, sex, baseline weight introduced by losses to follow up. Primary analysis was conducted 
on all available data. Both groups lost a significant amount of weight over time, but the 
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difference in change between the groups at 12 months was non-significant (P=0.56). ANCOVA 
using weight at 12 months as the dependent variable, adjusting for age, sex, baseline weight, 
baseline physical activity score and baseline confidence score revealed that the Internet group 
were 0.6 kg heavier (95% CI: -1.4 to 2.5, p = 0.56) than the usual care group after 12 months 
(Figure 2). Similar results were produced from BOCF data (Internet group 0.8 kg heavier (95% 
CI: -0.4 to 1.9, p = 0.2)) and LOCF data (Internet group 0.5 kg heavier (95% CI: -0.8 to 1.8, p = 
0.4)). 
Jolly et al (2011) analysed BOCF in the primary analysis and LOCF data was analysed in a 
sensitivity analysis. The intervention group lost 1kg more than the general practice participants 
at 12 months however there was no significant difference (P=0.69). When BOCF, the general 
practice participants still had the lowest weight loss from baseline (1.08kg (95% confidence 
interval 0.1 to 2.1) kg) compared with the intervention at 1.94kg. LOCF demonstrated 1.18kg 
greater weight loss at 12 months for the intervention group when compared with the control 
group..  
Five studies conducted statistical analysis on an intention to treat basis with Moore et al (2003) 
applying this ‘where possible’. Five studies adjusted for loss to follow up and subsequent 
missing data. Davies et al adjusted for failure to consent and drop out rate.  Relton, Strong and 
Li (2011) adjusted for baseline co-variates. This study based statistical analysis on two 
assumptions. Twelve month weight data were not available for 262 of the 301 participants who 
were inactive at 12 months (33 plan completers and 229 who had failed to complete their plan). 
Firstly, it was assumed that the self-reported 12 month weights for the 39 randomly selected 
inactive participants were representative of all participants who were inactive at 12 months, 
therefore the estimate of the mean weight loss at 12 months for all participants in the P4P 
programme is 5.0 kg (95% CI: 3.4–6.6 kg). Secondly, it was assumed that those who failed to 
complete their plan returned to their baseline weight at 12 months, then the estimated overall 
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mean weight loss for all participants in the programme is 4.0 kg (95% CI: 2.4–5.6 kg). Mean 
weight loss of participants active at 12 months were calculated and compared with those who 
were inactive. Logistic regression was used to adjust for baseline covariates (age, sex, baseline 
BMI, target weight loss).  
Two cluster RCT’s made an adjustment to account for cluster and within cluster variation. 
Davies et al (2007) used ‘robust generalised estimating equations with exchangeable correlation 
structure’.Moore et al (2003) analysed change in both continuous and categorical outcome 
variables by using STATA. 
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4 Discussion 
What is the effect of UK based weight management programmes on weight 
loss maintenance (follow up of 12 months in order to assess the impact of 
interventions on weight loss) for adults? 
Seven studies in this systematic review examined weight loss in adults as a result of a weight 
management programme with a follow up of 12 months based in the UK.  
One of the studies (Davies et al, 2007) reported a significant difference (P=0.027) in weight loss 
between intervention (2.98kg) and control (1.86kg) group at 12 month follow up. Four studies 
(two RCT’s and two cluster RCT’s) reported weight loss at 12 months with no significant 
difference between control and intervention group. One pilot study (Ross, Laws, Reckless & 
Lean (2008) and one audit (Relton, Strong & Li 2011) both reported weight loss at 12 months as 
result of an intervention. Although no significant difference was reported in the RCT’s this does 
not mean that the intervention was completely ineffective. For example, the significant 
difference reported by Davies et al translates to intervention group weight loss of 1.1kg greater 
than control group at 12 month follow up. Jolly et al reported 1kg weight loss at 12 months but 
no significance difference. It raises several questions. For example, did the control group 
receive any intervention? What did the intervention group receive? What was the duration 
between intervention end and follow up measurements? What were the attrition rates? How was 
the outcome measured? 
The Cochrane Handbook for Systematic Reviews of Interventions (Higgins & Green, 2011) 
detail that a control group may receive placebo, no treatment, standard treatment or an active 
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intervention such as standard drug. If studies are testing for similar outcome but used different 
control interventions then this should be considered when reviewing and comparing studies.  
Of the two cluster RCT’s Moore et al (2003) reported the least amount of weight loss of 0.9kg at 
12 months in the control group which compares less favorably with Davies et al (2007) who 
reported weight loss of 1.86kg. The control group in Moore et al (2003) study participated in 
‘routine clinical practice’ and no further information was detailed within the study. It is relevant to 
note that Davies et al (2007) control group received ‘enhanced standard care’. This group was 
provided with the same contact time with healthcare professionals as the intervention group. 
They were allowed to use these resources as they saw fit within usual care. In addition one 
inclusion criteria that all participants had to meet was referral to the study within four weeks of 
being diagnosed with type 2 diabetes. This may have provided motivation for all participants 
therefore contributing towards weight loss in both groups at 12 months when compared with 
baseline.  
Of the three randomised controlled trials McConnon et al (2006) reported the greatest control 
group mean weight loss at 12 months of 1.9kg. Participants in this group were advised to 
continue with usual approach to weight loss and provided with information at baseline outlining 
information available in primary care. The quality score was 75% for this study which was lower 
than the other two RCT’s at 93%. This report stated that analysis was based on ‘all available 
data’. However it is not clear whether participants who did not start the analysis were excluded 
from the intervention. Full application of intention to treat (ITT) is only possible when complete 
outcome data are available for all randomised subjects. ITT is inadequately described and 
applied in this study. Clinical effectiveness may be overestimated if ITT is not done (Bollini, 
Pampallona, Tibaldi, Kupelnick & Munizza, 1990). Nanchahal (2012) reported weight loss of 
1.3kg at 12 months. These participants were asked to contact their GP to receive usual weight 
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management care. This could include referral to a dietitian, exercise on referral, ‘shape up’ 
programme, prescription of weight loss medication, weight loss surgery or no other treatment. 
This treatment offered more than that provided to the control group by Jolly et al (2011) who lost 
less weight at 1.08kg at 12 months. They were sent vouchers for 12 free sessions at a local 
sports centre. Participants were not given an appointment to attend and were given no 
individual advice or support on diet or exercise. All control groups lost weight at 12 months 
when compared with baseline. These results suggest that the intervention received may have 
contributed towards this. Also it is worth considering that having agreed to participate in a 
weight management trial could perhaps suggest motivation towards achieving weight loss.  
Each study employed a different intervention and reported a range of mean weight losses at 12 
months. For example, Jolly et al (2011) reported the most weight loss of the three RCT’s of 
2.98kg for intervention group and 12 months weights were recorded for 68% of participants. 
Nanchahal (2012) reported 2.39kg and McConnon et al (2006) 1.3kg. Nanchalal et al (2012) 
intervention involved a structured one to one programme delivered over 14 visits with a trained 
provider and 12 month weights were recorded for 57% of participants. Jolly et al (2012) involved 
group visits by participants to a commercial training provider. In contrast McConnon et al (2006) 
provided participants with no group contact and minimal face to face contact with study co-
coordinators. Participants were responsible for daily internet contact themselves with 
motivational statements provided based on individual progress. It is not detailed how many 
participant weights were recorded at 12 months however it is reported that 29% were using the 
website at 12 months. It is not clear whether lower weight loss at 12 months follow up is linked 
with self help intervention or less participant engagement or possibly a combination of both. 
These factors warrant further consideration in future studies. 
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The studies demonstrate that intervention is contributing towards weight loss for both groups at 
12 months. However we do not know that participants would not have lost weight anyway and 
having agreed to take part in the trial perhaps motivation is a factor.  However the lack of a 
significant difference between intervention and control group may be attributable to the 
intervention provided to the control group. For example, what results would absolutely no 
intervention for the control group produce? Could there be a link between intervention duration 
or intensity and weight loss from baseline to 12 month follow up? 
Nanchahal et al intervention duration was 9 months and Jolly et al intervention was 12 weeks, 
both with follow up at 12 months. The mean weight loss from baseline to 12 months for 
intervention group was 2.39kg and 2.08kg respectively. McConnon et al intervention duration 
was 12 months and intervention group weight loss was 1.3kg. The less effective self-help 
approach together with poor engagement with the intervention tool of 29% may have 
contributed to this lower weight loss when compared with the other two RCT’s. Also it is not 
possible to conclude how intense each intervention was. Davies et al (2007) reported 
intervention group mean weight loss from baseline to 12 months of 2.98kg. A six hour structured 
group education programme was delivered by two healthcare educators to participants. It is not 
detailed what care, if any, participants received after this. It must be noted that participants were 
referred to this study within four weeks of diagnosis for type 2 diabetes therefore motivation may 
have been a factor for successful weight loss and maintenance. Moore et al (2003) reported a 
lower mean weight loss at 12 months of 0.5kg for the intervention group. General practitioners 
or practice nurses saw patients every two weeks until 10% of weight was lost and then every 1-
2 months until study end. These studies do not provide enough information to assess whether 
intensity or duration of the intervention can promote weight loss at 12 month follow up when 
compared with baseline. Further research is required in this respect. For example, would 
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intense interventions of a shorter duration promote sustained weight loss at 12 month follow up? 
What are the cost implications and how do they compare to longer less intense interventions? 
The cohort study (Ross, Laws, Reckless & Lean 2008) reported mean weight change at 12 
months of -2.96kg and ‘Pounds for Pounds’ (P4P) weight loss scheme (Relton, Strong & Li 
2011) reported mean weight change of -4.0kg. However the plan completion rate of 38% was 
lower than that reported by Ross, Laws, Reckless & Lean (2008) at 75%. It is not clear what 
factors contributed towards this. Perhaps P4P was  more rigid in structure than Counterweight 
having focused on achieving target weight loss at plan completion, monthly weigh in, and 
cumulative credit on this basis up to maximum weight loss of 3.2kg per month. Ross, Laws, 
Reckless & Lean (2008) focus was on 5-10% weight loss and they provided participants with 
nine appointments in 12 months after initial screening i.e. 6 individual appointments(10-30 mins 
each) or 6 group sessions(1 hour each) over 3 months The financial incentive provided by 
Relton, Strong and Li (2011) study may have promoted motivation required for participants to 
achieve weight loss goals. However the absence of a control group means that it is unknown 
whether this weight loss would have been observed in a control group who were equally 
motivated to lose weight but were not offered the programme.  
The motivational aspect of each study merits discussion because this could be a potential 
contributory factor towards weight loss. The fact that all control groups lost weight at 12 months 
when compared with baseline and having volunteered to participate in a weight management 
trial would suggest a certain element of motivation. The financial motivation provided by Relton, 
Strong & Li (2011) may have been a factor for recruitment and participation however it is 
relevant to note that at 12 months 34% of participants were inactive and failed to complete their 
plan, 7% completed and left and 14% were active. Mean weight loss of 4kg at 12 month follow 
up suggest that money could be a contributory motivational factor in this study. A randomised 
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controlled trial is required to compare the intervention with a control group. It should also be 
recognised that the incompleteness of data at 12 months means that the overall estimation of 
weight loss is sensitive to assumptions made about the weight change trajectory of participants 
with no 12 month weight. Participants in the trial by Davies et al (2007) could possibly have 
been motivated having been referred to this study within four weeks of type 2 diabetes 
diagnosis. This may also be reflected in the low attrition rates when compared with the other 
studies. Attrition will be discussed in question 3. However it is also important to consider that 
participants from study by McConnon et al (2006) and Moore et al (2003) were extremely obese 
(BMI ≥ 30 kg/m2) and therefore it is likely that many also had co-morbidities. Jolly et al (2011) 
specify co-morbidities in the inclusion criteria and subsequent eligibility. Therefore perhaps the 
time scale between diagnosis and referral is relevant in promoting and sustaining weight loss at 
12 month follow up..  
How do weight management programmes impact on adult participants of UK 
based weight management programmes on weight loss maintenance (follow 
up of 12 months to assess effectiveness of intervention on weight loss) 
focusing on effect on diet, physical activity and behaviour modification? Is 
there a significant difference (P<0.05) between groups at 12 months? 
As previously noted NICE CG43 recommends the use of multi component intervention with 
tailored advice on physical activity, eating behavior, healthy eating and lifestyle changes. It 
specifies that people should be expected to lose no more than 0.5-1kg per week and that 
programmes that do not meet these criteria are unlikely to maintain long term weight loss. SIGN 
115 recommends that weight management programmes include diet, physical activity and 
behavior change in order to achieve weight loss and maintenance of same. It specifies that diets 
should produce 600kcal daily deficiency and physical activity should equate to loss of 1800-
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2500 kcal weekly. This translates to 225-300 minutes of moderate intensity per week or five 45-
60 minute sessions. Behavior modification guidelines include less television watching and 
regular self weighing. This raises several questions in respect of this systematic review. Have 
results for all three components been reported? Have ‘P’ values been reported for each 
component and is there a significant difference between firstly the groups and secondly each 
component (P<0.05)? Are national guidelines being met or exceeded?  
Four studies (table 5) have reported using a multi-component weight loss approach and have 
assessed and provided results on at least one of these components. All information was self 
reported and obtained using questionnaires. No significant difference was found between 
groups at 12 months for any component in the four studies.  
McConnon et al (2006) reported no dietary significant difference between groups in text only 
and no further information was provided. Nanchalal et al reported on all three components. Diet 
(p=0.036) is closest to the significant difference value of 0.05 when compared with physical 
activity (p=0.206) and behavior modification (p=0.093). Why is this? Is this the easiest or most 
convenient element to change or control? Diet data was based on participants who completed 
the 12 months follow up. Those that lost 5% or more of baseline weight stated a reduction in 
portion sizes and fat and sugar intake. A higher proportion (one in three compared with one in 
five) of the intervention group lost at least 5% initial weight (difference 14.7%(3.0 to 26.4, 
P=0.01). Participants who lost 5% or more of baseline weight were more likely to state that they 
had reduced portion sizes and fat and sugar intake than those who did not (P=0.036). It should 
be noted that loss of 5% or more of baseline weight may not reduce a person from an obese to 
a non obese state. It is difficult to put these results into context because there is not enough 
information provided. What are the characteristics of these participants i.e. how many were 
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overweight (>25 kg/m2) or obese (>30 kg/m2)? What were the portion sizes and what was 
energy intake?. 
All four studies reported on changes in physical activity from baseline to 12 months and no 
significant differences were reported between the groups. Participants in the study by 
Nanchahal et al (2012) were more likely to use the stairs instead of a lift, join a gym and walk 
instead of take a car. Did the intervention group exercise more the control group?  Davies et al 
(2007) reported that physical activity levels for intervention group were greater than that of the 
control group at 12 months with no significant difference (P=0.81). However the latter two 
studies did not specify how much exercise the participants were doing at baseline i.e. were they 
meeting or exceeding the guidelines? How does this compare to results at 12 months?. Jolly et 
al reported increased physical activity changes at 12 months between baseline (mean 
560kcals/week) and 12 months (mean=1552 kcals/week) in both groups. It should be noted that 
at programme end the intervention group reported greater mean physical activity levels of 
1958kcals/week than the control group at 1608 kcals/week. However the mean increase from 
programme end (12 weeks) to 12 months was greater in the control group at 158 kcals/week 
than in the intervention group which reported a decrease of 495 kcals/week (mean activity levels 
1463kcals/week). Therefore whilst the intervention resulted in weight loss an increase in 
physical activity was not sustained at 12 months. The control group received 12 vouchers for 
local leisure centre and it is likely that the emphasis in such a venue would promote physical 
activity once you enter the facility which is perhaps reflected in the results of this study. The 
intervention group meetings did not include actual exercise participation. It was about guidance, 
motivation and associated benefits and subsequent weigh in. Participants taking time out to go 
to these sessions would also have to make time for exercise sessions. Also the individual cost 
of continuing with the intervention after programme end must be considered and compared with 
that of attending the leisure centre. The cost of the intervention was provided in this study but 
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not the cost of the control intervention. This could have prompted cessation of attendance after 
programme end by intervention participants. Although provision of vouchers to an exercise 
facility can promote weight loss at 12 months it should be noted that having agreed to 
participate in this trial the control group may be more motivated than those referred by say a GP 
or PN. Similarly McConnon et al (2007) reported a reduction in self-rated physical activity score 
over the intervention period (P=0.6) with a mean reduction of 0.34 in the sample with no further 
information provided. 
Nanchahal et al (2012) was the only study to report on behavior modification. Participants who 
lost 5% or more of baseline weight reported that attending regular meetings, discussion on 
portion sizes and using a pedometer were useful and they would continue to do this to maintain 
their weight. Further information is required in order to identify other influential elements. For 
example, did participants report spending less time watching television? How did they reward 
themselves for weight loss? 
Questions are still outstanding which need to be addressed. Whilst these studies incorporate a 
multi-component approach to weight loss it is not clear whether NICE and SIGN guidelines are 
realistic. Do they need to be revised? Do they contribute to a sustainable weight loss at 12 
month follow up? Jolly et al is the only study which has provided enough data to answer some 
of these questions and the intervention group met SIGN physical activity guidelines at 12 
months follow up. Physical activity in the intervention group had decreased at 12 months when 
compared with baseline. Therefore are these guidelines sustainable? It cannot be concluded 
whether physical activity was the strongest component because no ‘P’ values have been 
reported for diet and behavior modification in this study. Reporting of further detail such as 
frequency, intensity, timing and type of physical activity would be beneficial. Assessment and 
data reporting of all three components is required in future studies in order to identify which is 
Alison Sarah Moore (0818494) MSc Nutrition Science & Exercise Studies(XN7519) 8
th
 October 2012 
Page 63 of 86 
the weakest and strongest component and also to investigate a significant difference. It is 
relevant to compare not only intervention and control group but also assess whether there is a 
significant difference between the three components. Detail should be reported for daily energy 
intake and expenditure in order to compare it with the guidelines.  
How is withdrawal/loss to follow up within a weight management programme 
(continuation of programme or follow up of at least 12 months in order to assess 
the impact of interventions on weight loss) dealt with in the statistical analysis? 
The basis of calculation for each study has reported using the definition of clinical significance 
associated with >5% weight loss. It is relevant to note that the health benefits associated with 
this is unknown within each study because it has not been measured. This definition should be 
interpreted with caution because it implies that there is no limit on the amount of weight that can 
be regained once net weight loss remains below the criterion. It assumes that the bounds 
around which weight loss maintenance is placed are known. Moore et al and McConnon et al 
have included a designated body weight. Going forward all studies should consider 
incorporating similar in addition to specification of standardised conditions. This prompts the 
question that if all these studies are using this same definition then why is there such variation in 
the sample size and assumed loss to follow up (LTFU) between the six studies (table 6 and 
table 7)? This is an important question because it impacts on the estimated sample size and 
subsequent (LTFU) and missing data. An accurate estimation of LTFU may be achieved by 
reviewing and comparing assumed and actual LTFU figures thereby reducing the need for 
adjustment and subsequent bias as will now be discussed. 
Due to the different assumptions made by various methods regarding accounting for missing 
data the analytical methods chosen may influence interpretation of study results. Six studies 
have statistically assessed the effect of participant withdrawal from the weight management 
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programme and subsequent loss to follow up. The key parameters of these studies are detailed 
in table 6 and table 7. Intention to treat (ITT) means that the participants were analysed in the 
groups to which they were randomised regardless of whether they adhered to the intervention. 
Therefore participants who strayed from the protocol were kept in the analysis. This estimates 
the effects of allocating an intervention in practice not the subgroup of participants who adhere 
to it (Bollini, Pampallona, Tibaldi, Kupelnick & Munizza, 1990). Five of these studies have used 
the intention to treat (ITT) analysis. Moore et al (2003) used it ‘where possible’, however if ITT is 
not used then overestimation of clinical effectiveness may be caused. The randomisation 
feature may be lost if analysis is not performed on the groups produced by the randomisation 
process (Hollis, 1999). Although McConnon et al (2003) report in the text that analysis was ITT 
they provide data results for responders and non-responders. This is acceptable to do however 
full application of ITT is possible only when complete outcome data are available for all 
randomised subjects. A problem with ITT is loss to follow up as demonstrated by all six studies. 
This means that the outcome may not be measured on those that drop out but the ITT principle 
suggests that they should still be included in the analysis. Data may not be available for these 
participants and so in order to include them it is necessary to find out whether data is available 
for them or impute the outcomes. Therefore assumptions on the lost participants must be made. 
There are many approaches to this. For example, Jolly et al assumed that participants for whom 
weight at follow-up was not available had their baseline weight for the primary analysis. Davies 
et al did not replace missing outcomes and derived an average over time of continuous 
outcomes. This effect measured the cumulative effect of the treatment and has the maximum 
number of participants. It should be noted that the latter study had participant loss of 8% in the 
intervention group and 11% in the control group which is lower when compared with the other 
five studies suggesting that these levels are unusually low. One cause of this could be 
motivation because all participants were referred within four weeks of being diagnosed with type 
2 diabetes. The outcome for this study was a continuous measure and imputation for missing 
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data is more difficult as there are more than two possibilities for each participant (Newell, 1992). 
Although Nanchahal et al reported in the text that missing values were imputed the strategy for 
this was not reported. Did they assume the best strategy i.e. did participants achieve an 
average clinically significant weight loss of 7%? Did they assume the worst strategy i.e. did 
participants return to baseline weight or gain weight?  
The baseline observation carried forward (BOCF) is one approach used to handle missing data 
from early treatment discontinutation. This requires that the patient remain active in the in the 
trial for response evaluation. If the patient drops out the baseline information is used as the final 
response regardless of the reason for drop out. In contrast the last observation carried forward 
(LOCF) uses the last observed non missing value in place of the missing endpoint. McConnon 
et al used both of these methods. They report that BOCF and LOCF results were similar to 
those found using ANCOVA statistical analysis. They report in text that the intervention group 
was 0.8kg heavier and 0.5kg heavier than the control group at 12 months. Complete cases 
reported control group weight loss of 0.6kg more than the intervention group. However no 
further data was provided. Jolly et al reported BOCF greater weight loss between intervention 
group of 0.86kg and LOCF of 1.5kg when compared with the control group. Complete cases 
reported 1.18kg greater weight loss in the intervention group. LOCF results should be treated 
with caution because it provides biased estimates of treatment effects. In addition LOCF is liable 
to underestimate the treatment effect if there is approximately equal drop out in both groups. 
Jolly et al report a difference in drop out rate for intervention group of 39% and control group of 
28%. The assumed LTFU was 20%. McConnon et al reported a drop out rate for intervention of 
51% and control group of 30%. The assumed LTFU was 22%. It should also be noted that these 
cases of unequal drop outs the bias can be much larger in either direction. Multiple imputation 
can also be used to handle missing data. Nanchalal et al utilised this method. They detailed that 
‘for each outcome the full set of imputation variables comprised the outcomes at each of the 
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three occasions together with a set of baseline variables selected for their non-negligible 
association with missingness and weight loss”. Alternatively analysis of available data but 
consideration of drop out rate as a marker of trial quality should be considered. Single 
imputation cannot reflect the uncertainty about the actual value. Therefore analysis that treat 
imputed values like observed values can underestimate this uncertainty leading to standard 
errors that are too small and p-values which are systematically too significant.  
Imputation of missing data necessary for a full ITT analysis is controversial. It may be best to 
report results for available participants only. The effects on missing participants should also be 
considered by sensitivity analysis. In addition it would be beneficial to consider treatment related 
and non-treatment related reasons for dropout and actual treatment outcomes from patients. 
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5 CONCLUSION 
The consequences of an obese population have been described in the ‘Introduction’ section. 
The health and financial implications of increasing obesity in the UK are detailed by Foresight 
(Future Choices Project, 2007). In order to take control of this situation with an aim to reduce 
obesity levels the government responded with ‘Healthy Weight, Healthy Lives’ in 2008. This 
commitment, support and action by the UK government are essential in order to reverse the 
rising tide of obesity.  
‘Healthy Weight, Healthy Lives’ (2008) identify primary care as the first port of call for advice 
about weight control and NICE (2006) recommend that clinical management be offered to obese 
patients by primary care physicians. However research (section 1.2) has reported that general 
practitioners and practice nurses’ lack the necessary training and education in this area 
promoting a reluctance to deal with the obesity epidemic single handedly. The limited resources 
within the NHS have prompted outsourcing to commercial weight management programmes. 
This relieves pressure on general practices in terms of time and finance. It also offers 
participants a wide selection of venues and times. 
The principles of weight management are primarily to achieve clinically significant weight loss 
and secondly to maintain lost weight. Whilst the clinically significant benefits of >5% weight loss 
have been demonstrated it is important to note that it cannot automatically be assumed that 
<5% weight loss is not clinically significant. Weight maintenance is often cited as an elusive goal 
and the more difficult component of weight management to achieve. However studies detailed in 
section 1.5 (weight loss maintenance) demonstrate that this is possible.  The problem is weight 
regain. There is little purpose in committing time and money to reducing obesity if the weight is 
regained. This is counter-productive and weight loss maintenance is essential. Research has 
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revealed that defining this is problematic and as such does not promote ease of comparability 
across studies. Going forward although any weight maintenance definition will be somewhat 
arbitrary it should be compatible with national and international expert committees. It should 
also include a designated body weight under standardised conditions and avoid the use of body 
weight percentage loss. 
NICE CG43 and SIGN 115 national guidelines recommend the use of multi-component weight 
management programmes which comprise diet, physical activity and exercise in order to lose 
weight and maintain a healthy body weight. The inclusion criteria reflect this requirement and a 
systematic review was conducted of all literature pertaining to weight loss maintenance through 
a multi-component weight management programme. Weight loss maintenance was defined as 
follow up at 12 months to assess effectiveness of intervention on weight loss. Seven studies 
met the eligibility criteria and quality was assessed with three studies scoring 93% and one 
scoring 89%, 82%, 75% 73%.  
What is the effect of UK based weight management programmes on weight loss 
maintenance (follow up of 12 months to assess effectiveness of intervention on weight 
loss) for adults? 
Both groups in all studies reported weight loss at 12 months. All control groups received an 
intervention and the research suggests that this could have contributed towards weight loss at 
12 months and possibly lack of a significant difference between groups. In addition it is worth 
considering that having agreed to participate in a weight management trial could perhaps 
prompt motivation towards achieving weight loss. One study (Davies et al, 2007) reported a 
significant difference between groups. Attrition rates were low when compared with the other 
studies. Motivation was possibly greater given that all participants were referred within four 
weeks of being diagnosed with type two diabetes which may have prompted motivation. 
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However it is important to consider that participants in the study by McConnon et al (2006), 
Moore et al (2003) and Jolly et al (2011) were all obese and it is likely that they too had co-
morbidity. In fact this was part of the eligibility criteria in the latter study. Therefore perhaps the 
time scale between diagnosis and referral to weight management RCT is relevant and certainly 
warrants further investigation in future research studies. One study (Relton, Strong & Li, 2011) 
paid participants to lose weight and reported greater weight loss at 12 months when compared 
with the other six studies. However attrition rates were high. The absence of a control group 
means that it is unknown whether this weight loss would have been observed in a control group 
who were equally motivated to lose weight but not offered the programme. Different 
interventions were used in each study and there are so many variables that it was not possible 
to draw conclusions as to the most effective. There is not enough information to confirm the 
extent to which intensity and duration of intervention has affected the outcome. Also all control 
groups received an intervention which impacted on results and subsequent outcome. 
How do weight management programmes impact on weight loss maintenance 
((follow up of 12 months to assess effectiveness of intervention on weight loss)) 
focusing on effect on diet, physical activity and behaviour modification?  
Whilst all seven studies reported using this approach only four studies reported results on at 
least one of these components. All information was self reported and obtained using 
questionnaires and there were no significant difference between groups for any component. 
National clinical guidelines (SIGN 115 & NICE CG43) detail the exercise, diet and behavior 
modification are necessary to lose and maintain weight. One study (Nanchahal et al, 2012) 
reported on all three components and ‘p’ value for diet was closest to the significant difference 
level of 0.05 when compared with the other two components. It is not clear whether this is the 
strongest component because a significant difference between components was not 
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investigated. A significant difference should be assessed not only between groups but also 
between components. This will identify the weakest and strongest component and identify in 
which direction focus is required. One study (Jolly et al, 2011) provided enough information on 
physical activity levels to compare it to the national guidelines. The intervention group is in line 
with national guidelines when compared with baseline and intervention end (12 weeks) but this 
was not sustained to 12 months. It is relevant to consider whether a longer intervention period 
would have sustained these levels. It cannot be concluded whether the national guidelines are 
sustainable and/or require revision. In future studies it is important that results from all 
components be reported. Information on energy intake and expenditure must be assessed. This 
will enable comparability with the national guidelines and assessment of whether these are 
realistic or sustainable. 
How is withdrawal/loss to follow up within a weight management programme 
(continuation of programme or follow up of at least 12 months in order to assess the 
impact of interventions on weight loss) dealt with in the statistical analysis? 
Withdrawal and loss to follow up is a problem for all but one study (Davies et al, 2007). Due to 
the different assumptions made by different methods regarding accounting for missing data the 
analytical methods chosen may influence interpretation of results. It is relevant to note that all 
study’s refer to the clinically significant health benefits associated with >5% weight loss however 
the health benefits of this in each study is unknown because it has not been measured. High 
attrition rates were apparent in all but one study. Four studies were conducted on an intention to 
treat (ITT) basis. One study was unclear and another did it where possible. Imputation of 
missing data for a full ITT analysis is controversial. Adjustments must be made to take account 
of this. The studies describe three methods used to account for missing data; baseline 
observation carried forward (BOCF), Last observation carried forward (LOCF) and multiple 
imputation (MI). There are advantages and disadvantages with each method. It may be best to 
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report results for available participants only. The effects on missing participants should be 
considered by a sensitivity analysis. In addition it would be relevant to consider treatment 
related and non-treatment related reasons for dropout and actual treatment outcomes for 
patients. Alternatively analysis of available data but consideration of drop out rate as a marker 
of trial quality would be acceptable. It should also be noted that the assumed loss to follow up is 
lower than actual loss to follow up in all but one study. If this element of each study were to be 
reviewed then perhaps there would be a smaller gap between assumed and actual therefore 
less adjustments would be required. 
All seven studies are pragmatic and assess whether the intervention works under real life 
conditions in terms that matter to the patient. It is concerned with whether the intervention works 
and not how or why. This study type is beneficial for deciding what services should be provided 
but give limited insight into the mechanics of the intervention. Perhaps the issues discussed in 
this dissertation could be further answered through explanatory research. This would assess 
whether an intervention works under ideal or selected conditions and is concerned with how and 
why an intervention works. Although these studies are valuable for understanding questions of 
efficacy they are of limited value when assessing whether we should provide a service to a wide 
variety of patients in a wide variety of circumstances. The distinction between pragmatic and 
explanatory research is important because it will determine key methodological issues relating 
to patient selection, definition of the intervention and controls, use of blinding and placebos, 
choice of outcome measure and type of analysis. 
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7 Appendix 1
Appendix 1 Amalgamated Data Extraction Forms 
Data collection form 
Intervention review – RCTs and non-RCTs 
This form can be used as a guide for developing your own data extraction form. Sections can be expanded and 
added, and irrelevant sections can be removed. It is difficult to design a single form that meets the needs of all 
reviews, so it is important to consider carefully the information you need to collect, and design your form 
accordingly. Information included on this form should be comprehensive, and may be used in the text of your 
review, ‘Characteristics of included studies’ table, risk of bias assessment, and statistical analysis. 
 
Notes on using a data extraction form:  
 Be consistent in the order and style you use to describe the information for each report. 
 Record any missing information as unclear or not described, to make it clear that the information was not 
found in the study report(s), not that you forgot to extract it.  
 Include any instructions and decision rules on the data collection form, or in an accompanying document. It is 
important to practice using the form and give training to any other authors using the form. 
 
Review title or ID 
Weight management in primary care: the Counterweight Project – Study 3 
 
 
Study ID (surname of first author and year first full report of study was published e.g. Smith 2001)  
Ross, Laws, Reckless & Lean (2005) 
 
Report ID (if different to 
Study ID) 
Report IDs of other reports of this study (e.g. duplicate 
publications, follow-up studies) 
The Counterweight Team, 
2008 
 
 
The Counterweight Team, 
2008 
Evaluation of the Counterweight Programme for obesity 
management in primary care: a starting point for continuous 
improvement 
Engaging patients, clinicians and health funders in weight 
management: the Counterweight Programme 
 
 
Notes:         
Weight management in primary care: the Counterweight Project:  
Overview: Weight Change at 12 months 
Evaluation of the Counterweight Programme for obesity management in primary care: a starting 
point for continuous improvement 
Overview: Primary outcome measures were weight change and percentage of patients achieving 
>5% loss at 12 and 24 months 
Engaging patients, clinicians and health funders in weight management: the Counterweight 
Programme 
Overview: To explore key barriers and facilitators of practice and patient engagement in the 
Counterweight Programme and to describe key strategies used to address barriers in the wider 
implementation of this weight management programme in UK primary care 
Relevance of the Project (“Methods – Design”) 
When Counterweight was established there was no evaluated model for weight management in 
primary care. A cluster randomisation model including a deferred intervention would have had 
limitations, because data collection could have an intervention effect. A within-practice 
experimental design with a control group was not possible, as 
Counterweight works with the whole practice team. 
‘Practice Intervention’ 
The unique feature of this programme was the mentoring provided by the weight management 
advisers in routine clinical settings. 
‘Patient Intervention’ 
No additional incentive (other than reporting outcomes back to practices) was offered to practices 
for data measurement and recording. 
 
General Information 
 
Date form completed 
(dd/mm/yyyy) 
17/07/2012 
Name/ID of person 
extracting data 
Alison Moore 
 
Reference citation 
 
      
 
Study author contact 
details 
The Counterweight Team 
Telephone: 07968 820081/07803 726604 
Email: enquiries@counterweight.org 
Publication type 
(e.g. full report, abstract, 
letter) 
Full Report 
 
Notes:       
 
 
  
Study eligibility 
 
Study 
Characteristic
s 
Eligibility criteria 
(Insert inclusion criteria for each 
characteristic as defined in the Protocol) 
Eligibility criteria 
met?  
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) Yes   
Type of study Randomised Controlled Trial 
 No  
      
Quasi-randomised Controlled Trial 
  
No  
      
Controlled Before and After Study 
 Contemporaneous data collection 
 Comparable control site 
 At least 2 x intervention and 2 x 
control clusters 
 No  
      
Interrupted Time Series 
 At least 3 time points before and 
3 after the intervention 
 Clearly defined intervention point 
 No  
      
Other design (specify): 
Prospective evaluation of a new 
continuous improvement model for weight 
management in primary care. 
 
   
      
Participants 
 
Mean age for 1906 patients at baseline 
was 
49.4 years (SD 13.5 years, range 18.1–
76.0 years); 
77% were female; and, of those enrolled 
in the 
programme, obesity was severe (mean 
weight 
101.1 kg, BMI 37.1 kg/m2). Nearly three-
quarters of 
patients had ≥1, nearly half ≥2, and over a 
quarter ≥3 
obesity-related comorbidities (Table 1).  
 
   
      
Types of 
intervention 
Primary care practice nurses from 65 UK 
general 
practices delivered interventions to 1906 
patients with body mass index (BMI) ≥30 
kg/m2 or ≥28 kg/m2 with obesity-related 
comorbidities.  
1. Practice Intervention 
2. Participant Intervention 
 
   
      
Types of Primary Outcome          
outcome 
measures 
Primary outcome 
measures were weight change at 12 and 
24 months and percentage of patients 
achieving and maintaining ≥5% loss at 
these time points.  
Secondary Outcome 
total-cholesterol 
low-density 
lipoprotein  
cholesterol  
HDL-cholesterol  
systolic blood pressure  
diastolic blood pressure  
fasting glucose (in patients with diabetes 
only) 
H 
 
 
 
INCLUDE  Yes 
 
 
EXCLUDE   
 
Reason for 
exclusion 
 
      
Notes:         
 
 
 
DO NOT PROCEED IF STUDY EXCLUDED FROM REVIEW 
Characteristics of included studies 
Methods 
 
 Descriptions as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Aim of study (e.g. 
efficacy, 
equivalence, 
pragmatic) 
To determine to what extent measures of success seen 
in intensive clinical trials can be achieved in routine 
primary care. Primary outcome measures were weight 
change and percentage of patients achieving ≥5% loss 
at 12 and 24 months. 
      
Design(e.g. parallel, 
crossover, non-
RCT) 
Prospective evaluation of a new continuous improvement 
model for weight management in primary care. 
      
Unit of allocation 
(by individuals, 
cluster/ groups or 
body parts) 
Groups       
Start date 
 
1st January 2001 
 
‘Patient 
Intervention’ 
End date 
 
31st December 2004 
 
Patient 
Intervention’ 
Duration of 
participation 
(from recruitment to 
last follow-up) 
Recruitment was continuous and data capture for the 
evaluation presented in this paper was from 1 January 
2001 to 31 December 2004. 
Patient 
Intervention’ 
Ethical approval 
needed/ obtained 
for study 
   
Yes  
The Counterweight Programme was 
approved by the UK West Midlands 
Multi-Centre Research Ethics 
Committee (UK 99/07/74) and 
subsequently by Local Research Ethics 
Committees in each area 
 
      
Notes:         
The aim of collecting secondary outcome data was to assess whether data followed expected well-
documented trends in line with associated weight management,10,11 rather than to assess the 
impact of weight change. A data set of investigations related to secondary consequences of obesity 
was recommended and collected in line with local guidelines and policies. Counterweight aimed to 
improve identification and management of secondary diseases, such as diabetes and 
hypertension, including the use of appropriate medications.(Patient Intervention) 
Participants 
 
 Description 
Include comparative information for each intervention or 
comparison group if available 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Population 
description 
(from which study 
participants are 
drawn) 
65 general practices from seven UK regions ‘Method, 
Design’ 
Setting 
(including location 
and social context) 
Primary Care 
Practices that reflected UK profiles, varying in size, 
location, and category of social deprivation, were invited 
to participate. 
      
Inclusion criteria  
 
 
body mass index (BMI) ≥30 kg/m2 or ≥28 kg/m2 with 
obesity-related comorbidities 
      
Exclusion criteria 
 
 
Not mentioned       
Method of 
recruitment of 
participants (e.g. 
phone, mail, clinic 
patients) 
Patients were identified for the Counterweight 
Programme by GPs and practice nurses during normal 
appointments. 
      
Informed consent 
obtained  
 
   
 Unclear 
            
Total no. 
randomised  
(or total pop. at start 
of study for NRCTs) 
N/A  
Clusters 
(if applicable, no., 
type, no. people per 
cluster) 
N/A       
Baseline 
imbalances 
 
 
N/A       
Withdrawals and 
exclusions 
(if not provided below 
by outcome) 
The 56 practices identified 2095 patients, of which 1906 
satisfied eligibility criteria. At data-set closure, 1419 
patients had reached ≥12 months, and 825 had reached 
24 months. 
 
‘Results’ 
Age 
 
Mean age for 1906 patients at baseline was 
49.4 years (SD 13.5 years, range 18.1–76.0 years); 
‘Patient 
Characteristics
’ 
Table 1 
Sex 
 
77% were female; and,  
 
      
Race/Ethnicity 
 
Not provided       
Severity of illness 
 
Of those enrolled in the programme, obesity was severe 
(mean weight 101.1 kg, BMI 37.1 kg/m2).  
‘Patient 
Characteristics
’ 
Table 1 
Co-morbidities 
 
Nearly three-quarters of patients had ≥1, nearly half ≥2, 
and over a quarter ≥3 obesity-related comorbidities 
(Table 1). 
      
Other relevant 
sociodemographics 
 
According to practice location by using the Carstairs 
Index (Scotland),22 and the Jarman Index (England).23 
It was recognised that this would not necessarily reflect 
individual patient status but was expected to reflect the 
practice profile very broadly. In England (E) affluence is 
split into 10 categories, with category one being the most 
deprived; while in Scotland (S) there are seven 
categories, with seven being the most deprived. As 
scales and bandings differ the following aggregates 
were used: affluent = E8–10, S1–2, intermediate = E4–
7,S3–5, and deprived = E1–3, S6–7. 
Results 
Twenty-two practices from deprived areas, 22 from 
intermediately-deprived areas, and 12 practices from 
affluent areas contributed 36.4%, 29.5%, and 34.2% of 
patients respectively 
‘Patient 
Intervention’ 
Subgroups 
measured 
 
N/A       
Subgroups reported 
 
N/A       
Notes:         
 
 
 
Outcomes 
Copy and paste table for each outcome. 
 
Outcome 1 
 Description as stated in report/paper 
Weight Change at 12 months 
Weight change at 24 months 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Outcome name 
 
Weight change who had lost ≥5% of their initial weight Table 3 
Time points 
measured 
(specify whether from 
start or end of 
intervention) 
Baseline, 3, 6, 9, 12 months       
Time points reported 
 
Baseline, 3, 6, 9, 12 months       
Outcome definition 
(with diagnostic criteria 
if relevant) 
Weight change who had lost ≥5% of their initial weight       
Person measuring/ 
reporting 
 
The practice nurse role was to deliver patient education 
through discussion about weight management, 
communication of information, and the transfer of 
behaviour change skills and strategies during weight-
management sessions. In several 
practices healthcare assistants took on this role. Weight 
management advisers conducted patient consultations 
      
Unit of measurement  
(if relevant) 
N/A       
Scales: upper and 
lower limits (indicate 
whether high  or low 
score is good) 
N/A       
Is outcome/tool 
validated? 
   
Yes  
N/A       
Imputation of missing 
data 
(e.g. assumptions 
made for ITT analysis) 
Baseline data are presented for all 1906 enrolled 
patients, together with results at 3, 6, 12, and 24 
months. As some patients missed one or more 
appointments or dropped out, mean weight changes 
reflect a patient sub-group of those who attended, 
comprising different individuals at different time-points. 
‘Results’ 
Assumed risk 
estimate 
(e.g. baseline or 
population risk noted  
in Background) 
            
Power             
Notes:         
Discussion 
This study presents, for the first time, prospective evidence of an effective model of weight 
management for primary care. Of the practices that initially agreed to implement Counterweight, 
86% became active, and weight change data compare favourably with those achieved in specialist 
research settings.9  
Despite no extra practice funding, more than two-thirds of practices enrolled new patients beyond 
12 months, allocating time previously spent managing obesity somewhat haphazardly. Almost half 
of all patients attended 12-month follow-up. The most favourable results were seen in high 
attenders, suggesting that processes to optimise attendance and retention are worthy of further 
investigation. 
 
Other 
 
Study funding 
sources 
(including role of 
funders) 
Roche Products Ltd provided an initial 6-year 
unencumbered educational grant-in-aid to the 
Counterweight Project Board and to Robert Gordon’s 
University, Aberdeen. Roche Products Ltd had no input to 
the design and conduct of the study; nor to collection, 
management, analysis, and interpretation of the data; and 
nor to preparation, review, or approval of the manuscript. 
The programme was designed and run by the 
Counterweight Project Team independent of Roche 
Products Ltd. Since completion of the evaluation phase in 
2005, the Scottish Government has funded the 
Counterweight Programme. In England individual Primary 
Care Trusts commission the programme. No 
commercialorganisation has any ongoing interest in the 
Counterweight Programme. The Weight Management 
Adviser team is employed by the Robert Gordon 
University, and central data collection and analyses are 
managed by Glasgow University. There is a Counterweight 
website: www.counterweight.org 
      
Possible conflicts 
of interest 
(for study authors) 
GFL,3 GSF,5 MFQ,3 JHB,1–4 SMH,3 NF,1–5 DWH,1–4 
HMR,3,6 DJH,5 SR,5 DSM,5 BS5 declare potential 
competing interests: Have acted as consultants. 2Have 
received lecture honoraria. 3Have attended 
national/international meetings as guests of Roche 
Products Ltd. 4Involvement as above with other 
pharmaceutical companies with an interest in obesity. 
5Research grant. 6HMR was employed by Roche 
Products Ltd 2000–2007 but reported and was responsible 
to the Chair of the Counterweight Project Team. HMR was 
employed by the Robert Gordon University from 2007. The 
programme national coordinator was employed by the 
sponsor, but reported, and was responsible, to the Chair of 
the Counterweight Project Team. All intellectual property 
rights reside with the Counterweight Project Team 
      
Notes:         
 
 
Notes:         
 
 
Definitions 
 
Assumed risk estimate An estimate of the risk of an event or average score without the 
intervention, used in Cochrane 'Summary of findings tables'. If a study 
provides useful estimates of the risk of average score of different 
subgroups of the population, or an estimate based on a representative 
observational study, you may wish to collect this information. 
Change from baseline A measure for a continuous outcome calculated as the difference 
between the baseline score and the post-intervention score.  
Clusters A group of participants who have been allocated to the same 
intervention arm together, as in a cluster-randomised trial, e.g. a whole 
family, town, school or patients in a clinic may be allocated to the same 
intervention rather than separately allocating each individual to different 
arms. 
Co-morbidities The presence of one or more diseases or conditions other than those of 
primary interest. In a study looking at treatment for one disease or 
condition, some of the individuals may have other diseases or 
conditions that could affect their outcomes. 
Compliance Participant behaviour that abides by the recommendations of a doctor, 
other health care provider or study investigator (also called adherence 
or concordance). 
Contemporaneous data 
collection 
When data is collected at the same point(s) in time or covering the 
same time period for each intervention arm in a study (that is, historical 
data are not used as a comparison). 
Controlled Before and 
After Study 
A non-randomised study design where a control population of similar 
characteristics and performance as the intervention group is identified. 
Data are collected before and after the intervention in both the control 
and intervention groups 
Exclusions Participants who were excluded from the study or the analysis by the 
investigators. 
Imputation Assuming a reasonable value for a measure where the true value is not 
available (e.g. assuming last observation carried forward for missing 
participants). 
Integrity of delivery The degree to which the specified procedures or components of an 
intervention are delivered as originally planned. 
Interrupted Time Series A research design that collects observations at multiple time points 
before and after an intervention (interruption). The design attempts to 
detect whether the intervention has had an effect significantly greater 
than the underlying trend. 
Post-intervention The value of a continuous outcome measured at some time point 
following the beginning of the intervention (may be during or after the 
intervention period). 
Power The probability that a trial will detect, as statistically significant, an 
intervention effect of a specified size. 
Providers The person or people responsible for delivering an intervention and 
related care, who may or may not require specific qualifications (e.g. 
doctors, physiotherapists) or training. 
Quasi-randomised 
controlled trial 
A study in which the method of allocating people to intervention arms 
was not random, but was intended to produce similar groups when used 
to allocate participants. Quasi-random methods include: allocation by 
the person's date of birth, by the day of the week or month of the year, 
by a person's medical record number, or just allocating every alternate 
person. 
Reanalysis Additional analysis of a study's results by a review author (e.g. to 
introduce adjustment for correlation that was not done by the study 
authors). 
Report ID A unique ID code given to a publication or other report of a study by the 
review author (e.g. first author's name and year of publication). If a 
study has more than one report (e.g. multiple publications or additional 
unpublished data) a separate Report ID can be allocated to each to 
help review authors keep track of the source of extracted data. 
Sociodemographics Social and demographic information about a study or its participants, 
including  economic and cultural information, location, age, gender, 
ethnicity, etc. 
Study ID A unique ID code given to an included or excluded study by the review 
author (e.g. first author's name and year of publication from the main 
report of the study). Although a study may have multiple reports or 
references, it should have one single Study ID to help review authors 
keep track of all the different sources of information for a study. 
Theoretical basis The use of a particular theory (such as theories of human behaviour 
change) to design the components and implementation of an 
intervention 
Unit of allocation The unit allocated to an intervention arm. In most studies individual 
participants will be allocated, but in others it may be individual body 
parts (e.g. different teeth or joints may be allocated separately) or 
clusters of multiple people. 
Unit of analysis The unit used to calculate N in an analysis, and for which the result is 
reported. This may be the number of individual people, or the number of 
body parts or clusters of people in the study. 
Unit of measurement  The unit in which an outcome is measured, e.g. height may be 
measured in cm or inches; depression may be measured using points 
on a particular scale. 
Validated A process to test and establish that a particular measurement tool or 
scale is a good measure of that outcome. 
Withdrawals Participants who voluntarily withdrew from participation in a study 
before the completion of outcome measurement. 
 
 
Sources: 
Cochrane Collaboration Glossary, 2010. Available from 
http://www.cochrane.org/training/cochrane-handbook. 
 
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 
Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from 
www.cochrane-handbook.org. 
 
Last JM (editor), A Dictionary of Epidemiology, 4th Ed. New York: Oxford University Press, 
2001. 
 
Schünemann H, Brożek J, Oxman A, editors. GRADE handbook for grading quality of evidence 
and strength of recommendation. Version 3.2 [updated March 2009]. The GRADE Working 
Group, 2009. Available from http://www.cc-ims.net/gradepro. 
 
 Data collection form 
Intervention review – RCTs and non-RCTs 
 
 
 
This form can be used as a guide for developing your own data extraction form. Sections can 
be expanded and added, and irrelevant sections can be removed. It is difficult to design a single 
form that meets the needs of all reviews, so it is important to consider carefully the information 
you need to collect, and design your form accordingly. Information included on this form should 
be comprehensive, and may be used in the text of your review, ‘Characteristics of included 
studies’ table, risk of bias assessment, and statistical analysis. 
 
Notes on using a data extraction form:  
 Be consistent in the order and style you use to describe the information for each report. 
 Record any missing information as unclear or not described, to make it clear that the 
information was not found in the study report(s), not that you forgot to extract it.  
 Include any instructions and decision rules on the data collection form, or in an 
accompanying document. It is important to practice using the form and give training to any 
other authors using the form. 
 
Review title or ID 
A pragmatic randomised controlled trial in primary care of the Camden Weight Loss (CAMWEL) 
programme 
 
Study ID (surname of first author and year first full report of study was published e.g. Smith 2001)  
Nanchahal et al (2012) 
 
Report ID (if different to 
Study ID) 
Report IDs of other reports of this study (e.g. duplicate 
publications, follow-up studies) 
            
 
Notes:         
 
General Information 
 
Date form completed 
(dd/mm/yyyy) 
17th July 2012 
Name/ID of person 
extracting data 
Alison Moore 
 
Reference citation 
 
 
 
Study author contact 
details 
      
 
Publication type 
(e.g. full report, abstract, 
letter) 
Randomised Controlled Trial 
 
Notes:       
To evaluate effectiveness of a structured one-to-one behaviour change programme on weight loss 
in obese and overweight individuals. 
Study eligibility 
 
Study 
Characteristic
s 
Eligibility criteria 
(Insert inclusion criteria for each 
characteristic as defined in the Protocol) 
Eligibility criteria 
met?  
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) Yes No 
Uncle
ar 
Type of study Randomised Controlled Trial 
Yes   
      
Quasi-randomised Controlled Trial 
  
No  
      
Observational Study 
 No  
 
Controlled Before and After Study 
 Contemporaneous data collection 
 Comparable control site 
 At least 2 x intervention and 2 x 
control clusters 
 
Ye
s 
 
      
Interrupted Time Series 
 At least 3 time points before and 
3 after the intervention 
 Clearly defined intervention point 
  Yes 
Baseline, 6 
months, 12 
months 
Other design (specify): 
      
 
 No  
      
Participants 
 
381 adults with body mass index 25 
kg/m2 randomly assigned to intervention 
(n¼191) or control (n¼190) group. 
 
   
      
Types of 
intervention 
A structured one-to-one programme, 
delivered over 14 visits during 12 months 
by trained advisors in three primary care 
centres compared with usual care in 
general practice.  
It follows NICE guidelines and offers multi 
component intervention with tailored 
advice on physical activity, eating 
behaviour, healthier eating and lifestyle 
changes. 
Background to Intervention: 
The intervention combined evidence-
based components recognised as 
essential for behaviour change and 
successful weight loss23—healthier eating, 
increased physical activity incorporated 
into patients' everyday lifestyles, tailored 
goal setting, keeping food and activity 
diaries, self-monitoring, positive 
reinforcement, coping with lapses and 
Yes   
      
high-risk situations and long-term 
support—derived from theoretical 
frameworks underpinning health 
promotion that have an emphasis on long-
term changes in habits. This includes, for 
example, social cognitive theory,24 which 
addresses diet and activity-related social 
support, outcome expectations, self-
efficacy and self-regulation as well as diet 
and physical activity monitoring to assess 
changes over time and goal setting.25 It 
also emphasised SMART (Specific, 
Measurable, Attainable, Relevant, Timely) 
goal setting, the relationship between 
goals and satisfaction and the 
achievement of goals and rewards, and 
systems thinking,26 which focuses on 
environmental changes and stresses 
long-term changes in routines. The 
programme also incorporated NICE 
guidance on management of overweight 
and obesity27 as well as evidence-based 
principles of behaviour modification,23 
adherence to treatment28 and results from 
our pilot study (figure 1). 
Staff Training 
Six CAMWEL advisors were recruited 
from various occupational backgrounds 
including healthcare, in line with the NHS 
health trainers initiative.35 The advisors 
received initial training over 2 days and 
further meetings with the research team 
every 3–4 months. Training of advisors 
included briefing on the obesity epidemic; 
food and physical activity behaviours 
associated with excess weight; principles 
of best practice and behaviour change 
strategies; evidence for what has been 
shown to work in weight loss 
management programmes; the use of 
motivational interviewing methods, 
counselling techniques and cognitive–
behavioural therapy methods to provide 
tailored support for behaviour change; 
together with details of the study design 
and role play. All advisors were given a 
copy of the National Obesity Forum CD-
Rom ‘Managing Obesity in Primary Care’. 
A script and schedule of topics for 
discussion were provided to the advisors 
for each session. The topics included 
personally agreed weight loss goals, 
eating and physical activity goals, 
exploration of motivations for losing 
weight, personal cues to reduce 
unhealthy eating and sedentary 
behaviour, support from family and 
friends, triggers associated with habits 
and routines, long-term benefits of small 
changes and the importance of 
scheduling and time management. A 
commercially available weight 
management software package 
(http://www.perfect-diet-tracker.com) was 
used to record and monitor participant 
progress and keep notes of each session 
by the advisors. The advisors were 
provided with access to a book giving the 
calorie content of foods available in the 
UK,33 a kit including 100-calorie portions 
of various food items and Adams Food 
and Alcohol Portion Pots 
(http://www.adamsportionpot.com). 
Participants Background 
The intervention participants were given 
pedometers and handouts associated 
with each session, including a tailored 
motivational booklet to encourage 
increased levels of physical activity and a 
book of walks in the local area specially 
prepared for the study (appendix 1). 
Further details are available from the 
corresponding author (KN).  
 
Types of 
outcome 
measures 
Primary: 
The aim of this study was to develop and 
evaluate the efficacy of an intervention 
programme with 12 month follow up for an 
ethnically diverse overweight/obese 
population recruited from general 
practices . 
Secondary: 
Changes in weight, per cent 
body fat, waist circumference, blood 
pressure 
and heart rate between baseline and 12 
months. 
Behaviour change (after Table 5) 
Participant satisfaction with care received 
by allocation group at 12 months (Table 
4) 
Participant assessment with care received 
by allocation group at 12 months (Table 
4) 
 
 
Yes   
      
 
INCLUDE  Yes 
 
 
EXCLUDE   
 
Reason for 
exclusion 
 
      
Notes:         
Usual Care Group: 
provided a copy of the Quick reference NICE clinical guideline on Obesity to all participating 
general practitioners (GPs)27 and asked control participants to contact their general practice to 
receive usual weight management care provided by the practice, which could include referral to a 
dietitian (http://www.camden.nhs.uk/adult-weight-management-service.htm), exercise on referral, 
the ‘Shape-Up’ programme (http://camden.gov.uk/ccm/navigation/leisure/sport-and-physical-
activity/get-active-and-healthy/lose-weight/), prescription of weight loss medication, weight loss 
surgery or no further treatment.  
All participants were given the British Heart Foundation booklet: “So you want to lose weight … for 
good.”36 
 
 
 
DO NOT PROCEED IF STUDY EXCLUDED FROM REVIEW 
Characteristics of included studies 
Methods 
 
 Descriptions as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Aim of study (e.g. 
efficacy, 
equivalence, 
pragmatic) 
Pragmatic parallel group RCT trial reflecting the likely 
performance of the programme as delivered in practice. 
‘S&W’ end 
section para 5 
& ‘Aims’ 1st 
para      
Design(e.g. parallel, 
crossover, non-
RCT) 
RCT       
Unit of allocation 
(by individuals, 
cluster/ groups or 
body parts) 
Two groups – intervention and usual care       
Start date 
 
January 2010 
 
‘Results’ pg 4 
para 1 
End date 
 
January 2011 
 
      
Duration of 
participation 
(from recruitment to 
last follow-up) 
18 Months 
Recruitment July 2009 – January 2010 
Study Jan 2010-Jan 2011 
‘Recruitment’ 
section 
Ethical approval 
needed/ obtained 
for study 
   
Yes 
‘Footnote’-Ethics approval was 
provided by the London School of 
Hygiene & Tropical Medicine Ethics 
Committee etc 
      
Notes:         
All GP practices in Camden were visited and invited to attend. 
Confounding Variables – Partially Considered: 
No amending BMI to account for ethnic background such as Asian. 
Were participants taking any medication, including slimming medication that might affect results? 
Effect of £30 on outcome? 
 
 
Participants 
 
 Description 
Include comparative information for each intervention or 
comparison group if available 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Population 
description 
(from which study 
participants are 
drawn) 
All GP practices were visited & invited to participate 
Participating practices were wrote to a sample of patients 
with BMI>25kg/m2 
‘Recruitment’ 
section para 2 
Setting 
(including location 
and social context) 
Camden – local GP practice. 23/39 practices opted to 
participate in the study. 
The intervention takes place in one of three primary care 
centres compared with usual care in general practice 
(asbstract – ‘interventions’) 
 
‘Recruitment’ 
section 
Inclusion criteria  
 
 
> 18 years of age  
BMI > 25kg/m² 
Attending a participating practice 
Willing to attend visits with a CAMWEL advisor for 12 
months 
‘Baseline 
Measurements
’ paragraph 
Exclusion criteria 
 
 
Pregnancy or lactation 
Diagnosis of renal failure 
Use of a pacemaker 
Recent cancer diagnosis 
Participation in another weight management study 
      
Method of 
recruitment of 
participants (e.g. 
phone, mail, clinic 
patients) 
-Participating practices wrote to a sample of patients with 
BMI > 25kg/m² 
-GP’s & PN’s had a referral ‘prescription’ pad with a tear-
off slip given to patient with contact details of the trial 
office 
-Posters & fliers were put in waiting areas and local 
pharmacies. 
-Final 6 wks of recruitment period 3 practices 
supplemented recruitment by sending text messages to 
potentially eligible patients using electronic record (EMIS) 
and messaging (Iplato) systems. 
All practices were reimbursed for time spent on 
recruitment 
      
Informed consent 
obtained  
 
Yes Written consent required and letter 
from GP 
“Baseline 
Measurements
’, para 1 (5th 
line) 
Total no. 
randomised  
(or total pop. at start 
of study for NRCTs) 
191 participants randomised to intervention 
190 participants randomised to control group 
      
Clusters 
(if applicable, no., 
type, no. people per 
cluster) 
N/A       
Baseline 
imbalances 
 
 
At Baseline: 
Height measurements (no shoes) 
Weight measurements (light clothes & using Tanita 
scales). Scales also reported % body fat, BMR, & 
metabolic age (age expected for a given value of BMR) 
Waist measurements 
Blood Pressure & Heart Rate 
All this information was printed out & given to participants 
‘Baseline 
Measurements
’ 
Withdrawals and 
exclusions 
(if not provided below 
by outcome) 
8 excluded – did not meet inclusion criteria 
3 excluded  - declined to participate 
See ‘Figure 2’ 
chart 
Age 
 
Median Age – 48.5 years ‘Baseline 
Characteristics
’ 
Sex 
 
72.63% women – control group & 71.73% women – 
intervention group 
      
Race/Ethnicity 
 
Control Group: 70.63% - Caucasian 
Intervention Group: 74.25% - Caucasian 
      
Severity of illness 
 
Low 
Intervention(57 in total lost to follow up) 
6 months: 4 participants were lost to follow up due to 
personal illness  
12 months: 6 participants were lost to follow up due to 
personal illness 
Control (61 in total lost to follow up) 
Unknown reasons for loss to follow up 
      
Co-morbidities 
 
None       
Other relevant 
sociodemographics 
 
The London Borough of Camden has areas of affluence 
alongside areas of deprivation. 
47% in employment are educated to degree level or 
above. 
17% in employment have no qualifications. 
27% of Camden belong to minority ethnic groups 
‘Recruitment’ 
section 
Subgroups 
measured 
 
N/A       
Subgroups reported 
 
N/A       
Notes:         
GP consent had to be granted for participant to be included (baseline measurements para) 
£30 voucher was given to participants who completed each follow up appointment (“Outcomes” 
para 1) 
Self completed questionnaires included the following validated measures (“Outcomes” para 2): 
-EuroQol Visual Analogue Scale 
-Obesity & Weight Loss Quality of Life 
-Hospital anxiety & depression scale 
-Rosenburg measure of self-esteem 
-Duke-UNC Functional Social Support Questionairre 
-Three factor eating questionnaire 
-Physical activity (PAR Q) 
-Socio demographic information 
Deprivation was ascertained by using the Index of Multiple Deprivation based on the participants 
postal code 
Baseline Characterics 
The majority (72%) were women,  
12% (47/381) had diagnosed diabetes,  
1.3% (5/381) were on antipsychotic medication,  
60% were in employment,  
47% were university graduates and 73% described their ethnicity as Caucasian (table 1).  
Participants wanted to lose an average of 18 kg (SD =12.4), representing 16.7% of their baseline 
weight.  
There were no significant differences between groups for any of these variables. 
Response Rates 
There were no significant differences in follow-up rate at 12 months by randomisation group (60.0% 
control, 53.9% intervention, p=0.23), but those followed up tended to be older, have lower BMI, fat 
mass and per cent body fat, and were less likely to be from a deprived area than those not followed 
up (table 2).  
 
 
 
Intervention groups 
Copy and paste table for each intervention and comparison group  
 
Intervention Group 1 
 Description as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Group name 
 
Intervention       
No. randomised to 
group 
(specify whether no. 
people or clusters) 
191 randomly assigned to intervention group       
Theoretical basis 
(include key references) 
 
N/A       
Description (include 
sufficient detail for 
replication, e.g. content, 
dose, components) 
-Structured one to one programme 
-Delivered over 14 visits during 12 months by trained 
advisors in three primary care centres 
Advisors 
-6 CAMWEL advisors were recruited and trained 
-Participants were invited to attend 30 minute 
sessions with an advisor every fortnight for the first 12 
weeks, every 3 weeks for 12 weeks & monthly for the 
next 12 weeks (14 sessions) 
-A script & schedule of topics for discussion were 
provided to the advisors for each session 
Participants 
-Given pedometers 
-Given hand outs associated with each session 
including tailored motivational booklet to encourage 
increased levels of physical activity 
 
      
Duration of treatment 
period 
12 months       
Timing (e.g. frequency, 
duration of each 
episode) 
Participants were invited to attend 30 minute sessions 
with an advisor every fortnight for the first 12 weeks, 
every 3 weeks for 12 weeks & monthly for the next 12 
weeks (14 sessions) 
      
Delivery (e.g. 
mechanism, medium, 
intensity, fidelity) 
30 minute sessions with an advisor        
Providers 
(e.g. no., profession, 
training, ethnicity etc. if 
relevant) 
Advisors were recruited from various occupational 
backgrounds including healthcare, in line with the 
NHS health trainers initiative. 
      
Co-interventions 
 
 
N/A       
Economic variables 
(i.e. intervention cost, 
changes in other costs 
as result of intervention) 
Cost analysis is noted to have been provided in a 
separate paper  
July 2012-AM contacted authors and they responded 
that this paper was in progress and not available yet. 
      
Resource 
requirements 
(e.g. staff numbers, cold 
chain, equipment) 
Participation of local (Camden) GP practice - 23/39 
practices opted to participate in the study. 
All practices were reimbursed for time spent on 
recruitment – details to be provided in separate paper. 
£30 voucher was given to participants who completed 
each follow up appointment (“Outcomes” para 1) 
Three centres were provided for participants of 
interevention group to attend sessions. 
      
Integrity of delivery 
 
 
High       
Compliance 
 
 
Compliance of advisors - high       
Notes:         
 
 
 
 
Outcomes 
Copy and paste table for each outcome. 
 
Outcome 1 
 Description as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Outcome name 
 
Primary Oucome: Mean Difference in Weight Loss 
Based on the intention-to-treat analysis using imputed 
missing values (table 3), at 12-month follow-up, 
structured 
support resulted in a mean difference in weight 
loss between the two groups of _0.70 (_2.71 to 0.76) 
kg. 
A higher proportion of participants lost 5% or more of 
their baseline weight in the intervention (32.7%, 95% CI 
24.9% to 40.5%) when compared with the usual care 
(20.4%, 95% CI 13.3% to 27.5%) group (OR 1.80 (1.02 
to 3.18, p¼0.04). 
Print Table 3 
Time points 
measured 
(specify whether from 
start or end of 
intervention) 
Baseline 
6 months (noted in figure 2) 
12 months 
      
Time points reported 
 
Baseline 
6 months 
12 months 
Table 3 
Outcome definition 
(with diagnostic criteria 
if relevant) 
Weight loss of 7%  at 12 months from baseline (see 
section ‘sample size’) 
      
Person measuring/ 
reporting 
 
CAMWEL advisors       
Unit of measurement  
(if relevant) 
Height: measured to the nearest 0.1 cm using a 
stadiometer. 
Weight (in light clothing) was measured 
using the Tanita (BC 420 MA) scales. The scales also 
reported per cent body fat, basal metabolic rate and 
metabolic age (age expected for a given value of basal 
metabolic rate). 
Waist was measured midway between 
the iliac crest and the costal margin to the nearest 
0.1 cm. 
Blood pressure and heart rate were measured 
using a digital automatic monitor (Omron Model 
M10-IT), with the average of three readings recorded 
0.2 where possible. 
      
Scales: upper and 
lower limits (indicate 
whether high  or low 
score is good) 
Inclusion criteria - BMI >25 kg/m2       
Is outcome/tool 
validated? 
   
Yes No Unclear 
            
Imputation of missing 
data 
(e.g. assumptions 
made for ITT analysis) 
Primary analyses were conducted on an intention-to-
treat basis, using multiple imputation (MI) to account for 
missing data at follow up. 
Exclusion of subjects with missing data is inefficient 
and can lead to biased results if those dropped are 
atypical in some respect50 and MI can both increase 
efficiency and reduce bias in such settings. 
Missingness in this study is dominated by attrition, but 
there 
are also some intermediate missing outcome values 
and 
missing baseline values (although not for weight) so the 
‘Fully Conditional Specification’ form of MI has been 
used.53 For each outcome, the full set of imputation 
variables comprised the outcomes at each of the three 
occasions, together with a set of baseline variables 
selected for their non-negligible association with 
missingness 
or weight loss. 
The imputation procedure was carried out separately for 
the two groups (intervention and control), and the 
resulting multiply imputed data sets were combined for 
the final MI analysis. A total of 200 imputations were 
used to stabilise the results and to ensure negligible 
loss of power.50 Analyses using only data on 
participants who completed 12-month follow-up were 
also conducted. 
Exploratory analyses (not using MI) were conducted 
excluding subjects who had bariatric surgery or were 
prescribed weight loss medication during the course of 
the trial. We also examined whether the degree of 
weight loss was associated with baseline characteristics 
or with changes in health or quality-of-life measures. 
Analyses were performed using STATA V.11. 
      
Assumed risk 
estimate 
(e.g. baseline or 
population risk noted  
in Background) 
High loss to follow up but used multiple imputation used 
to counter any biases. 
 
      
Power             
Notes:         
Secondary Outcomes were differences in waist circumference, per cent body fat, blood pressure 
and heart rate from baseline to 12 months. 
The printout from the Tanita scales, including weight, BMI and metabolic age, was given to all 
participants. 
For all outcomes, the following baseline variables were included: age, weight, per cent body fat, 
BMI, fat mass, metabolic age, deprivation status and employment status as well as totals from the 
Obesity and Weight Loss Quality-of Life, EuroQol Visual Analogue Scale, Hospital Anxiety and 
Depression Scaleanxiety, Three-Factor Eating Questionnaire emotional eating and RPAQ scales. 
Multiple Imputation, the practice of 'filling in' missing data with plausible values, is an attractive 
approach to analyzing incomplete data 
AM – discuss the use of multiple imputation (MI) 
 
 
Other 
 
Study funding 
sources 
(including role of 
funders) 
This work was supported by Camden Primary Care Trust 
(NHS 
Camden). The funding source had no role in the design or 
conduct of the study; collection, management, analysis or 
interpretation of the data and preparation, review or 
approval of the manuscript. 
      
Possible conflicts 
of interest 
(for study authors) 
All authors have completed the Unified Competing 
Interest form at http://www.icmje.org/coi_disclosure.pdf 
(available on request from the corresponding author) and 
declare that KN, TP, EH, MH, AS, UG and JLT had salary 
support from NHS Camden for the submitted work. AK 
was Director of Public Health at Camden Primary Care 
Trust between 2004 and 2009. The views expressed here 
are personal, and no financial support was received for the 
other authors’ involvement in the CAMWEL Trial. No 
authors have had a relationship with companies that might 
have an interest in the 
submitted work in the previous 3 years nor do their 
spouses, partners or children have financial relationships 
that may be relevant to the submitted work. DH is on the 
scientific advisory board for LighterLife and no other 
authors have non-financial interests that may be relevant 
to the submitted work. 
      
Notes:         
 
Risk of Bias assessment 
See Chapter 8 of the Cochrane Handbook. Additional domains may be added for non-
randomised studies. 
 
Domain Risk of bias 
 
Support for judgement 
Result – high loss to follow up but 
similar to other weight management 
studies. 
Location in 
text or source 
Strenghts & 
limitations 
Low 
risk 
High 
risk 
Unclear 
Random 
sequence 
generation 
(selection bias) 
Yes   
Participants were randomly allocated 
(allocation ratio1:1) to the control or 
intervention group (TP, EH, AS), using 
a computer-generated randomisation 
application written in VBA for MS 
Access (TP). The Taves method of 
minimisation48 was used to ensure the 
groups were balanced for general 
practice, gender, age group (#50/ >50 
years), BMI category (#30/>30 kg/m2), 
diagnosis of diabetes (yes/no) and 
taking antipsychotic medication or not 
‘Randomisation’ 
section 
Allocation 
concealment 
(selection bias) 
 
  Unclear 
       
Blinding of 
participants and 
personnel 
(performance bias) 
 No  
Outcome group: All/      
No  
      
(if separate 
judgement by 
outcome(s) 
required) 
  Unclear 
Outcome group:  N/A - 
 
      
Blinding of 
outcome 
assessment 
(detection bias) 
Yes   
Outcome group: All/      
The study was single blinded with 
members of the study team assessing 
baseline and follow-up measurements 
blinded to group assignment. 
      
(if separate 
judgement by 
outcome(s) 
required) 
  N/A 
Outcome group:       
N/A 
      
Incomplete 
outcome data 
(attrition bias) 
 
Yes   
Outcome group: All/      
All 
      
(if separate 
judgement by 
outcome(s) 
required) 
   
Outcome group:       
N/A 
 
Selective 
outcome 
reporting? 
(reporting bias) 
 No  
            
Other bias 
 
 
   
            
Notes:         
“Selective reporting of outcomes within published studies based on the nature or direction of their 
results has been widely suspected, but direct evidence of such bias is currently limited to case 
reports”..Empirical evidence for selective reporting of outcomes in randomized trials: comparison of 
protocols to published articles; JAMA. 2004 May 26;291(20):2457-65) 
 
 
Data and analysis 
Copy and paste the appropriate table for each outcome, including additional tables for each 
time point and subgroup as required. 
 
For RCT/CCT 
Continuous outcome 
 Description as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/other
) 
Comparison 
 
Control group – usual care with GP       
Outcome 
 
Primary Outcome: Mean Difference in Weight Loss 
 
      
Subgroup 
 
N/A       
Time point 
(specify from start or 
end of intervention) 
18 Months 
Recruitment July 2009 – January 2010 
Study Jan 2010-Jan 2011 
      
Post-intervention 
or change from 
baseline? 
Measured and reported 6 & 12 months        
Results Intervention Comparison       
Mean 
6 
months 
SD  
- 1.73 
No. 
Participant
s 
134 
Mean 
6 
month
s 
SD  
- 0.95 
No. 
Participant
s 
129 
Mean 
12 
Months 
-2.39 103 Mean 
12 
Month
s 
-1.31 114 
Any other results 
reported (e.g. mean 
difference, CI, P 
value) 
            
No. missing 
participants 
 
Loss to Follow Up 
(Intervention) 
6 months (n=57) 
12 months (n=88) 
Loss to Follow Up (Control) 
6 months (n=61) 
12 months (n=76) 
 
      
Reasons missing 
 
6 months 
-could not be 
contacted(n=41) 
-personal illness (n=4) 
-family illness(n=4) 
-moved house (n=4) 
-no time to attend(n=4) 
12 months 
-Could not be 
contacted(n=31) 
-Declined to 
attend/Unspecified 
reason(n=21) 
-DNA 
appointment(n=15) 
-personal illness(n=6) 
-no time to attend(n=4) 
-Felt waste of time to 
attend(n=2) 
-Pregnancy(n=1) 
-Unknown(n=8) 
6 months 
-Unknown(n=61) 
12 months 
-Could not be contacted(n=30) 
-Declined to attend(unspecified 
reason)(n=9) 
-DNA appointment(n=15) 
-Personal illness(n=1) 
-no time to attend(n=4) 
-felt to be waste of time 
attending(n=3) 
-unknown(n=14) 
Figure 2 
No. participants 
moved from other 
group 
None None       
Reasons moved 
 
N/A N/A       
Unit of analysis 
(individuals, cluster/ 
groups or body 
parts) 
Groups        
Statistical 
methods used and 
appropriateness of 
these (e.g. 
adjustment for 
correlation) 
Comparisons between groups for continuous variables 
were performed using two-sample t tests and regression 
methods, adjusting for the baseline value of the variable. 
c2 tests and logistic regression were used for categorical 
variables. Changes were calculated as value at follow-up 
minus baseline value. Primary analyses were conducted 
on an intention-to-treat basis, using multiple. imputation 
(MI) to account for missing data at follow up. 
      
Reanalysis 
required? (specify) 
   
 No  
            
Reanalysis 
possible? 
   
 No  
            
Reanalysed results 
 
            
Notes:   
Exploratory Analysis       
Thirty-eight participants were known to have been prescribed drugs for weight loss or to have 
undergone 
weight loss surgery during the trial period. Of these, 27were followed up at 12 months (12 control: 
mean weight change _2.44 kg (_7.15 to 2.27); 15 intervention: mean weight change _3.51 kg 
(_6.95 to _0.08)). The difference 
between groups was 1.07 kg (_4.32 to 6.46, p¼0.69). In analysis excluding these participants, 
those in the intervention 
group showed significantly greater reductions in weight (1.72 kg (0.29 to 3.14, p¼0.02)), waist 
circumference (2.52 cm (0.32 to 4.72, p¼0.03)), BMI (0.63 kg/m2 (0.11 to 1.14, p¼0.02)) and per 
cent baseline weight loss (1.94% (0.32 to 3.56, p¼0.02)) when compared with the control group at 
12 months. In addition, a higher 
 
 
For RCT/CCT 
Other outcome 
 Description as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Comparison 
 
Intervention –v- control group       
Outcome 
 
Waist Circumference 
Percentage body fat 
Percentage weight change 
Heart rate 
The intervention programme was also associated with 
weak evidence of beneficial trends in waist 
circumference, 
per cent body fat and per cent weight change. 
Heart rate was reduced by 3.7 (0.3 to 7.0, p¼0.03) beats 
per minute in the intervention group compared with the 
control group. 
“secondary 
outcomes” 
page 7 
Subgroup 
 
N/A       
Time point 
(specify from start or 
end of intervention) 
18 Months 
Recruitment July 2009 – January 2010 
Study Jan 2010-Jan 2011 
      
No. participant Intervention Control  
       
Results Intervention 
result 
SD (or other 
variance) 
Control 
result 
SD (or other 
variance) 
See Table 3 
for results on: 
Waist 
Circumference
(cm) 
Percent body 
fat 
Percent weight 
loss 
Percent lost 
>5% baseline 
weight 
BMI kg/m₂ 
Systolic BP 
Diastolic BP 
Heart 
Rate(BPM) 
              
Overall results SE (or other variance) 
            
Any other results 
reported  
 
N/A       
No. missing 
participants 
 
????? ?????       
Reasons missing 
 
????? ?????       
No. participants 
moved from other 
group 
N/A N/A       
Reasons moved 
 
N/A N/A       
Unit of analysis (by 
individuals, 
cluster/groups or 
body parts) 
Individuals and groups       
Statistical methods 
used and 
appropriateness of 
these 
Comparisons between groups for continuous variables 
were performed using two-sample t tests and regression 
methods, adjusting for the baseline value of the variable. 
c2 tests and logistic regression were used for categorical 
variables. Changes were calculated as value at follow-up 
minus baseline value. Primary analyses were conducted 
on an intention-to-treat basis, using multiple. imputation 
(MI) to account for missing data at follow up. 
      
Reanalysis 
required? (specify) 
   
Yes No
 Unclear 
            
Reanalysis 
possible? 
   
Yes No
 Unclear 
            
Reanalysed results 
 
            
Notes:         
 
 
 
 
Definitions 
 
Assumed risk estimate An estimate of the risk of an event or average score without the 
intervention, used in Cochrane 'Summary of findings tables'. If a study 
provides useful estimates of the risk of average score of different 
subgroups of the population, or an estimate based on a representative 
observational study, you may wish to collect this information. 
Change from baseline A measure for a continuous outcome calculated as the difference 
between the baseline score and the post-intervention score.  
Clusters A group of participants who have been allocated to the same 
intervention arm together, as in a cluster-randomised trial, e.g. a whole 
family, town, school or patients in a clinic may be allocated to the same 
intervention rather than separately allocating each individual to different 
arms. 
Co-morbidities The presence of one or more diseases or conditions other than those of 
primary interest. In a study looking at treatment for one disease or 
condition, some of the individuals may have other diseases or 
conditions that could affect their outcomes. 
Compliance Participant behaviour that abides by the recommendations of a doctor, 
other health care provider or study investigator (also called adherence 
or concordance). 
Contemporaneous data 
collection 
When data is collected at the same point(s) in time or covering the 
same time period for each intervention arm in a study (that is, historical 
data are not used as a comparison). 
Controlled Before and 
After Study 
A non-randomised study design where a control population of similar 
characteristics and performance as the intervention group is identified. 
Data are collected before and after the intervention in both the control 
and intervention groups 
Exclusions Participants who were excluded from the study or the analysis by the 
investigators. 
Imputation Assuming a reasonable value for a measure where the true value is not 
available (e.g. assuming last observation carried forward for missing 
participants). 
Integrity of delivery The degree to which the specified procedures or components of an 
intervention are delivered as originally planned. 
Interrupted Time Series A research design that collects observations at multiple time points 
before and after an intervention (interruption). The design attempts to 
detect whether the intervention has had an effect significantly greater 
than the underlying trend. 
Post-intervention The value of a continuous outcome measured at some time point 
following the beginning of the intervention (may be during or after the 
intervention period). 
Power The probability that a trial will detect, as statistically significant, an 
intervention effect of a specified size. 
Providers The person or people responsible for delivering an intervention and 
related care, who may or may not require specific qualifications (e.g. 
doctors, physiotherapists) or training. 
Quasi-randomised 
controlled trial 
A study in which the method of allocating people to intervention arms 
was not random, but was intended to produce similar groups when used 
to allocate participants. Quasi-random methods include: allocation by 
the person's date of birth, by the day of the week or month of the year, 
by a person's medical record number, or just allocating every alternate 
person. 
Reanalysis Additional analysis of a study's results by a review author (e.g. to 
introduce adjustment for correlation that was not done by the study 
authors). 
Report ID A unique ID code given to a publication or other report of a study by the 
review author (e.g. first author's name and year of publication). If a 
study has more than one report (e.g. multiple publications or additional 
unpublished data) a separate Report ID can be allocated to each to 
help review authors keep track of the source of extracted data. 
Sociodemographics Social and demographic information about a study or its participants, 
including  economic and cultural information, location, age, gender, 
ethnicity, etc. 
Study ID A unique ID code given to an included or excluded study by the review 
author (e.g. first author's name and year of publication from the main 
report of the study). Although a study may have multiple reports or 
references, it should have one single Study ID to help review authors 
keep track of all the different sources of information for a study. 
Theoretical basis The use of a particular theory (such as theories of human behaviour 
change) to design the components and implementation of an 
intervention 
Unit of allocation The unit allocated to an intervention arm. In most studies individual 
participants will be allocated, but in others it may be individual body 
parts (e.g. different teeth or joints may be allocated separately) or 
clusters of multiple people. 
Unit of analysis The unit used to calculate N in an analysis, and for which the result is 
reported. This may be the number of individual people, or the number of 
body parts or clusters of people in the study. 
Unit of measurement  The unit in which an outcome is measured, e.g. height may be 
measured in cm or inches; depression may be measured using points 
on a particular scale. 
Validated A process to test and establish that a particular measurement tool or 
scale is a good measure of that outcome. 
Withdrawals Participants who voluntarily withdrew from participation in a study 
before the completion of outcome measurement. 
 
 
Sources: 
Cochrane Collaboration Glossary, 2010. Available from 
http://www.cochrane.org/training/cochrane-handbook. 
 
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 
Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from 
www.cochrane-handbook.org. 
 
Last JM (editor), A Dictionary of Epidemiology, 4th Ed. New York: Oxford University Press, 
2001. 
 
Schünemann H, Brożek J, Oxman A, editors. GRADE handbook for grading quality of evidence 
and strength of recommendation. Version 3.2 [updated March 2009]. The GRADE Working 
Group, 2009. Available from http://www.cc-ims.net/gradepro. 
 
 
Data collection form 
Intervention review – RCTs and non-RCTs 
 
 
This form can be used as a guide for developing your own data extraction form. Sections can 
be expanded and added, and irrelevant sections can be removed. It is difficult to design a single 
form that meets the needs of all reviews, so it is important to consider carefully the information 
you need to collect, and design your form accordingly. Information included on this form should 
be comprehensive, and may be used in the text of your review, ‘Characteristics of included 
studies’ table, risk of bias assessment, and statistical analysis. 
 
Notes on using a data extraction form:  
 Be consistent in the order and style you use to describe the information for each report. 
 Record any missing information as unclear or not described, to make it clear that the 
information was not found in the study report(s), not that you forgot to extract it.  
 Include any instructions and decision rules on the data collection form, or in an 
accompanying document. It is important to practice using the form and give training to any 
other authors using the form. 
 
Review title or ID 
Effectiveness of the diabetes education and self management for ongoing and newly diagnosed 
(DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised 
controlled trial 
 
 
Study ID (surname of first author and year first full report of study was published e.g. Smith 2001)  
Davies et al, 2008 
 
Report ID (if different to 
Study ID) 
Report IDs of other reports of this study (e.g. duplicate 
publications, follow-up studies) 
            
 
Notes:         
Adults with type 2 diabetes were referred within four weeks of diagnosis, with those in the 
intervention arm attending a structured group education programme within 12 weeks of diagnosis 
 
General Information 
 
Date form completed 
(dd/mm/yyyy) 
20th July 2012 
Name/ID of person 
extracting data 
Alison Moore 
Reference citation 
 
      
 
 
Study author contact 
details 
      
 
Publication type 
(e.g. full report, abstract, 
letter) 
Full Study 
 
Notes:       
There are 6 studies on DESMOND which assess various elements. The focus for this dissertation 
is on Study 2 (my list) in particular. 
 
Study eligibility 
 
Study 
Characteristic
s 
Eligibility criteria 
(Insert inclusion criteria for each 
characteristic as defined in the Protocol) 
Eligibility criteria 
met?  
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) Yes   
Type of study Cluster Randomised Controlled Trial 
Yes   
      
Quasi-randomised Controlled Trial 
  
No  
      
Controlled Before and After Study 
 Contemporaneous data collection 
 Comparable control site 
 At least 2 x intervention and 2 x 
control clusters 
 No  
      
Interrupted Time Series 
 At least 3 time points before and 
3 after the intervention 
 Clearly defined intervention point 
 No  
      
Other design (specify): 
      
 
 No  
      
Participants 
 
824 adults (55% men, mean age 59.5 
years). 
 
 
Yes   
      
Types of 
intervention 
A structured group education programme 
for 
six hours delivered in the community by 
two trained healthcare professional 
educators compared with usual are.  
 
   
      
Types of 
outcome 
measures 
      
 
 
   
      
 
INCLUDE  Yes 
 
 
EXCLUDE   
 
Reason for 
exclusion 
 
      
Notes:         
DESMOND sessions are interactive and the educators are trained to promote a non-didactic 
approach. 
As well as providing practical information about diet, activity, goal-setting and self-management of 
diabetes, 
the sessions are intended to encourage individuals to share with the group their own experiences 
of being diagnosed as diabetic 
In the control arm, consenting patients received their practice’s usual care for diabetes. ‘Usual 
care’ is not standardized across practices. In many cases, this might include a group-based 
educational intervention, but it might also involve one-to-one counselling with a specialist diabetes 
nurse or some other form of education. (Study Mgt Section) 
Control practices were resourced to enable them to provide contact time with healthcare 
professionals equivalent to that provided by the structured group education programme. The 
practices were allowed to use the resources as they saw fit within their usual care routine. 
Participating practices in the control arm were therefore resourced to provide a robust comparator 
to the intervention and so received “enhanced” standard care. (Study 3 – Table 1) 
 
 
DO NOT PROCEED IF STUDY EXCLUDED FROM REVIEW 
Characteristics of included studies 
Methods 
 
 Descriptions as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Aim of study (e.g. 
efficacy, 
equivalence, 
pragmatic) 
To evaluate the effectiveness of a structured group 
education programme on biomedical, psychosocial, and 
lifestyle measures in people with newly diagnosed type 2 
diabetes. 
Abstract 
Design(e.g. parallel, 
crossover, non-
RCT) 
Cluster RCT 
Setting 207 general practices in 13 primary care sites in 
the United Kingdom. 
 
      
Unit of allocation 
(by individuals, 
cluster/ groups or 
body parts) 
Cluster       
Start date 
 
      
 
      
End date 
 
      
 
      
Duration of 
participation 
(from recruitment to 
last follow-up) 
1st October 2004 -        
Ethical approval 
needed/ obtained 
for study 
   
Yes  
This study was approved by the 
Huntingdon local research ethics 
committee. 
      
Notes:         
Referral of patients with newly diagnosed type 2 diabetes began on 1 October 2004 and ended on 
31 January 2006.”Results” 
Study management 
At each site a local coordinator oversaw the trial, recruited and trained practices, and maintained 
contact with practice staff. Performance of the sites and local coordinators was monitored regularly, 
with each site 
receiving a visit before the trial and a minimum of one monitoring visit per year. Practice staff sent 
biomedical 
data to the local coordinator for forwarding to the central coordinating centre. 
 
 
Participants 
 
 Description 
Include comparative information for each intervention or 
comparison group if available 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Population 
description 
(from which study 
participants are 
drawn) 
The trial was carried out in 13 sites in primary care, 
involving 17 primary care organisations across England 
and Scotland. Randomisation was at practice level, with 
stratification by training status and type of contract with 
the primary care organisation (General Medical Services 
or Personal Medical Services). Randomisation was 
undertaken independently at the University of Sheffield 
using Random Log (D Machin, University of 
Southampton). 
“Methods” 
Setting 
(including location 
and social context) 
13 sites in primary care       
Inclusion criteria  
 
 
Participants with type 2 diabetes were referred within four 
weeks of diagnosis, with those in the intervention arm 
attending a structured group education programme within 
12 weeks of diagnosis. 
“Methods” 
Exclusion criteria 
 
 
We excluded participants if they were aged less than 18 
years, had 
severe and enduring mental health problems, were not 
primarily responsible for their own care, were unable to 
participate in a group programme (for example, 
housebound or unable to communicate in English), or 
were participating in another research study. 
“Methods” 
Method of 
recruitment of 
participants (e.g. 
phone, mail, clinic 
patients) 
Clinic Patients “Methods” 
Informed consent 
obtained  
 
   
Yes  
Participantsgave informed consent 
in accordance with the guidelines 
from the International Conference 
on Harmonisation and WHO good 
clinical practice standards. 
“Methods” 
Total no. 
randomised  
(or total pop. at start 
of study for NRCTs) 
207 practices randomised (105 control, 102 intervention) 
824 Adults 
Patient Control Randomistation Patients referred from 77 
practices (n=488) 
Patient Intervention Randomisation Patients referred 
from 85 practices (n=621) 
Flowchart pg 4 
Clusters 
(if applicable, no., 
type, no. people per 
cluster) 
13 Clusters       
Baseline 
imbalances 
 
 
            
Withdrawals 
(if not provided below 
by outcome) 
 INDIVIDUAL NOT PROVIDED – PRACTICE 
INFORMATION ONLY 
                                   Control                                           
Intervention 
4 months                   N=6                                                    
N=4 
8months                  N=9                                                       
N=10 
12months                 N=8                                                       
N=7 
 
Age 
 
Characteristics Control group (n=387) Intervention group 
(n=437) 
Mean (range) age (years) 60.0 (29-87)                            
59.0 (28-87) 
      
Sex 
 
                                          Control                                           
Intervention 
% (No) women*                43 (168)                                       
47 (204) 
      
Race/Ethnicity 
 
                                          Control                                           
Intervention 
 
% (No) white European        94 (327)                                   
94 (398) 
      
Severity of illness 
 
Low – referred to trial if diagnosed with Type 2 diabetes 
within 4 weeks. 
      
Co-morbidities 
 
Unknown but see Table 4       
Other relevant 
sociodemographics 
 
Not provided       
Subgroups 
measured 
 
Not provided       
Subgroups reported 
 
Not provided       
Notes:         
 
 
 
Intervention groups 
Copy and paste table for each intervention and comparison group  
 
Intervention Group 1 
 Description as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Group name 
 
Intervention       
No. randomised to 
group 
(specify whether no. 
people or clusters) 
102 invited practices 
Patients referred from 85 practices (n=621) 
Consented (n=437, 70%) 
Completed questionnaire (n=420) 
      
Theoretical basis 
(include key references) 
 
            
Description (include 
sufficient detail for 
replication, e.g. content, 
dose, components) 
The structured group education programme is based 
on a series of psychological theories of learning: 
Leventhal’s common sense theory,24 the dual 
process theory,25 and the social learning theory.26 
The philosophy of the programme was founded on 
patient empowerment, as evidenced in published 
work.27 28 
The intervention was devised as a group education 
programme, with a written curriculum suitable for the 
broadest range of participants, to be deliverable in a 
community setting and to be integrated into routine 
care.  
Registered healthcare professionals received 
formal training to deliver the programme and were 
supported by a quality assurance component of 
internal and external assessment to ensure 
consistency of delivery.  
The programme was six hours long, deliverable in 
either one day or two half day equivalents and 
facilitated by two educators. Learning was elicited 
rather than taught, with the behaviour of the educators 
promoting a non-didactic approach. The contents of 
the curriculum were aimed specifically at participants 
attending within 12 weeks of diagnosis. 
Most of the curriculum was focused on lifestyle 
factors, such as food choices, physical activity, and 
cardiovascular risk factors. Attendees were 
encouraged to consider medication as an option in 
their self managementstrategy.  
The programme activates participants to consider their 
own personal risk factors and, in keeping with theories 
of self efficacy,26 to choose a specific, achievable 
goal of behaviour change to work on. The broad 
content of the curriculum and an overview of the 
quality assurance have been reported elsewhere.22 
The programme module was intended as the first step 
in an ongoing cycle of diabetes care, integrating 
education with clinical management. The randomised 
controlled trial therefore had three important functions: 
an evaluation of the intervention itself and its 
generalisability, an assessment of the effectiveness of 
providing structured group education at diagnosis, and 
showing at what point any benefits of education begin 
to diminish. 
“The 
Intervention” 
Duration of treatment 
period 
The programme was six hours long, deliverable in 
either one day or two half day equivalents and 
facilitated by two educators 
      
Timing (e.g. frequency, 
duration of each 
episode) 
The programme was six hours long, deliverable in 
either one day or two half day equivalents and 
facilitated by two educators 
      
Delivery (e.g. 
mechanism, medium, 
intensity, fidelity) 
Group educations programme       
Providers 
(e.g. no., profession, 
training, ethnicity etc. if 
relevant) 
Registered healthcare professionals received 
formal training to deliver the programme and were 
supported by a quality assurance component of 
internal and external assessment to ensure 
consistency of delivery.  
      
Co-interventions 
 
 
N/A       
Economic variables 
(i.e. intervention cost, 
changes in other costs 
as result of intervention) 
See study 5 or 6       
Resource 
requirements 
(e.g. staff numbers, cold 
chain, equipment) 
Primary care practice       
Integrity of delivery 
 
 
High       
Compliance 
 
 
High       
Notes:         
 
 
 
Outcomes 
Copy and paste table for each outcome. 
 
Outcome 1 
 Description as stated in report/paper 
Haemoglobin A1c levels, 
 Blood pressure,  
weight,  
blood lipid levels,  
smoking status, 
physical activity,  
quality of life,  
beliefs about illness, 
depression, and  
emotional impact of diabetes at baseline 
and up to 12 months 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Outcome name 
 
Biomedical   
Questionnaire  
      
Time points 
measured 
(specify whether from 
start or end of 
intervention) 
Baseline, 4, 8, 12 months       
Time points reported 
 
Baseline 4, 8, 12 months       
Outcome definition 
(with diagnostic criteria 
if relevant) 
We collected outcome measures at baseline and at 4, 
8, and 12 months. Biomedical data were collected at 
practice visits. Questionnaire data were collected from 
participants at the beginning of the study and by postal 
questionnaire at 4, 8, and 12 months. We sent out a 
reminder and a further copy of the questionnaire if the 
original was unreturned after two weeks. 
      
Person measuring/ 
reporting 
 
Registered healthcare professionals received formal 
training to deliver the programme and were supported 
by a quality assurance component of internal and 
external assessment to ensure consistency of delivery. 
      
Unit of measurement  
(if relevant) 
BMI, KG, % body fat etc       
Scales: upper and 
lower limits (indicate 
whether high  or low 
score is good) 
Low BMI and weight is good       
Is outcome/tool 
validated? 
   
Yes  
Reputable questionaires used and 
valid BMI, weight, supervision 
      
Imputation of missing 
data 
(e.g. assumptions 
made for ITT analysis) 
No 
Missing outcomes were not replaced and we derived an 
average over time of continuous outcomes. 
“statistical 
analysis” 
Assumed risk 
estimate 
(e.g. baseline or 
population risk noted  
in Background) 
            
Power 90% “Sample Size” 
Notes:         
Assuming a failure to consent rate of 20% (not eligible as well as declining to participate) and a 
dropout rate of 20%, 1000 participants (500 in each arm) needed to be referred. “statistical 
analysis” 
 
Other 
 
Study funding 
sources 
(including role of 
funders) 
Funding: This study was funded by Diabetes UK. The 
project office 
administration was funded by an unrestricted educational 
grant from 
Novo Nordisk. The researchers were independent of any 
of the study 
funders. The study sponsor was the University Hospitals of 
Leicester N 
HS Trust. The research team and the principle investigator 
were 
employees of the sponsor during the period of the study. 
      
Possible conflicts 
of interest 
(for study authors) 
Competing interests: None declared.       
Notes:         
 
 
 Data and analysis 
Copy and paste the appropriate table for each outcome, including additional tables for each 
time point and subgroup as required. 
 
For RCT/CCT 
Continuous outcome 
 Description as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/other
) 
Comparison 
 
Control Group – Usual Care       
Outcome 
 
Biomedical 
Lifestyle 
      
Subgroup 
 
N/A       
Time point 
(specify from start or 
end of intervention) 
Unknown       
Post-intervention 
or change from 
baseline? 
            
Results Intervention Comparison  
Mean SD (or 
other 
variance, 
specify)  
No. 
participant
s 
Mean SD (or 
other 
variance, 
specify) 
No. 
participant
s 
                                    
Any other results 
reported (e.g. mean 
difference, CI, P 
value) 
Lifestyle Outcomes (smoking and physical activity) 
Scores for belief in illness 
Depression and emotional impact of diabetes 
      
No. missing 
participa 
NOT PROVIDED – PRACTICE INFORMATION ONLY 
Control Practice                                           Intervention 
4 months                   N=6                                                    
N=4 
8months                  N=9                                                       
N=10 
12months                 N=8                                                       
N=7 
 
 
 
 
 
 
      
Reasons missing 
 
Not provided unless the person died  
 
 
 
 
 
      
No. participants 
moved from other 
group 
N/A N
/
A 
      
Reasons moved 
 
N/A  
 
 
 
 
 
      
Unit of analysis 
(individuals, cluster/ 
groups or body 
parts) 
Cluster / Group/ Individual       
Statistical 
methods used and 
appropriateness of 
these (e.g. 
adjustment for 
correlation) 
Statistical analysis 
Statistical analysis was carried out on an intention to 
treat basis. Results are reported according to consolidated 
standards of reporting trials guidelines for cluster 
randomised trials.40 We summarised continuous variables 
using means, standard deviations, medians, and 
ranges, and categorical variables using counts and 
percentages. Missing outcomes were not replaced and 
we derived an average over time of continuous 
outcomes. This procedure measures the cumulative 
effect of the treatment and has the maximum number of 
participants. To adjust for a potential clustering effect 
we used robust generalised estimating equations41 with 
exchangeable correlation structure. For binary outcomes 
we used a logit link with a binomial distribution 
for the outcome, and for continuous outcomes we used 
an identity link with a normal distribution. For ordinal 
outcomes we used an ordinal regression model with 
proportional odds assumption, adjusted for clusters.42 
To investigate whether changes in illness beliefs are 
predictive of changes in outcome variable, we carried 
out multiple regressions with adjustment for age, sex, 
and baseline value of the outcome variable. Variables 
were entered in specified sequence, and we report 
standardised regression weights (β). Adjustments were 
not made for multiple testing. All the results from 
planned analyses are reported and small P values are 
interpreted taking into account the overall pattern of 
the results. Statistical significance was set at 5%. Data 
were analysed independently at the University of 
Sheffield using Stata version 9. 
      
Reanalysis 
required? (specify) 
   
No  
            
Reanalysis 
possible? 
   
N/A 
            
Reanalysed results 
 
            
Notes:         
This  study concerned multiple sites and educators. –consistency – how to maintain it? 
The programme involved 34 educators, trained for two days. Quality assurance was provided 
during the trial to ensure consistency in the quality and integrity of the intervention delivered. As a 
result, this intervention is replicable. 
The significance of our results to clinical practice lies in their generalisability. 
In summary, our structured group education programme encapsulates a patient centred approach 
to diabetes care. 
WHAT IS ALREADY KNOWN ON THIS TOPIC 
The diabetes national service framework promotes 
structured education for all from diagnosis of diabetes 
However, until now, there has been no scientific evaluation 
and no programmes demonstrably meeting all the quality 
criteria 
WHAT THIS STUDY ADDS 
A structured group education programme for patients with 
newly diagnosed type 2 diabetes was associated with 
benefits in illness beliefs, weight loss, physical activity, 
smoking status, and depression but not in haemoglobin A1c 
levels 
Most of the changes were sustained over 12months without 
further reinforcement 
The intervention is generalisable and replicable 
 
 
 
 
Definitions 
 
Assumed risk estimate An estimate of the risk of an event or average score without the 
intervention, used in Cochrane 'Summary of findings tables'. If a study 
provides useful estimates of the risk of average score of different 
subgroups of the population, or an estimate based on a representative 
observational study, you may wish to collect this information. 
Change from baseline A measure for a continuous outcome calculated as the difference 
between the baseline score and the post-intervention score.  
Clusters A group of participants who have been allocated to the same 
intervention arm together, as in a cluster-randomised trial, e.g. a whole 
family, town, school or patients in a clinic may be allocated to the same 
intervention rather than separately allocating each individual to different 
arms. 
Co-morbidities The presence of one or more diseases or conditions other than those of 
primary interest. In a study looking at treatment for one disease or 
condition, some of the individuals may have other diseases or 
conditions that could affect their outcomes. 
Compliance Participant behaviour that abides by the recommendations of a doctor, 
other health care provider or study investigator (also called adherence 
or concordance). 
Contemporaneous data 
collection 
When data is collected at the same point(s) in time or covering the 
same time period for each intervention arm in a study (that is, historical 
data are not used as a comparison). 
Controlled Before and 
After Study 
A non-randomised study design where a control population of similar 
characteristics and performance as the intervention group is identified. 
Data are collected before and after the intervention in both the control 
and intervention groups 
Exclusions Participants who were excluded from the study or the analysis by the 
investigators. 
Imputation Assuming a reasonable value for a measure where the true value is not 
available (e.g. assuming last observation carried forward for missing 
participants). 
Integrity of delivery The degree to which the specified procedures or components of an 
intervention are delivered as originally planned. 
Interrupted Time Series A research design that collects observations at multiple time points 
before and after an intervention (interruption). The design attempts to 
detect whether the intervention has had an effect significantly greater 
than the underlying trend. 
Post-intervention The value of a continuous outcome measured at some time point 
following the beginning of the intervention (may be during or after the 
intervention period). 
Power The probability that a trial will detect, as statistically significant, an 
intervention effect of a specified size. 
Providers The person or people responsible for delivering an intervention and 
related care, who may or may not require specific qualifications (e.g. 
doctors, physiotherapists) or training. 
Quasi-randomised 
controlled trial 
A study in which the method of allocating people to intervention arms 
was not random, but was intended to produce similar groups when used 
to allocate participants. Quasi-random methods include: allocation by 
the person's date of birth, by the day of the week or month of the year, 
by a person's medical record number, or just allocating every alternate 
person. 
Reanalysis Additional analysis of a study's results by a review author (e.g. to 
introduce adjustment for correlation that was not done by the study 
authors). 
Report ID A unique ID code given to a publication or other report of a study by the 
review author (e.g. first author's name and year of publication). If a 
study has more than one report (e.g. multiple publications or additional 
unpublished data) a separate Report ID can be allocated to each to 
help review authors keep track of the source of extracted data. 
Sociodemographics Social and demographic information about a study or its participants, 
including  economic and cultural information, location, age, gender, 
ethnicity, etc. 
Study ID A unique ID code given to an included or excluded study by the review 
author (e.g. first author's name and year of publication from the main 
report of the study). Although a study may have multiple reports or 
references, it should have one single Study ID to help review authors 
keep track of all the different sources of information for a study. 
Theoretical basis The use of a particular theory (such as theories of human behaviour 
change) to design the components and implementation of an 
intervention 
Unit of allocation The unit allocated to an intervention arm. In most studies individual 
participants will be allocated, but in others it may be individual body 
parts (e.g. different teeth or joints may be allocated separately) or 
clusters of multiple people. 
Unit of analysis The unit used to calculate N in an analysis, and for which the result is 
reported. This may be the number of individual people, or the number of 
body parts or clusters of people in the study. 
Unit of measurement  The unit in which an outcome is measured, e.g. height may be 
measured in cm or inches; depression may be measured using points 
on a particular scale. 
Validated A process to test and establish that a particular measurement tool or 
scale is a good measure of that outcome. 
Withdrawals Participants who voluntarily withdrew from participation in a study 
before the completion of outcome measurement. 
 
 
Sources: 
Cochrane Collaboration Glossary, 2010. Available from 
http://www.cochrane.org/training/cochrane-handbook. 
 
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 
Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from 
www.cochrane-handbook.org. 
 
Last JM (editor), A Dictionary of Epidemiology, 4th Ed. New York: Oxford University Press, 
2001. 
 
Schünemann H, Brożek J, Oxman A, editors. GRADE handbook for grading quality of evidence 
and strength of recommendation. Version 3.2 [updated March 2009]. The GRADE Working 
Group, 2009. Available from http://www.cc-ims.net/gradepro. 
 
Cluster randomisation 
Cluster randomised trial designs can be used to overcome some of the problems associated 
with ‘lifestyle intervention’ trials in general practice. A cluster randomisation trial is one in which 
intact social units, or clusters of individuals rather than individuals themselves, are randomised 
to different intervention groups.9 When randomisation occurs at the group level, all participants 
recruited from the practice, school or workplace are allocated to either the intervention or the 
control group. The outcomes to measure the effect of the intervention are still assessed at the 
individual level, but the level at which the comparison is made is the practice, school or 
workplace. Cluster RCT design is recommended when delivery of an intervention is likely to 
affect others within the group or cluster.6,9–11 Cluster RCTs are being used increasingly where 
delivery of an intervention is at a group (or practice) level,12,13 and outcomes are measured at 
the patient level.14 
Data collection form 
Intervention review – RCTs and non-RCTs 
 
 
This form can be used as a guide for developing your own data extraction form. Sections can 
be expanded and added, and irrelevant sections can be removed. It is difficult to design a single 
form that meets the needs of all reviews, so it is important to consider carefully the information 
you need to collect, and design your form accordingly. Information included on this form should 
be comprehensive, and may be used in the text of your review, ‘Characteristics of included 
studies’ table, risk of bias assessment, and statistical analysis. 
 
Notes on using a data extraction form:  
 Be consistent in the order and style you use to describe the information for each report. 
 Record any missing information as unclear or not described, to make it clear that the 
information was not found in the study report(s), not that you forgot to extract it.  
 Include any instructions and decision rules on the data collection form, or in an 
accompanying document. It is important to practice using the form and give training to any 
other authors using the form. 
 
Review title or ID 
Improving management of obesity in primary care: cluster randomised trial 
  
Study ID (surname of first author and year first full report of study was published e.g. Smith 2001)  
Moore, 2003 
 
Report ID (if different to 
Study ID) 
Report IDs of other reports of this study (e.g. duplicate 
publications, follow-up studies) 
            
 
Notes:         
 
 
General Information 
 
Date form completed 
(dd/mm/yyyy) 
19th July 2012 
Name/ID of person 
extracting data 
Alison Moore 
 
Reference citation 
 
      
 
 
Study author contact 
details 
      
 
Publication type 
(e.g. full report, abstract, 
letter) 
Full Study 
 
Notes:       
The objective of this study is to evaluate a training programme intended to improve the 
management of obesity, delivered to general practice teams. 
 
Study eligibility 
 
Study 
Characteristic
s 
Eligibility criteria 
(Insert inclusion criteria for each 
characteristic as defined in the Protocol) 
Eligibility criteria 
met?  
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) Yes No 
Uncle
ar 
Type of study  Cluster Randomised Controlled Trial 
Yes   
      
Quasi-randomised Controlled Trial 
  
No  
      
Controlled Before and After Study 
 Contemporaneous data collection 
 Comparable control site 
 At least 2 x intervention and 2 x 
control clusters 
 No  
      
Interrupted Time Series 
 At least 3 time points before and 
3 after the intervention 
 Clearly defined intervention point 
 No  
Baseline, 3, 
12, 18 months 
Other design (specify): 
      
 
 No  
      
Participants 
 
44 general practices invited consecutively 
attending obese adults to participate; 843 
patients attended for collection of baseline 
data and were subsequently randomised. 
 
 
Yes   
      
Types of 
intervention 
4.5 hour training programme promoting 
an obesity management model to GP’s & 
PN’s. 
The training covered information on the 
clinical benefit of weight loss and effective 
treatment options, including reduction of 
dietary energy intake, increased physical 
activity, and pharmaceutical intervention. 
 
Yes   
      
Types of 
outcome 
measures 
Difference in weight between patients in 
intervention and control groups at 12 
months (main outcome measure) and at 3 
months and 18 months; change in 
practitioners' knowledge and behaviour in 
obesity management consultations 
 
   
      
 
INCLUDE   
 
EXCLUDE   
  
Reason for 
exclusion 
 
      
Notes:         
 
 
 
DO NOT PROCEED IF STUDY EXCLUDED FROM REVIEW 
Characteristics of included studies 
Methods 
 
 Descriptions as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Aim of study (e.g. 
efficacy, 
equivalence, 
pragmatic) 
To evaluate a training programme intended to improve the 
management of obesity, delivered to general practice 
teams 
      
Design(e.g. parallel, 
crossover, non-
RCT) 
Cluster RCT       
Unit of allocation 
(by individuals, 
cluster/ groups or 
body parts) 
Cluster       
Start date 
 
The only reference is ‘Training was delivered between 
June and November 2000’.  There is no participant start 
date mentioned. 
 
‘Results’ 
End date 
 
The only reference is ‘Training was delivered between 
June and November 2000’.  There is no participant start or 
end date mentioned. 
 
      
Duration of 
participation 
(from recruitment to 
last follow-up) 
Not specified       
Ethical approval 
needed/ obtained 
for study 
   
Yes  
Ethical approval The Northern and 
Yorkshire regional medical research 
ethics committee and five local 
research ethics committees approved 
the study 
 
      
Notes:         
 
 
 Participants 
 
 Description 
Include comparative information for each intervention or 
comparison group if available 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Population 
description 
(from which study 
participants are 
drawn) 
44 general practices invited consecutively attending 
obese adults to participate; 843 patients attended for 
collection of baseline data and were subsequently 
randomised. 
 
      
Setting 
(including location 
and social context) 
Northern and Yorkshire region of England 
 
      
Inclusion criteria  
 
 
The study protocol required practice staff to invite 
consecutively attending obese adults (body mass index ≥ 
30 kg/m2) aged 16 to 64 years to participate in the trial 
over a defined six month recruitment period 
Recruitment 
Exclusion criteria 
 
 
All general practitioners and practice nurses in the 44 
practices (a total of 245 staff) were eligible to participate. 
In a previous trial,8 staff working in primary care but 
between practices (for example, district nurses and 
health visitors) were a source of contamination, so we 
asked for these staff to be excluded from the study. 
Recruitment 
Method of 
recruitment of 
participants (e.g. 
phone, mail, clinic 
patients) 
Patients were asked to return a consent form to the 
practice by stamped addressed envelope or on their next 
visit. The recruitment strategy was extended to include 
assistance from study personnel and mail shots. 
Towards the end of the recruitment period, a researcher 
accessed the list of patients who had been recruited in 
the early stages and invited them to attend for collection 
of baseline data, so that all patients had been weighed 
within two months of randomisation. All practices were 
randomised simultaneously in June 2000. 
Recruitment 
Informed consent 
obtained  
 
   
Yes  
Patients were asked to return a 
consent form to the practice by 
stamped addressed envelope or on 
their next visit. 
      
Total no. 
randomised  
(or total pop. at start 
of study for NRCTs) 
44 practices, 245 staff,  
 
Figure 1 
Clusters 
(if applicable, no., 
type, no. people per 
cluster) 
Intervention – Practice (22), Staff (115) 
Control – Practice (22), Staff (116) 
Figure 1 
Baseline 
imbalances 
 
 
            
Withdrawals and 
exclusions 
(if not provided below 
by outcome) 
 
View larger version: 
 
      
Age 
 
Mean age 
Intervention 48.4(10.9) years (SD) 
Control 48.8(12.2) years (SD)  
      
Sex 
 
Male 104 (25%) – Intervention 
Male 116 (27%) - Control 
      
Race/Ethnicity 
 
Not provided       
Severity of illness 
 
Extremely obesity       
Co-morbidities 
 
Not provided       
Other relevant 
sociodemographics 
 
Median (interquartile range) 
socioeconomic status 
3.4 (-
0.9-5.8) 
2.4 
(0.1-
7.1) 
 
      
Subgroups 
measured 
 
N/A  
Subgroups reported 
 
N/A       
Notes:         
 
 
 
Intervention groups 
Copy and paste table for each intervention and comparison group  
 
Intervention Group 1 
 Description as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Group name 
 
Intervention       
No. randomised to 
group 
(specify whether no. 
people or clusters) 
Intervention – 22 Practices, 115 staff, 415 patients 
Control – 22 Practices, 116 Staff, 428 patients 
      
Theoretical basis 
(include key references) 
 
N/A       
Description (include 
sufficient detail for 
replication, e.g. content, 
dose, components) 
At the start of the intervention period, we provided all 
practices with a list of their patients who had entered 
the trial. The educational strategy was based on a 
previous nutrition training programme.8 We delivered 
three 90 minute sessions, intended to be delivered at 
intervals of no less than one week and no more than 
two weeks apart, to the 22 intervention practices. We 
asked all general practitioners and practice nurses to 
attend all three sessions. Four dietitians were trained 
in the standardised delivery of the training and then 
delivered the programme to small group, 
multidisciplinary general practice teams. The 
programme promoted a model approach to obesity 
treatment, which incorporated best evidence and was 
perceived to be brief enough that primary care staff 
could deliver it to their patients. The training covered 
information on the clinical benefit of weight loss and 
effective treatment options, including reduction of 
dietary energy intake, increased physical activity, and 
pharmaceutical intervention. 
The model of obesity management entailed 
practitioners seeing patients regularly (about every 
two weeks) until they had lost 10% of their original 
body weight and then less regularly (about every one 
to two months) for maintenance of weight over a 
sustained period. Current and target weight and 
dietary and activity targets were to be recorded in the 
patients' records to facilitate continuity of support 
across practice teams. Prescription of a moderate 
energy deficit diet was advocated, as recommended 
by the Scottish Intercollegiate Guidelines Network.11 
A “ready reckoner” was produced to allow 
practitioners to estimate a patient's daily energy 
requirement and then to calculate a daily 500 kcal (2.5 
MJ) deficit. Diet sheets and supporting written 
resources facilitated the dietary prescription to 
patients. At the end of the three training sessions, 
practices devised individualised weight management 
protocols based on the model and were encouraged 
to implement this with patients recruited to the study. 
Control practices were asked to provide usual care to 
their patients. 
      
Duration of treatment 
period 
No exact dates provided 
6 month recruitment period and 18 month 
intervention/follow up 
      
Timing (e.g. frequency, 
duration of each 
episode) 
Patients saw practitioners regularly (about every 2 
weeks) until they lost 10% of body weight and then 
less regularly (1-2 months) for maintenance 
      
Delivery (e.g. 
mechanism, medium, 
intensity, fidelity) 
patients attended a one to one meeting with 
practitioner  
      
Providers 
(e.g. no., profession, 
training, ethnicity etc. if 
relevant) 
General practitioners and practice nurses       
Co-interventions 
 
 
N/A       
Economic variables 
(i.e. intervention cost, 
changes in other costs 
as result of intervention) 
No financial incentives were provided to the practice        
Resource 
requirements 
(e.g. staff numbers, cold 
chain, equipment) 
Participation of practices and time for training and 
delivering the intervention 
      
Integrity of delivery 
 
 
Unclear       
Compliance 
 
 
Unclear       
Notes:         
Impact of the Intervention 
Practitioners' knowledge of the principles of obesity management improved, and trained 
practitioners were more likely to implement weight management strategies promoted in the training. 
Patients from trained practices were seen more often and were more likely to have weight, target 
weights, and dietary targets documented in their records, but in absolute terms the level of 
implementation was low. Target weights were recorded for only 14% of participating patients in 
trained practices, compared with just 3% of participating patients in control practices, in the year 
after delivery of the training. Patients in trained practices attended two more consultations than did 
those in control practices, averaging eight consultations in the year after the intervention. 
Treatment as per protocol would entail fortnightly follow up until 10% of initial body weight was lost, 
potentially some 20 or more consultations in the year. The low level of implementation of the 
obesity management model means that we cannot draw conclusions about its effectiveness. 
 
 
 
Outcomes 
Copy and paste table for each outcome. 
 
Outcome 1 
 Description as stated in report/paper 
Difference in weight between patients in intervention 
and control groups at 12 months (main outcome 
measure) and at 3 months and 18 months; change in 
practitioners' knowledge and behaviour in obesity 
management consultations. 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Outcome name 
 
Weight 
3 months after training 
12 months after training 
18 months after training 
      
Time points 
measured 
(specify whether from 
start or end of 
intervention) 
Baseline, 3, 12, 18 months       
Time points reported 
 
Baseline, 3, 12, 18 months       
Outcome definition 
(with diagnostic criteria 
if relevant) 
Mean Weight 
Mean BMI 
      
Person measuring/ 
reporting 
 
Researchers were collecting outcome measurements 
GP and PN were reporting 
      
Unit of measurement  
(if relevant) 
Weight (kg) 
BMI kgm2 
      
Scales: upper and 
lower limits (indicate 
whether high  or low 
score is good) 
            
Is outcome/tool 
validated? 
   
 Unclear 
            
Imputation of missing 
data 
(e.g. assumptions 
made for ITT analysis) 
No 
A clinically significant effect of intervention can be 
achieved with as little as 5% (or 3-5 kg) weight loss in 
obese people.1 2 We designed the study to have 80% 
power to detect a mean difference in weight between 
treatment arms of approximately 3-5 kg, assuming 5% 
significance and a within practice correlation coefficient 
of 0.05. Allowing for withdrawal and loss to follow up of 
15%, this gave a required number of patients per 
treatment arm of approximately 660, equivalent to 22 
practices recruiting 30 patients each. We collated all 
data on a purposefully designed database by using 
Microsoft Access software. We analysed change in both 
continuous and categorical outcome variables by using 
STATA to account for both within cluster and between 
cluster variation. We did analyses on an intention to 
treat basis, where possible 
      
Assumed risk 
estimate 
(e.g. baseline or 
population risk noted  
in Background) 
            
Power 80%       
Notes:         
 
 
 
Other 
 
Study funding 
sources 
(including role of 
funders) 
Funding NHS Executive, Northern and Yorkshire       
Possible conflicts 
of interest 
(for study authors) 
None declared       
Notes:         
 
 
 
Data and analysis 
Copy and paste the appropriate table for each outcome, including additional tables for each 
time point and subgroup as required. 
 
For RCT/CCT 
Continuous outcome 
 Description as stated in report/paper 
Mean Weight 3,12,18 months 
Mean BMI 
Change in Practitioners knowledge of Obesity 
Management 
Location in 
text or source 
(pg & 
¶/fig/table/other
) 
Comparison 
 
Control Group       
Outcome 
 
Mean Weight 3,12,18 months 
Mean BMI 
Change in Practitioners knowledge of Obesity 
Management 
      
Subgroup 
 
N/A       
Time point 
(specify from start or 
end of intervention) 
Not clear       
Post-intervention 
or change from 
baseline? 
            
Results Intervention Comparison       
Mean SD (or 
other 
variance, 
specify)  
No. 
participant
s 
Mean SD (or 
other 
variance, 
specify) 
No. 
participant
s 
                                    
Any other results 
reported (e.g. mean 
difference, CI, P 
value) 
Mean Weight 3,12,18 months 
Mean BMI 
Change in Practitioners knowledge of Obesity 
Management 
      
No. missing 
participants 
 
Withdrew detailed 
above but no ‘missing 
data’ reported 
            
Reasons missing 
 
Not provided             
No. participants 
moved from other 
group 
None             
Reasons moved 
 
N/A             
Unit of analysis 
(individuals, cluster/ 
groups or body 
parts) 
Cluster and individual       
Statistical 
methods used and 
appropriateness of 
these (e.g. 
adjustment for 
correlation) 
As above – no mention of accounting for missing data       
Reanalysis 
required? (specify) 
   
 No  
            
Reanalysis 
possible? 
   
 No 
            
Reanalysed results 
 
N/A       
Notes:         
 
 
 
 
 
Other information 
 Description as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Key conclusions of 
study authors 
 
This training programme resulted in only limited 
implementation of an approach to obesity 
management and did not achieve improved patient 
weight loss. A more in-depth training programme 
might be more successful at changing practitioners' 
behaviour but is unlikely to be generalisable to most 
general practices in the United Kingdom. Other 
strategies to manage obesity in primary care urgently 
need to be considered and evaluated. These might 
include motivated and dedicated obesity specialists 
placed at the level of the primary care trust, use of 
leisure services, and use of the commercial weight 
loss sector. 
Comment 
Analysis was on ‘intention to treat’ where possible 
Samples were biased towards women 
Sample was skewed towards extreme obesity 
Retention was a problem 
Reduce/Eliminate Contamination: GP’s & PN’s only 
were offered training. In reality enforcing this is difficult 
& many additional practice staff (district nurses & 
health visitors) turned up for training. Previous study 
(8) demonstrated that this was a source of 
contamination so these were excluded to avoid this. 
Although they detected no evidence of contamination 
between the intervention groups this cannot be ruled 
out. 
      
References to other 
relevant studies 
 
            
Correspondence 
required for further 
study information 
(from whom, what and 
when) 
      
Notes:         
 
 
 
Definitions 
 
Assumed risk estimate An estimate of the risk of an event or average score without the 
intervention, used in Cochrane 'Summary of findings tables'. If a study 
provides useful estimates of the risk of average score of different 
subgroups of the population, or an estimate based on a representative 
observational study, you may wish to collect this information. 
Change from baseline A measure for a continuous outcome calculated as the difference 
between the baseline score and the post-intervention score.  
Clusters A group of participants who have been allocated to the same 
intervention arm together, as in a cluster-randomised trial, e.g. a whole 
family, town, school or patients in a clinic may be allocated to the same 
intervention rather than separately allocating each individual to different 
arms. 
Co-morbidities The presence of one or more diseases or conditions other than those of 
primary interest. In a study looking at treatment for one disease or 
condition, some of the individuals may have other diseases or 
conditions that could affect their outcomes. 
Compliance Participant behaviour that abides by the recommendations of a doctor, 
other health care provider or study investigator (also called adherence 
or concordance). 
Contemporaneous data 
collection 
When data is collected at the same point(s) in time or covering the 
same time period for each intervention arm in a study (that is, historical 
data are not used as a comparison). 
Controlled Before and 
After Study 
A non-randomised study design where a control population of similar 
characteristics and performance as the intervention group is identified. 
Data are collected before and after the intervention in both the control 
and intervention groups 
Exclusions Participants who were excluded from the study or the analysis by the 
investigators. 
Imputation Assuming a reasonable value for a measure where the true value is not 
available (e.g. assuming last observation carried forward for missing 
participants). 
Integrity of delivery The degree to which the specified procedures or components of an 
intervention are delivered as originally planned. 
Interrupted Time Series A research design that collects observations at multiple time points 
before and after an intervention (interruption). The design attempts to 
detect whether the intervention has had an effect significantly greater 
than the underlying trend. 
Post-intervention The value of a continuous outcome measured at some time point 
following the beginning of the intervention (may be during or after the 
intervention period). 
Power The probability that a trial will detect, as statistically significant, an 
intervention effect of a specified size. 
Providers The person or people responsible for delivering an intervention and 
related care, who may or may not require specific qualifications (e.g. 
doctors, physiotherapists) or training. 
Quasi-randomised 
controlled trial 
A study in which the method of allocating people to intervention arms 
was not random, but was intended to produce similar groups when used 
to allocate participants. Quasi-random methods include: allocation by 
the person's date of birth, by the day of the week or month of the year, 
by a person's medical record number, or just allocating every alternate 
person. 
Reanalysis Additional analysis of a study's results by a review author (e.g. to 
introduce adjustment for correlation that was not done by the study 
authors). 
Report ID A unique ID code given to a publication or other report of a study by the 
review author (e.g. first author's name and year of publication). If a 
study has more than one report (e.g. multiple publications or additional 
unpublished data) a separate Report ID can be allocated to each to 
help review authors keep track of the source of extracted data. 
Sociodemographics Social and demographic information about a study or its participants, 
including  economic and cultural information, location, age, gender, 
ethnicity, etc. 
Study ID A unique ID code given to an included or excluded study by the review 
author (e.g. first author's name and year of publication from the main 
report of the study). Although a study may have multiple reports or 
references, it should have one single Study ID to help review authors 
keep track of all the different sources of information for a study. 
Theoretical basis The use of a particular theory (such as theories of human behaviour 
change) to design the components and implementation of an 
intervention 
Unit of allocation The unit allocated to an intervention arm. In most studies individual 
participants will be allocated, but in others it may be individual body 
parts (e.g. different teeth or joints may be allocated separately) or 
clusters of multiple people. 
Unit of analysis The unit used to calculate N in an analysis, and for which the result is 
reported. This may be the number of individual people, or the number of 
body parts or clusters of people in the study. 
Unit of measurement  The unit in which an outcome is measured, e.g. height may be 
measured in cm or inches; depression may be measured using points 
on a particular scale. 
Validated A process to test and establish that a particular measurement tool or 
scale is a good measure of that outcome. 
Withdrawals Participants who voluntarily withdrew from participation in a study 
before the completion of outcome measurement. 
 
 
Sources: 
Cochrane Collaboration Glossary, 2010. Available from 
http://www.cochrane.org/training/cochrane-handbook. 
 
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 
Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from 
www.cochrane-handbook.org. 
 
Last JM (editor), A Dictionary of Epidemiology, 4th Ed. New York: Oxford University Press, 
2001. 
 
Schünemann H, Brożek J, Oxman A, editors. GRADE handbook for grading quality of evidence 
and strength of recommendation. Version 3.2 [updated March 2009]. The GRADE Working 
Group, 2009. Available from http://www.cc-ims.net/gradepro. 
 
 
Data collection form 
Intervention review – RCTs and non-RCTs 
 
 
This form can be used as a guide for developing your own data extraction form. Sections can 
be expanded and added, and irrelevant sections can be removed. It is difficult to design a single 
form that meets the needs of all reviews, so it is important to consider carefully the information 
you need to collect, and design your form accordingly. Information included on this form should 
be comprehensive, and may be used in the text of your review, ‘Characteristics of included 
studies’ table, risk of bias assessment, and statistical analysis. 
 
Notes on using a data extraction form:  
 Be consistent in the order and style you use to describe the information for each report. 
 Record any missing information as unclear or not described, to make it clear that the 
information was not found in the study report(s), not that you forgot to extract it.  
 Include any instructions and decision rules on the data collection form, or in an 
accompanying document. It is important to practice using the form and give training to any 
other authors using the form. 
 
Review title or ID 
Comparison of range of commercial or primary care led weight reduction programmes with minimal 
intervention control for weight loss in obesity: Lighten Up randomised controlled trial 
  
Study ID (surname of first author and year first full report of study was published e.g. Smith 2001)  
Jolly et al (2011) 
 
Report ID (if different to 
Study ID) 
Report IDs of other reports of this study (e.g. duplicate 
publications, follow-up studies) 
            
 
Notes:         
This study investigates the effectiveness of several pragmatic interventions in primary care patients 
recruited in the NHS. 
‘Pragmatic Interventions’ 
Pragmatic research asks whether an intervention works under real-life conditions and whether it 
works in terms that matter to the patient. It is simply concerned with whether the intervention works, 
not how or why. Pragmatic studies are most useful for deciding what services should be provided 
but give only limited insight into why interventions do or do not work. 
Explanatory research asks whether an intervention works under ideal or selected conditions. It is 
more concerned with how and why an intervention works. Explanatory studies are valuable for 
understanding questions of efficacy but are of limited value for telling us whether we should provide 
a service to a wide variety of patients in a wide variety of circumstances. 
The distinction between pragmatic and explanatory research is important because it will determine 
key methodological issues relating to patient selection, definition of the intervention and controls, 
use of blinding and placebos, choice of outcome measure and type of analysis. 
 
 
 
General Information 
 
Date form completed 
(dd/mm/yyyy) 
25th July 2012 
Name/ID of person 
extracting data 
Alison Moore 
 
Reference citation 
 
      
 
 
Study author contact 
details 
      
 
Publication type 
(e.g. full report, abstract, 
letter) 
Full Report 
 
Notes:       
 
 
Study eligibility 
 
Study 
Characteristic
s 
Eligibility criteria 
(Insert inclusion criteria for each 
characteristic as defined in the Protocol) 
Eligibility criteria 
met?  
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) Yes   
Type of study Randomised Controlled Trial 
Yes   
      
Quasi-randomised Controlled Trial 
  
No  
      
Controlled Before and After Study 
 Contemporaneous data collection 
 Comparable control site 
 At least 2 x intervention and 2 x 
control clusters 
 No  
      
Interrupted Time Series 
 At least 3 time points before and 
3 after the intervention 
 Clearly defined intervention point 
 No  
      
Other design (specify): 
      
 
 No  
      
Participants 
 
740 obese or overweight men and women 
with a comorbid 
disorder identified from general practice 
records.  
 
   
      
Types of 
intervention 
 Weight loss programmes of 12 
weeks’ duration: Weight Watchers;  
 Slimming World;  
 Rosemary Conley;  
 group based dietetics led 
programme; 
Yes   
      
 general practice one to one 
counselling; pharmacy led one to 
one counselling;  
 choice of any of the six 
programmes.  
 Thecomparator group was 
provided with 12 vouchers 
enabling free entrance 
 to a local leisure (fitness) centre.  
 
Types of 
outcome 
measures 
The primary outcome was weight loss at 
programme end (12 weeks).  
Secondary outcomes were weight loss at 
one year, self reported physical activity, 
and percentage weight loss at programme 
end and one year.  
   
      
 
INCLUDE  Yes 
 
 
EXCLUDE   
 
Reason for 
exclusion 
 
      
Notes:         
 
 
DO NOT PROCEED IF STUDY EXCLUDED FROM REVIEW 
Characteristics of included studies 
Methods 
 
 Descriptions as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Aim of study (e.g. 
efficacy, 
equivalence, 
pragmatic) 
To assess the effectiveness of a range of weight 
management 
programmes in terms of weight loss. 
      
Design(e.g. parallel, 
crossover, non-
RCT) 
Eight arm randomised controlled trial       
Unit of allocation 
(by individuals, 
cluster/ groups or 
body parts) 
Groups       
Start date 
 
Recruitment took place from January to May  
Follow-up assessments took place between April 2009 and 
August 2010 
 
“Participants” 
 
“Outcome 
Assessment” 
End date 
 
August 2010 
 
“Outcome 
Assessment” 
Duration of 
participation 
(from recruitment to 
last follow-up) 
17 months       
Ethical approval 
needed/ obtained 
for study 
   
Yes  
Ethical approval: South Birmingham 
Research Ethics Committee 
(08/H1207/331) granted ethical 
approval. 
“Conclusion” 
Notes:         
 
 
 
 
 
Participants 
 
 Description 
Include comparative information for each intervention or 
comparison group if available 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Population 
description 
(from which study 
participants are 
drawn) 
Eligible participants were registered with general 
practices in South Birmingham Primary Care Trust, were 
aged at least 18 years, and had a raised body mass 
index recorded in their primary care notes within the 
previous 15 months. The body mass index threshold for 
invitation was that which makes them eligible for primary 
care obesity management services in the NHS and 
varied according to ethnic group and the presence or 
absence of comorbidities (box 1). The threshold for 
invitation for people with no obesity related comorbidity 
was a body mass index of 30 or above. For people of 
South Asian ethnicity, this threshold was lower. The 
general practitioner had to confirm that the patient had no 
medical contraindications for any of the intervention 
programmes before a letter of invitation was sent. 
We excluded patients if they were unable to understand 
English or were pregnant. Seventeen practices took part. 
“Population” 
Setting 
(including location 
and social context) 
1. The participants allocated to commercial 
providers had a choice of times and venues. 
2. The Size Down Programme is an NHS group 
based programme led by food advisers recruited 
from the local community and trained by the 
dietetics department; sessions took place in 
various community venues. 
3. Participants randomised to the general practice or 
pharmacy arms attended 12 one to one sessions 
in the general practice or pharmacy 
4. Participants allocated to the comparator group 
were sent vouchers for 12 free sessions at a local 
authority run leisure centre (a council run facility 
open to all members of the public and usually 
consisting of a swimming pool, fitness suite, and 
other sports halls or courts). 
      
Inclusion criteria  
 
 
Criteria for invitation to weight loss programmes 
• White Europeans and all ethnic groups apart from 
South Asians with no comorbidities: BMI ≥30 
• White Europeans and all ethnic groups apart from 
South Asians with comorbidities: BMI ≥28 
• South Asians with no comorbidities: BMI ≥25 
• South Asians with comorbidities 
The general practitioner had to confirmthat the patient 
had no medical contraindications for any of the 
intervention programmes before a letter of invitation was 
sent 
Box 1 
Exclusion criteria 
 
 
We excluded patients if they were unable to understand 
English or were pregnant. Seventeen practices took part. 
“Population” 
Method of 
recruitment of 
participants (e.g. 
phone, mail, clinic 
patients) 
Eligible participants were registered with general 
practices in South Birmingham Primary Care Trust. 
Eligible patients were invited to participate in the trial by a 
standard 
letter from their general practitioner, which included the 
patients’ information leaflet and a free telephone number 
for a 
call centre managing the recruitment and randomisation. 
The 
nurses at the call centre provided more information to 
patients 
about the trial, collected baseline information, took verbal 
consent, and randomised patients to the trial arms. The 
nurses 
then booked participants into their first treatment session 
and 
sent confirmation, along with verification of consent and 
information on how to withdraw from the trial if they 
changed 
their minds. Participants allocated to the general practice, 
pharmacy, or minimal intervention (comparator) groups 
were 
sent details about how to arrange their first session. 
“Population” 
Informed consent 
obtained  
 
   
Yes  
Verbal consent obtained “Population” 
Total no. 
randomised  
(or total pop. at start 
of study for NRCTs) 
740 randomised 
Weight Watchers (n=100) 
Slimming World (n=100) 
Rosemary Conley (n=100) 
Size Down (n=100) 
General Practice (n=70) 
Pharmacy (n=70) 
Choice (n=100) 
Exercise Comparator (n=100) 
Table 1 
Clusters 
(if applicable, no., 
type, no. people per 
cluster) 
N/A       
Baseline 
imbalances 
 
 
N/A       
Withdrawals and 
exclusions 
(if not provided below 
by outcome) 
At programme end, 658 (88.9%) participants were 
followed up; 522 (70.5%) were followed up at one year 
(fig 1⇓). 
Figure 1 
Age 
 
Mean (SD) age (years)  
WW 50.71 (14.56)  
SW 48.84 (14.91)  
RC 49.76 (14.51)  
Size Down 48.75 (15.63)  
General Practice 50.48 (13.79)  
Pharmacy 48.94 (15.82)  
Choice 47.45 (14.35)  
Exercise Comparator 49.67 (13.83) 
      
Sex 
 
Men are as below: Work out as % and then get female 
participants. 
WW = 28 
SW = 35 
RC = 31 
Size Down =36 
General Practice = 23(33) 
Pharmacy  = 19(27) 
Choice = 30(30) 
Exercise Comparator =25(25) 
      
Race/Ethnicity 
 
See table 1       
Severity of illness 
 
Not provided       
Co-morbidities 
 
Obesity       
Other relevant 
sociodemographics 
 
            
Subgroups 
measured 
 
N/A       
Subgroups reported 
 
N/A       
Notes:         
 
 
 
Intervention groups 
Copy and paste table for each intervention and comparison group  
 
Intervention Group 1 – Commercial Operator 
 Description as stated in report/paper 
The participants allocated to the commercial operators 
Weight 
Watchers, Slimming World, and Rosemary Conley 
had a choice 
of locations and times for the programme.13-15 
Participants were 
provided with vouchers that exempted them from 
paying for 12 
consecutive weeks of the programmes. Each 
programme was 
provided in accordance with the respective 
organisation’s 
guidance and ran continuously, with no set start date; 
the group 
leaders were trained by the respective organisations. 
The trial 
participants attended alongside people who paid to 
attend the 
programmes. 
Weight Watchers is group based, and the participant 
was able to join at any time. One to one support is 
available for new members and during weighing. This 
is followed by a group talk from the leader, with 
discussion. Meetings took place in community venues 
and lasted one hour. Core programme material 
delivered over five weeks included a food points 
system (based on age, sex, height, weight, and 
activity), beating hunger, taking more physical activity, 
eating out, and keeping motivated. Other sessions 
delivered to the whole group covered recipes, health 
and nutrition, and keeping active. The plan aims for 
500 kcal (2.09 MJ) deficit/day, leading to 0.5-1.0 kg 
weight loss a week. Physical activity is encouraged; 
the objective is to gradually build up to 10 000 steps 
daily. Predominant strategies used to change 
behaviour included stages of change, food and activity 
diaries, goal setting, and evaluation of progress. 
Rewards are given for every 3.2 kg (7 lb) lost 
and for loss of 5% and 10% of body weight. 
Slimming World is group based, and the participant 
was able to join at any time. Meetings took place in 
community venues and lasted 90 
minutes. Also included is access to a website, 
magazines, and one to one telephone support from a 
consultant or other members. Members are 
encouraged to eat mainly foods with low energy 
density to achieve satiety, plus some extras rich in 
calcium and fibre, with controlled amounts of high 
energy dense foods. Weight loss goals are set by the 
individual. Physical activity is encouraged, with 
gradual build up to 30 minutes of moderately intense 
activity five days a week. The theoretical background 
is based on transactional analysis and motivational 
interviewing. Predominant behaviour change 
strategies used included weekly weighing; group 
support; and group praise for weight loss, new 
decisions, and continued commitment even in the 
absence of weight loss. Awards are given for 3.2 kg (7 
lbs) lost and loss of 10% of body weight. Individual 
support, if needed, uses self monitoring of food and 
emotions, for and against evaluations, visualisation 
techniques, and personal eating plans. 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Group name 
 
Weight Watchers, Slimming World, Rosemary Conley       
No. randomised to 
group 
(specify whether no. 
people or clusters) 
WW = (n=100) 
SW = (n=100) 
RC = (n=100) 
      
Theoretical basis 
(include key references) 
 
N/A       
Description (include 
sufficient detail for 
replication, e.g. content, 
dose, components) 
N/A       
Duration of treatment 
period 
12 consecutive weeks of the programmes.       
Timing (e.g. frequency, 
duration of each 
episode) 
Weekly       
Delivery (e.g. 
mechanism, medium, 
intensity, fidelity) 
Meetings       
Providers 
(e.g. no., profession, 
training, ethnicity etc. if 
relevant) 
Commercial weight programmes - the group leaders 
were trained by the respective organisations. 
      
Co-interventions 
 
 
N/A       
Economic variables 
(i.e. intervention cost, 
changes in other costs 
as result of intervention) 
See Table 7       
Resource 
requirements 
(e.g. staff numbers, cold 
chain, equipment) 
To detect a 2 (SD 3.2) kg difference in weight loss at 
the three 
months’ follow-up between any of the planned 
interventions 
and the comparator group, with 90% power and 5% 
significance 
level and assuming 20% loss to follow-up, we needed 
70 participants randomised to each group. The 
sample size calculation did not take account of 
adjustments for multiple comparisons. To account for 
dropouts, we allocated 100 participants to each arm, 
except for the general practice and pharmacy arms. 
Because of limited availability, provision of these 
programmes was restricted to 70 participants per arm, 
resulting in a total sample size of 740 participants. We 
selected 
the 2 kg difference as being achievable from previous 
published 
studies,7 17 and an important contribution towards a 
5% weight 
loss, which is associated with clinically meaningful 
health 
benefits. 
      
Integrity of delivery 
 
 
High       
Compliance 
 
 
Compliance of commercial provider = unknown       
Notes:         
 
 
 
 
 
 
 
 
 
 
 
Intervention Group 2 The Size Down Programme 
 Description as stated in report/paper 
The Size Down Programme was an NHS group based 
programme run in community venues by support 
workers trained by the dietetics 
service. This provided six weekly two hour sessions, 
with follow-up sessions at nine and 12 weeks. All 
participants joined together in week 
one of the programme. Its particular focus was on long 
term changes in patterns of eating behaviour, 
achieving a balanced diet, and increasing 
physical activity in daily life, and it used an interactive 
style. Topics covered included managing behaviour 
around food and prevention of 
relapse, the eatwell plate, nutritional information, 
planning strategies to deal with lapses into previous 
dietary behaviours, interactive visual 
aids to show the fat and sugar content of foods, and 
adaptation of recipes. The theoretical background was 
based on the cycle of change 
(Prochaska and Di Clemente). The benefits of 
physical activity, setting goals, and finding activities to 
fit into life were discussed. Predominant 
behaviour change strategies used included goal 
setting, stages of change, and self monitoring with a 
food diary. 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Group name 
 
The Size Down Programme       
No. randomised to 
group 
(specify whether no. 
people or clusters) 
100       
Theoretical basis 
(include key references) 
 
N/A       
Description (include 
sufficient detail for 
replication, e.g. content, 
dose, components) 
As above       
Duration of treatment 
period 
This provided six weekly two hour sessions, with 
follow-up sessions at nine and 12 weeks 
      
Timing (e.g. frequency, 
duration of each 
episode) 
Unknown       
Delivery (e.g. 
mechanism, medium, 
intensity, fidelity) 
Group sessions (6 weeks / 2 hour sessions)       
Providers 
(e.g. no., profession, 
training, ethnicity etc. if 
relevant) 
Provided support workers trained by the dietetics 
service 
      
Co-interventions 
 
 
N/A       
Economic variables 
(i.e. intervention cost, 
changes in other costs 
as result of intervention) 
See Table 2       
Resource 
requirements 
(e.g. staff numbers, cold 
chain, equipment) 
community venues and support workers       
Integrity of delivery 
 
 
Unknown       
Compliance 
 
 
Unknown       
Notes:         
 
 
 
Intervention Group 3 General Practice or Pharmacy 
 Description as stated in report/paper 
The general practice and pharmacy programmes 
comprised 12 one to one sessions in the general 
practice or pharmacy. The first session 
was planned to last 30 minutes, with follow-up 
sessions of 15-20 minutes. Sessions were client led 
and based around a problem solving 
approach. Sessions included weight and dieting 
history, exploration of goals and expectations of 
patients, the eatwell plate, setting goals to 
reduce calorie intake and increase physical activity, 
planning strategies to deal with challenging situations, 
use of food diaries, and maintaining 
weight loss. Weight loss goals were 5-10% of starting 
body weight, at a rate of 0.5-1 kg/week over three to 
six months, followed by maintenance. 
Physical activity goals were to aim to slowly increase 
activity levels to achieve 30 minutes of moderate 
activity on five days each week. The 
theoretical basis used stages of change and 
motivational interviewing. Predominant behaviour 
change strategies included goal setting, self 
monitoring with food diaries, hunger scale, waist 
measurements, and physical activity. Resources were 
provided as homework for discussion 
in the next session or for personal reflection. 
Participants were encouraged to reward themselves 
for success. 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Group name 
 
General Practice and Pharmacy Programmes       
No. randomised to 
group 
(specify whether no. 
people or clusters) 
General Practice n=70 
Pharmacy = 70 
      
Theoretical basis 
(include key references) 
 
N/A       
Description (include 
sufficient detail for 
replication, e.g. content, 
dose, components) 
Sessions were client led and based around a problem 
solving 
approach. Sessions included weight and dieting 
history, exploration of goals and expectations of 
patients, the eatwell plate, setting goals to 
reduce calorie intake and increase physical activity, 
planning strategies to deal with challenging situations, 
use of food diaries, and maintaining 
weight loss. Weight loss goals were 5-10% of starting 
body weight, at a rate of 0.5-1 kg/week over three to 
six months, followed by maintenance. 
Physical activity goals were to aim to slowly increase 
activity levels to achieve 30 minutes of moderate 
activity on five days each week. The 
theoretical basis used stages of change and 
motivational interviewing. Predominant behaviour 
change strategies included goal setting, self 
monitoring with food diaries, hunger scale, waist 
measurements, and physical activity. Resources were 
provided as homework for discussion 
in the next session or for personal reflection. 
Participants were encouraged to reward themselves 
for success. 
      
Duration of treatment 
period 
The general practice and pharmacy programmes 
comprised 12 one to one sessions in the general 
practice or pharmacy. The first session 
was planned to last 30 minutes, with follow-up 
sessions of 15-20 minutes. 
      
Timing (e.g. frequency, 
duration of each 
episode) 
Implied weekly but not stated       
Delivery (e.g. 
mechanism, medium, 
intensity, fidelity) 
12 one to one sessions       
Providers 
(e.g. no., profession, 
training, ethnicity etc. if 
relevant) 
general practice or pharmacy       
Co-interventions 
 
 
N/A       
Economic variables 
(i.e. intervention cost, 
changes in other costs 
as result of intervention) 
See Table 7       
Resource 
requirements 
(e.g. staff numbers, cold 
chain, equipment) 
Participating GP surgeries and pharmacies       
Integrity of delivery 
 
 
Unknown       
Compliance 
 
 
Unknown       
Notes:         
 
 
 
Intervention Group 4 Comparator Group 
 Description as stated in report/paper 
Participants allocated to the comparator group were 
sent vouchers for 12 free sessions at a local authority 
run leisure centre (a council run facility open to all 
members of the public and usually consisting of a 
swimming pool, fitness suite, and other sports halls or 
courts). Participants were not given an appointment to 
attend and were given no individual advice or support 
on diet or physical activity. Box 2 gives further details 
of the interventions, and fuller details are online. 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Group name 
 
Exercise / Comparator Group       
No. randomised to 
group 
(specify whether no. 
people or clusters) 
100       
Theoretical basis 
(include key references) 
 
N/A       
Description (include 
sufficient detail for 
replication, e.g. content, 
dose, components) 
As above       
Duration of treatment 
period 
Not specified       
Timing (e.g. frequency, 
duration of each 
episode) 
Not specified       
Delivery (e.g. 
mechanism, medium, 
intensity, fidelity) 
Delivered by attendance and participation in leisure 
facilities 
      
Providers 
(e.g. no., profession, 
training, ethnicity etc. if 
relevant) 
Leisure facility       
Co-interventions 
 
 
N/A       
Economic variables 
(i.e. intervention cost, 
changes in other costs 
as result of intervention) 
See Table 7       
Resource 
requirements 
(e.g. staff numbers, cold 
chain, equipment) 
Leisure Centre       
Integrity of delivery 
 
 
Unknown       
Compliance 
 
 
Unknown       
Notes:         
 
 
 
Outcomes 
Copy and paste table for each outcome. 
 
Outcome 1 – Primary Outcome 
 Description as stated in report/paper 
Weight Loss at Programme End 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Outcome name 
 
Weight Loss at Programme End (12 weeks) 
 
      
Time points 
measured 
(specify whether from 
start or end of 
intervention) 
Baseline 
Three months 
Twelve months 
      
Time points reported 
 
Programme End (Three Months) 
Twelve Months 
      
Outcome definition 
(with diagnostic criteria 
if relevant) 
The primary outcome was weight loss at three months’ 
follow-up (programme end). 
      
Person measuring/ 
reporting 
 
Programme End (Three Months) 
If participants were still attending their allocated weight 
loss intervention at programme end, the service 
providers weighed them and provided this data to the 
research team. 
 
      
Unit of measurement  
(if relevant) 
kg       
Scales: upper and 
lower limits (indicate 
whether high  or low 
score is good) 
            
Is outcome/tool 
validated? 
   
 Unclear 
            
Imputation of missing 
data 
(e.g. assumptions 
made for ITT analysis) 
Unsure 
“We assumed participants for whom 
weight at follow-up was not available to have their 
baseline weight for the primary analyses” 
      
Assumed risk 
estimate 
(e.g. baseline or 
population risk noted  
in Background) 
Unknown       
Power 90%       
Notes:         
Statistic Analysis: 
We preferred objectively measured weight, but we used self reported weights when they were the 
only measures available. 
 
 
 
 
 
Outcome 2 - Secondary outcomes were weight loss at one year, self reported physical activity, 
and percentage weight loss at programme end and one year. 
 Description as stated in report/paper 
Secondary outcomes were weight loss at one year, self 
reported physical activity, and percentage weight loss 
at programme end and one year. 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Outcome name 
 
Weight Loss at 1 Year 
Self Reported Physical Activity 
Percentage Weight Loss at Programme End and One 
Year 
      
Time points 
measured 
(specify whether from 
start or end of 
intervention) 
Baseline 
Three months 
Twelve months 
      
Time points reported 
 
Three months 
Twelve months 
      
Outcome definition 
(with diagnostic criteria 
if relevant) 
Secondary outcomes were weight loss at one year, self 
reported physical activity, and percentage weight loss 
at programme end and one year. 
      
Person measuring/ 
reporting 
 
Weight Loss at 12 Months 
A trained practice nurse, health trainer, or researcher 
blinded 
to the allocation group did the one year assessment at 
the 
participant’s general practice or home. This included 
assessment 
of weight and height, the IPAQ-short, and a free text 
question 
about their opinion of the service and whether they had 
tried 
any other weight loss programmes or strategies over 
the course 
of the year. The scales used for weight measurement 
during the 
study period in the practices and by the weight 
management 
services were all checked with standardised weights, 
unless a 
record of recent calibration was available. 
      
Unit of measurement  
(if relevant) 
Weight Loss at 1 Year – kg  
Self Reported Physical Activity –  
Percentage Weight Loss at Programme End and One 
Year - % 
      
Scales: upper and 
lower limits (indicate 
whether high  or low 
score is good) 
Unknown       
Is outcome/tool 
validated? 
   
Unclear 
            
Imputation of missing 
data 
(e.g. assumptions 
made for ITT analysis) 
Unsure 
“We assumed participants for whom 
weight at follow-up was not available to have their 
baseline weight for the primary analyses” 
      
Assumed risk 
estimate 
(e.g. baseline or 
population risk noted  
in Background) 
Unknown       
Power 90%       
Notes:         
 
 
 
Other 
 
Study funding 
sources 
(including role of 
funders) 
The study was funded by NHS South Birmingham. 
PAveyard 
is supported by a National Institute for Health Research 
(NIHR) career 
scientist award. AD is supported by a senior research 
fellowship award 
from the NIHR. KJ was part funded by the NIHR through 
the 
Collaborations for Leadership in Applied Health Research 
and Care for 
Birmingham and Black Country (CLAHRC-BBC) 
programme. The views 
expressed in this publication are those of the authors and 
not necessarily 
those of the NIHR, the Department of Health, NHS South 
Birmingham, 
the University of Birmingham, or the CLAHRC-BBC 
Steering Group. JD 
and JB were employed by the sponsoring organisation. 
Their roles are 
outlined above. The writing of the report and the decision 
to submit the 
article for publication rested with the authors from the 
University of 
Birmingham 
      
Possible conflicts 
of interest 
(for study authors) 
All authors have completed the ICMJE uniform 
disclosure form at www.icmje.org/coi_disclosure.pdf 
(available on 
request from the corresponding author) and declare: 
PAveyard and AL 
have received hospitality from Weight Watchers on one 
occasion; JD 
and JB were employed by the funding organisation and 
managed the 
service. 
      
Notes:         
 
 
Data and analysis 
Copy and paste the appropriate table for each outcome, including additional tables for each 
time point and subgroup as required. 
For RCT/CCT 
Continuous outcome 
 Description as stated in report/paper 
Weight Loss at Programme End (12 Weeks) 
Location in 
text or source 
(pg & 
¶/fig/table/other
) 
Comparison 
 
Commercial Provider 
The Size Down Programme 
GP or Pharmacy 
Comparator Group 
      
Outcome 
 
Weight Loss at Programme End (12 weeks)       
Subgroup 
 
N/A       
Time point 
(specify from start or 
end of intervention) 
Follow-up assessments took place between April 2009 and 
August 2010 
      
Post-intervention 
or change from 
baseline? 
Yes – See Table 2 and Table 3       
Results Intervention Comparison       
Mean SD (or 
other 
variance, 
specify)  
No. 
participant
s 
Mean SD (or 
other 
variance, 
specify) 
No. 
participant
s 
                                    
Any other results 
reported (e.g. mean 
difference, CI, P 
value) 
Secondary Outcomes: 
Weight Loss at 1 Year – kg  
Self Reported Physical Activity –  
Percentage Weight Loss at Programme End and One Year 
- % 
Exploratory Analysis: 
In an exploratory subgroup analysis, we examined weight 
loss 
separately in men and women by using a regression 
model, with 
the arm to which they were allocated and age as 
covariates. 
Furthermore, we examined whether the effects of each 
intervention varied by sex by adding multiplicative 
interaction 
terms for intervention by sex to the model. This is because 
commercial weight loss interventions are almost invariably 
run 
by women and treat their clients in groups dominated by 
women, 
so the effectiveness might vary by sex 
      
No. missing 
participants 
 
                  
Reasons missing 
 
Not provided             
No. participants 
moved from other 
group 
N/A N/A       
Reasons moved 
 
N/A N/A       
Unit of analysis 
(individuals, cluster/ 
groups or body 
parts) 
Groups       
Statistical 
methods used and 
appropriateness of 
these (e.g. 
adjustment for 
correlation) 
We did all analyses according to intention to treat and 
using Stata v11.0 and SPSS v17.0. We preferred 
objectively measured weight, but we used self reported 
weights when they were the only measures available. We 
assumed participants for whom weight at follow-up was 
not available to have their baseline weight for the primary 
analyses. We also did a sensitivity analysis using the last 
recorded weight as the follow-up weight. 
      
Reanalysis 
required? (specify) 
   
 No 
            
Reanalysis 
possible? 
   
Yes No
 Unclear 
N/A       
Reanalysed results 
 
N/A       
Notes:         
 
 
 
Other information 
 Description as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Key conclusions of 
study authors 
 
Commercially provided weight management services 
are 
more effective and cheaper than primary care based 
services led by specially trained staff, which are 
ineffective. 
      
References to other 
relevant studies 
 
            
Correspondence 
required for further 
study information 
(from whom, what and 
when) 
N/A 
Notes:         
What is already known on this topic 
Some commercial and primary care based weight management programmes have been shown to 
produce significantly greater weight loss than in a control group after one year 
What this study adds 
In a primary care population, group based programmes produced significant weight loss at one 
year after a 12 week programme 
One to one primary care based programmes were ineffective and most costly to provide 
Short commercial and NHS group based programmes have the potential to produce clinically useful 
weight loss at one year follow-up 
 
Definitions 
 
Assumed risk estimate An estimate of the risk of an event or average score without the 
intervention, used in Cochrane 'Summary of findings tables'. If a study 
provides useful estimates of the risk of average score of different 
subgroups of the population, or an estimate based on a representative 
observational study, you may wish to collect this information. 
Change from baseline A measure for a continuous outcome calculated as the difference 
between the baseline score and the post-intervention score.  
Clusters A group of participants who have been allocated to the same 
intervention arm together, as in a cluster-randomised trial, e.g. a whole 
family, town, school or patients in a clinic may be allocated to the same 
intervention rather than separately allocating each individual to different 
arms. 
Co-morbidities The presence of one or more diseases or conditions other than those of 
primary interest. In a study looking at treatment for one disease or 
condition, some of the individuals may have other diseases or 
conditions that could affect their outcomes. 
Compliance Participant behaviour that abides by the recommendations of a doctor, 
other health care provider or study investigator (also called adherence 
or concordance). 
Contemporaneous data 
collection 
When data is collected at the same point(s) in time or covering the 
same time period for each intervention arm in a study (that is, historical 
data are not used as a comparison). 
Controlled Before and 
After Study 
A non-randomised study design where a control population of similar 
characteristics and performance as the intervention group is identified. 
Data are collected before and after the intervention in both the control 
and intervention groups 
Exclusions Participants who were excluded from the study or the analysis by the 
investigators. 
Imputation Assuming a reasonable value for a measure where the true value is not 
available (e.g. assuming last observation carried forward for missing 
participants). 
Integrity of delivery The degree to which the specified procedures or components of an 
intervention are delivered as originally planned. 
Interrupted Time Series A research design that collects observations at multiple time points 
before and after an intervention (interruption). The design attempts to 
detect whether the intervention has had an effect significantly greater 
than the underlying trend. 
Post-intervention The value of a continuous outcome measured at some time point 
following the beginning of the intervention (may be during or after the 
intervention period). 
Power The probability that a trial will detect, as statistically significant, an 
intervention effect of a specified size. 
Providers The person or people responsible for delivering an intervention and 
related care, who may or may not require specific qualifications (e.g. 
doctors, physiotherapists) or training. 
Quasi-randomised 
controlled trial 
A study in which the method of allocating people to intervention arms 
was not random, but was intended to produce similar groups when used 
to allocate participants. Quasi-random methods include: allocation by 
the person's date of birth, by the day of the week or month of the year, 
by a person's medical record number, or just allocating every alternate 
person. 
Reanalysis Additional analysis of a study's results by a review author (e.g. to 
introduce adjustment for correlation that was not done by the study 
authors). 
Report ID A unique ID code given to a publication or other report of a study by the 
review author (e.g. first author's name and year of publication). If a 
study has more than one report (e.g. multiple publications or additional 
unpublished data) a separate Report ID can be allocated to each to 
help review authors keep track of the source of extracted data. 
Sociodemographics Social and demographic information about a study or its participants, 
including  economic and cultural information, location, age, gender, 
ethnicity, etc. 
Study ID A unique ID code given to an included or excluded study by the review 
author (e.g. first author's name and year of publication from the main 
report of the study). Although a study may have multiple reports or 
references, it should have one single Study ID to help review authors 
keep track of all the different sources of information for a study. 
Theoretical basis The use of a particular theory (such as theories of human behaviour 
change) to design the components and implementation of an 
intervention 
Unit of allocation The unit allocated to an intervention arm. In most studies individual 
participants will be allocated, but in others it may be individual body 
parts (e.g. different teeth or joints may be allocated separately) or 
clusters of multiple people. 
Unit of analysis The unit used to calculate N in an analysis, and for which the result is 
reported. This may be the number of individual people, or the number of 
body parts or clusters of people in the study. 
Unit of measurement  The unit in which an outcome is measured, e.g. height may be 
measured in cm or inches; depression may be measured using points 
on a particular scale. 
Validated A process to test and establish that a particular measurement tool or 
scale is a good measure of that outcome. 
Withdrawals Participants who voluntarily withdrew from participation in a study 
before the completion of outcome measurement. 
 
 
Sources: 
Cochrane Collaboration Glossary, 2010. Available from 
http://www.cochrane.org/training/cochrane-handbook. 
 
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 
Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from 
www.cochrane-handbook.org. 
 
Last JM (editor), A Dictionary of Epidemiology, 4th Ed. New York: Oxford University Press, 
2001. 
 
Schünemann H, Brożek J, Oxman A, editors. GRADE handbook for grading quality of evidence 
and strength of recommendation. Version 3.2 [updated March 2009]. The GRADE Working 
Group, 2009. Available from http://www.cc-ims.net/gradepro. 
 
 
Data collection form 
Intervention review – RCTs and non-RCTs 
 
 
This form can be used as a guide for developing your own data extraction form. Sections can 
be expanded and added, and irrelevant sections can be removed. It is difficult to design a single 
form that meets the needs of all reviews, so it is important to consider carefully the information 
you need to collect, and design your form accordingly. Information included on this form should 
be comprehensive, and may be used in the text of your review, ‘Characteristics of included 
studies’ table, risk of bias assessment, and statistical analysis. 
 
Notes on using a data extraction form:  
 Be consistent in the order and style you use to describe the information for each report. 
 Record any missing information as unclear or not described, to make it clear that the 
information was not found in the study report(s), not that you forgot to extract it.  
 Include any instructions and decision rules on the data collection form, or in an 
accompanying document. It is important to practice using the form and give training to any 
other authors using the form. 
 
Review title or ID 
The Internet for weight control in an obese sample: results of a randomised controlled trial 
 
Study ID (surname of first author and year first full report of study was published e.g. Smith 2001)  
McConnon et al (2007) 
 
Report ID (if different to 
Study ID) 
Report IDs of other reports of this study (e.g. duplicate 
publications, follow-up studies) 
            
 
Notes:         
 
 
General Information 
 
Date form completed 
(dd/mm/yyyy) 
17th July 2012 
Name/ID of person 
extracting data 
Alison Moore 
 
Reference citation 
 
      
 
 
Study author contact 
details 
      
 
Publication type 
(e.g. full report, abstract, 
letter) 
Full Study 
 
Notes:       
 
 
Study eligibility 
 
Study 
Characteristic
s 
Eligibility criteria 
(Insert inclusion criteria for each 
characteristic as defined in the Protocol) 
Eligibility criteria 
met?  
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) Yes 
 
 
 
 
Type of study Randomised Controlled Trial 
Yes   
      
Quasi-randomised Controlled Trial 
  
No  
      
Controlled Before and After Study 
 Contemporaneous data collection 
 Comparable control site 
 At least 2 x intervention and 2 x 
control clusters 
   
      
Interrupted Time Series 
 At least 3 time points before and 
3 after the intervention 
 Clearly defined intervention point 
   
Baseline, 6 
months, 12 
months 
Other design (specify): 
      
 
   
      
Participants 
 
Obese volunteers (n = 221) were 
randomly assigned to Internet group (n = 
111) or usual care group (n = 
110).  
 
Yes   
      
Types of 
intervention 
Supports a lifestyle approach to 
treating obesity, offering a combination of 
dietary advice, physical activity advice 
and behaviour therapy  
 
Yes   
      
Types of 
outcome 
measures 
The primary outcome was the ability of 
the Internet package to promote change 
in weight and BMI over six and 12 months 
compared with usual care. Secondary 
outcomes were the ability of the Internet 
package to promote change in reported 
lifestyle behaviours compared with usual 
care, along with differences in quality of 
life.  
Yes   
      
 
INCLUDE  Yes 
 
   
 
Reason for 
exclusion 
 
      
Notes:         
 
 
DO NOT PROCEED IF STUDY EXCLUDED FROM REVIEW 
 
 
 
Characteristics of included studies 
Methods 
 
 Descriptions as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Aim of study (e.g. 
efficacy, 
equivalence, 
pragmatic) 
• To develop an Internet-based interactive and 
personalised 
package for weight control (http://www.ukweight 
control.co.uk) 
• To explore acceptability of the Internet-based package to 
potential users 
• To conduct a randomised-controlled trial on the 
effectiveness 
of the Internet-based package in promoting 
weight loss compared with usual care 
• To promote the results through publication and 
dissemination via local and national health and community 
networks 
      
Design(e.g. parallel, 
crossover, non-
RCT) 
RCT       
Unit of allocation 
(by individuals, 
cluster/ groups or 
body parts) 
Groups       
Start date 
 
Recruitment May – November 2003 
 
      
End date 
 
1st January 2004 
1st January 2005 
      
Duration of 
participation 
(from recruitment to 
last follow-up) 
12 months       
Ethical approval 
needed/ obtained 
for study 
   
Yes  
Participants were recruited from GP 
practices in Leeds, 
UK, following ethical approval from 
Leeds (West) 
Research Ethics Committee in August 
2002. 
“Methods” 
Participants 
Notes:         
The start and end dates are not specifically mentioned in this paper however I checked this with the 
‘controlled trials register (http://www.controlled-trials.com/isrctn/pf/58621669) and they provided me 
with the anticipated start and end dates which I have applied above. 
 
 
Participants 
 
 Description 
Include comparative information for each intervention or 
comparison group if available 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Population 
description 
(from which study 
participants are 
drawn) 
Participants were recruited from GP practices in Leeds, 
UK, following ethical approval from Leeds (West) 
Research Ethics Committee in August 2002.  
 
The sample was predominantly white (95%), female 
(77%), with a mean (sd) age of 45.8 (10.6). The mean 
(sd) weight of the sample was 98.4 kg (17.4) with a 
median (IQR) BMI of 34.4 (31.9–38.7). Preliminary 
analysis 
showed no significant differences between the two 
groups at baseline (Table 1). 
 
“Methods” 
Participants 
 
“Results” 
Baseline 
characteristics 
Setting 
(including location 
and social context) 
The setting was the internet at a chosen location by the 
participant. 
 
On confirmation of informed written participant and GP 
consent, a baseline appointment was scheduled for each 
eligible participant, where height and weight were 
measured 
by the researcher and a baseline questionnaire 
completed, 
before each participant was randomly allocated 
into either the Internet group (n = 111) or the usual care 
group (n = 110). 
“Methods” 
Participants 
Inclusion criteria  
 
 
• BMI >30 kg/m2 
• 18–65 years of age (due to body composition 
changes 
• over the age of 65 years) 
• Able to access the Internet at least once per 
week 
• Able to read and write in English (for the 
purposes of accessing the site and completing 
questionnaires) 
Short paper 
‘Inclusion 
Criteria’ 
Exclusion criteria 
 
 
• Pregnant or lactating women 
• Women planning on becoming pregnant 
within the 
• next year 
• Any illness or reason where the GP feels that the 
patient 
• should not be taking part in a clinical trial. 
Short paper 
‘Inclusion 
Criteria’ 
Method of 
recruitment of 
participants (e.g. 
phone, mail, clinic 
patients) 
Posters and flyers were placed in patient waiting areas, 
advertising the study and asking interested potential 
participants to call 
the study centre or to inform their GP or practice nurse of 
their interest. 
Study procedure 
Eligible participants will be sent a covering letter, 
participant 
information sheet, consent form and an initial 
approach questionnaire. Consenting participants will be 
contacted by telephone to arrange a first visit with the 
research team at their GP surgery. At the first visit height, 
weight, waist and hip circumference will be measured for 
each participant. The baseline questionnaire will then be 
administered. At this point the participant will be 
randomly 
allocated using minimisation (Minim) into either 
the treatment group or the usual care group. Because of 
the nature of the intervention, it is not possible to blind 
either the participants or the researchers to the group 
assignment. Participants will be followed-up 6 months 
and 12 months after randomisation. At these visits they 
will have their height, weight, waist and hip 
measurements 
repeated, and will be asked to complete a further 
questionnaire at each visit. 
“Methods” 
Participants 
 
 
 
Small Study 
Informed consent 
obtained  
 
   
Yes  
And GP consent obtained also       
Total no. 
randomised  
(or total pop. at start 
of study for NRCTs) 
221 randomised participants Figure 1 
Clusters 
(if applicable, no., 
type, no. people per 
cluster) 
N/A       
Baseline 
imbalances 
 
 
????       
Withdrawals and 
exclusions 
(if not provided below 
by outcome) 
14 exclusions Figure 1 
Age 
 
Intervention Mean Age = 48.1 years 
Control Group Mean Age = 47.4 years 
Table 2 
Comparison of 
baseline 
characteristics 
of responders 
by 
treatment 
group 
Sex 
 
Gender Male/Female % 
 
Responders 21%/79% 
Non Responders 22%/78% 
Table 3: 
Comparison of 
baseline 
characteristics 
of responders 
versus non-
responders 
Race/Ethnicity 
 
Not mentioned       
Severity of illness 
 
Not mentioned        
Co-morbidities 
 
Obesity BMI >30 kg/m2 
 
      
Other relevant 
sociodemographics 
 
Not mentioned       
Subgroups 
measured 
 
N/A  
Subgroups reported 
 
N/A       
Notes:         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intervention groups 
Copy and paste table for each intervention and comparison group  
 
Intervention Group  
 Description as stated in report/paper 
The intervention 
Current research evidence supports a lifestyle 
approach to 
treating obesity, offering a combination of dietary 
advice, 
physical activity advice and behaviour therapy [14-17]. 
Based on these guidelines and clinical evidence, the 
intervention 
website was developed to reflect these factors. The 
website provided advice, tools and information to 
support 
behaviour change in terms of dietary and physical 
activity patterns. It was designed to enable patients to 
manage their own care and to vary the frequency of 
use 
according to their own needs. The website also 
offered 
personalised advice to participants, which, in the 
context 
of this trial, involved targeting the information provided 
to an individual, based on their responses to a series 
of 
online questions regarding eating and activity habits 
and 
current weight status. This enabled specific 
motivational 
statements to be generated to participants whenever 
they 
visited the website. Motivational statements were 
generated 
based on participants self report of progress in terms 
of reaching their personal behaviour change goals. In 
addition, details of progress in terms of self-reported 
weight loss were stored on the website, accessible 
only to 
the individual concerned. Automatic generic e-mails 
were 
generated if participants did not visit the website 
regularly 
to encourage them to visit more often. The website 
and 
questionnaires were piloted in a sample of overweight 
University staff. The results of this pilot were used to 
inform the final version of the website. 
The trial aimed to compare the additional effect of the 
website against usual care available within the UK. 
Participants 
randomised into the Internet group were given a 
demonstration of the website and its services, along 
with 
a username and password to access the website and 
were 
asked to log on to the website at least once a week 
over the 
trial period. Participants randomised to the usual care 
group were advised to continue with their usual 
approach 
to weight loss and were given a small amount of 
printed 
information at baseline, reflecting the type of 
information 
available within primary care. 
Location in 
text or source  
 
“The 
intervention” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Small Study 
“Intervention 
Group” 
 
Group name 
 
Intervention       
No. randomised to 
group 
(specify whether no. 
people or clusters) 
111 Figure 1 
Theoretical basis 
(include key references) 
 
            
Description (include 
sufficient detail for 
replication, e.g. content, 
dose, components) 
What the UK Weight Control Site Will Do 
The UK weight control site will provide free weight 
management 
information based on the best possible advice 
from experts in the field. It will enable patients to 
manage 
their own care and to vary the frequency of use 
according 
to their own needs. The site will offer personalised 
advice 
to participants, which, in the context of the Internet, 
involves targeting the information provided to an 
individual individual based on their responses to a 
series of online questions. This will enable targeted 
motivational statements to 
be generated to participants whenever they visit the 
site. In 
addition, details of progress in terms of self-reported 
weight loss will be stored on the site, accessible only 
to the 
individual concerned. Participants will be given a 
demonstration 
of the website and its services, along with a username 
and password to access the site. They will be 
encouraged to log on frequently over the first few days 
in 
order to get accustomed to the site. After that 
participants 
will be encouraged to visit the site as often as they 
wish. 
Site usage will be monitored, along with the nature of 
participant 
queries and the time spent in dealing with them. 
Automatic emails will be generated if participants do 
not 
visit the site regularly to encourage them to visit more 
often 
      
Duration of treatment 
period 
12 months       
Timing (e.g. frequency, 
duration of each 
episode) 
Baseline 
6 months after randomisation 
12 months after randomisation 
      
Delivery (e.g. 
mechanism, medium, 
intensity, fidelity) 
UK weight control site via the internet       
Providers 
(e.g. no., profession, 
training, ethnicity etc. if 
relevant) 
Unclear 
It is unclear whether or how training was provided to 
GP’s & PN’s however it is noted that interested 
potential participants to call 
the study centre or to inform their GP or practice nurse 
of their interest. It is unclear who responds to queries 
and who provides individual plans and motivational 
element of the interventions. 
Authors Contributions 
SK is the Principal Investigator, who conceived of the 
idea 
and obtained funding for the study.  
EH is a co-applicant on the grant and provides advice 
and guidance on the study design and conduct of the 
RCT.  
AM is co-ordinating the day-to-day running of the 
study.  
JP was the initial research manager on the project, 
who put together the content of the site and now 
advises on the web site content. 
DG is the statistician on the study.  
JT is the database manager and web designer/web 
master. All authors have contributed to the set up and 
design of the study. JR is an advisor on the study on 
aspects relating to project management. 
 
“Methods 
Participants” 
 
 
 
Small Study 
Co-interventions 
 
 
N/A       
Economic variables 
(i.e. intervention cost, 
changes in other costs 
as result of intervention) 
Cost-effectiveness results 
The cost-effectiveness analysis showed that total 
costs 
were higher in the Internet group than the usual care 
group (£992.40 compared to £276.12). This difference 
was almost entirely due to the fixed cost of developing 
the 
website package. When this fixed cost was excluded 
total 
costs were actually lower in the Internet group. 
In terms of incremental cost effectiveness [26] the 
incremental ratio is £39,248 (£716.28/0.01825). Thus 
a decision 
maker would have to be willing to pay £39,248 per 
QALY to choose the Internet program over the usual 
care approach. AS shown in the cost-effectiveness 
acceptability curve (Figure 3) the decision about which 
is the most cost effective strategy is uncertain. At 
willingness to pay values of £20,000–£30,000 per 
QALY, it is unlikely that Internetbased support would 
be regarded as cost-effective (probability it is cost-
effective is less than 0.5). As the service becomes 
more widely available, fixed costs will be spread over 
a greater number of individuals, thus total costs will 
reduce. This is likely to produce a much more 
favourable cost per QALY. 
 
      
Resource 
requirements 
(e.g. staff numbers, cold 
chain, equipment) 
Sample size 
With 180 participants in total we should be able to 
detect 
a difference of 5 kg weight loss (approximately 5% of 
body weight) or less than 2.5 kg/m2 in BMI between 
the 
two groups with 80% power. This assumes a two-
sample 
t-test, 5% significance levels, a standard deviation for 
weight of 12 kg and for BMI of 5.5 kg/m2. An 
additional 
22% of participants will be recruited to take account of 
any loss to follow-up, giving a target recruitment figure 
of 220 
NOTE: Minimal resource requirements in terms of 
location and spatial capacity due to internet use. 
Possible training costs attributed to GP/PN but not 
detailed here so unknown quantum. 
      
Integrity of delivery 
 
 
Medium       
Compliance 
 
 
Use of the website by Internet group participants 
Fifty-nine participants (53%) reported using the 
website at six months with 32 (29%) of these still 
using the website at 12 months and 52 participants 
(47%) indicating that they never used the website. The 
mean (sd) number 
of logons over the trial was 15.8 (15.2), this ranged 
from a minimum of one logon to a maximum of 77 
logons. The 
data failed to reveal any correlation between the 
number of logons and weight loss (p = 0.16). Only 
26% of the 
Internet group respondents at six months reported 
using the Internet daily for general use and no 
relationship 
between Internet use and number of logons to the 
website over the 12 months was established (CI = -
10.1 to 12.9, p = 0.82). Despite high attrition and low 
utilisation, of those who had reported use of the 
website at six months 39 (63%) rated it easy or very 
easy to use at six months, and 49 (78%) rated it as 
clear or very clear. With 28 (85%) and 25 (76%) of 
those respondents reporting use of the QALY. 
 
      
Notes:   
'Usual Care' Group 
Participants randomised to this group will be advised to continue with their usual approach to 
weight loss, e.g. to contact their GP, obtain a dietetic referral, or visit commercial slimming clubs. 
Participants will be given a small amount of printed information to prevent 'resentful demoralisation'. 
This will be developed to reflect the type of information available both within the primary care 
setting and featured on the website.       
 
 
Outcomes 
Copy and paste table for each outcome. 
 
Outcome 1 
 Description as stated in report/paper 
Primary outcome was the ability of the Internet package 
to promote change in weight and BMI over six and 12 
months compared with usual care 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Outcome name 
 
Internet Group       
Time points 
measured 
(specify whether from 
start or end of 
intervention) 
Baseline 
6 Months 
12 Months 
      
Time points reported 
 
Baseline 
12 Months 
      
Outcome definition 
(with diagnostic criteria 
if relevant) 
Primary outcome was the ability of the Internet package 
to promote change in weight and BMI over six and 12 
months compared with usual care 
      
Person measuring/ 
reporting 
 
Authors Contributions 
SK is the Principal Investigator, who conceived of the 
idea 
and obtained funding for the study.  
EH is a co-applicant on the grant and provides advice 
and guidance on the study design and conduct of the 
RCT.  
AM is co-ordinating the day-to-day running of the study.  
JP was the initial research manager on the project, who 
put together the content of the site and now advises on 
the web site content. 
DG is the statistician on the study.  
JT is the database manager and web designer/web 
master. All authors have contributed to the set up and 
design of the study. JR is an advisor on the study on 
aspects relating to project management. 
      
Unit of measurement  
(if relevant) 
N/A       
Scales: upper and 
lower limits (indicate 
whether high  or low 
score is good) 
            
Is outcome/tool 
validated? 
   
 Unclear 
            
Imputation of missing 
data 
(e.g. assumptions 
made for ITT analysis) 
Primary analyses were based on all existing data 
Analyses using LOCF and BOCF were performed to 
assess 
the robustness of the primary analysis for the effect of 
losses to follow up and missing data. 
An additional 22% of participants were recruited to take 
account of any loss to follow up. 
“Statistical 
Analysis” 
 
“Sample Size” 
Assumed risk 
estimate 
(e.g. baseline or 
population risk noted  
in Background) 
High attrition and low compliance       
Power 80%       
Notes:         
 
 
 
Outcome 2 
 Description as stated in report/paper 
Secondary outcomes were the ability of the Internet 
package to promote change in reported lifestyle 
behaviours compared with usual care, along with 
differences in quality of life 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Outcome name 
 
Usual Care       
Time points 
measured 
(specify whether from 
start or end of 
intervention) 
Baseline 
6 months  
12 months 
      
Time points reported 
 
Baseline 
12 Months 
      
Outcome definition 
(with diagnostic criteria 
if relevant) 
Secondary outcomes were the ability of the Internet 
package to promote change in reported lifestyle 
behaviours compared with usual care, along with 
differences in quality of life 
      
Person measuring/ 
reporting 
 
Authors Contributions 
SK is the Principal Investigator, who conceived of the 
idea 
and obtained funding for the study.  
EH is a co-applicant on the grant and provides advice 
and guidance on the study design and conduct of the 
RCT.  
AM is co-ordinating the day-to-day running of the study.  
JP was the initial research manager on the project, who 
put together the content of the site and now advises on 
the web site content. 
DG is the statistician on the study.  
JT is the database manager and web designer/web 
master. All authors have contributed to the set up and 
design of the study. JR is an advisor on the study on 
aspects relating to project management. 
      
Unit of measurement  
(if relevant) 
Lifestyle and dietary habits were assessed with a 
questionnaire previously used in the UK Women's 
Cohort Study [18]. This questionnaire obtained 
information on methods of cooking, 
portion size and frequency of consumption of various 
foods and participants' 'dieting' practices. Physical 
activity 
level was assessed using the Baecke physical activity 
questionnaire 
which measures work, leisure and sports activity 
providing a comprehensive evaluation of habitual 
physical 
activity [19]. Quality of life was assessed using the 
EuroQol questionnaire, a short, self administered 
questionnaire 
which was also used in the cost effectiveness analysis 
[20]. A brief series of questions were used to assess 
participants' confidence in their ability to make positive 
lifestyle changes on a scale of one to seven (where one 
indicates not at all confident and seven indicates very 
confident). These measures were combined in one 
questionnaire, which participants completed at 
baseline, six months and 12 months. Additional 
questions were added at six and 12 months for the 
purpose of the cost-effectiveness analysis of the 
programme. Participants in the Internet group also 
completed an additional section on their use and views 
of the website at six and 12 months. 
      
Scales: upper and 
lower limits (indicate 
whether high  or low 
score is good) 
N/A       
Is outcome/tool 
validated? 
   
 Unclear 
            
Imputation of missing 
data 
(e.g. assumptions 
made for ITT analysis) 
As before       
Assumed risk 
estimate 
(e.g. baseline or 
population risk noted  
in Background) 
High attrition and low compliance       
Power 80%       
Notes:         
Secondary measures 
A significant reduction in self-rated physical activity score over the intervention period was identified 
(p < 0.005) 
with a mean reduction of 0.34 in the sample, the difference in change between the two groups over 
the 12 
months was non-significant (p = 0.6). Quality of life was shown to increase significantly over the 
trial (p = 0.03), 
however no between group differences were established (p = 0.8). No significant changes in 
dietary habits or confidence 
scores were detected over the 12 months. 
 
 
Other 
 
Study funding 
sources 
(including role of 
funders) 
The Health Foundation       
Possible conflicts 
of interest 
(for study authors) 
None declared       
Notes:         
 
 
 
Data and analysis 
Copy and paste the appropriate table for each outcome, including additional tables for each 
time point and subgroup as required. 
 
For RCT/CCT 
Continuous outcome 
 Description as stated in report/paper 
Weight Loss 
Location in 
text or source 
(pg & 
¶/fig/table/other
) 
Comparison 
 
Internet –v- Usual Care       
Outcome 
 
Primary – weight loss at 12 months 
Secondary outcomes were the ability of the Internet 
package to promote change in reported lifestyle 
behaviours compared with usual care, along with 
differences in quality of life 
 
      
Subgroup 
 
N/A       
Time point 
(specify from start or 
end of intervention) 
Recruitment May-November 2003. 
1st January 2004 
1st January 2005 
      
Post-intervention 
or change from 
baseline? 
Primary Outcome 
Change in weight and BMI 
Change in BMI between the two groups at 12 months was 
non-significant, with a mean difference of 0.3 kg/m2 (CI = -
0.5 to 1, p = 0.4), ranging from -5.9 kg/m2 to +3.8 kg/m2 
for the Internet group and -8.1 kg/m2 to +3.5 kg/m2 for the 
usual care group at 12 months. Both groups lost a 
significant amount of weight over time, but the difference in 
change between the groups at 12 months was non-
significant. ANCOVA using weight at 12 months as the 
dependent variable, adjusting for age, sex, baseline 
weight, baseline physical activity score and baseline 
confidence score revealed that the Internet group were 0.6 
kg heavier (95% CI: -1.4 to 2.5, p = 0.56) than the usual 
care group after 12 months (Figure 2). Similar results were 
produced from BOCF data (Internet group 0.8 kg heavier 
(95% CI: -0.4 to 1.9, p = 0.2)) and LOCF data (Internet 
group 0.5 kg heavier (95% CI: -0.8 to 1.8, p = 0.4)), 
demonstrating the robustness of the results to alternative 
assumptions. We were also interested in the loss of 5% 
body weight, as this is associated with significant 
improvements in health 
[25]. Investigating weight loss as a percentage of the 
baseline weight, 22% of Internet responders lost 5% or 
more of their baseline weight by 12 months, with 18% of 
the usual care group losing at least this amount. 
Secondary Outcome 
A significant reduction in self-rated physical activity score 
over the intervention period was identified (p < 0.005) with 
a mean reduction of 0.34 in the sample, the difference in 
change between the two groups over the 12 months was 
non-significant (p = 0.6). Quality of life was shown to 
increase significantly over the trial (p = 0.03), however no 
between group differences were established (p = 0.8). No 
significant changes in dietary habits or confidence scores 
were detected over the 12 months. 
 
      
Any other results 
reported (e.g. mean 
difference, CI, P 
value) 
            
No. missing 
participants 
 
Intervention Group 
Lost to Follow Up 
6 months (n=42) 
12 months (n=15) 
12 month follow up 
(n=54) 
Usual Care Group 
Lost to Follow Up 
6 months (n=27) 
12 months (n=6) 
12 month follow up (n=77) 
      
Reasons missing 
 
Lost to Follow Up 
6 months (n=42) 
-Couldn’t contact(23) 
-Withdrawn(15) 
-DNA Visit(3) 
-Moved house(1) 
12 months (n=15) 
Couldn’t contact(7) 
-Withdrawn(3) 
-DNA Visit(3) 
-Pregnant(2) 
Lost to Follow Up 
6 months (n=27) 
-Couldn’t contact (11) 
-Withdrawn (10) 
-Did not attend visit (3) 
-Pregnant (2) 
-Moved house (1) 
12 months (n=6) 
-Couldn’t contact(5) 
-Withdrawn(1) 
 
      
No. participants 
moved from other 
group 
None None       
Reasons moved 
 
N/A N/A       
Unit of analysis 
(individuals, cluster/ 
groups or body 
parts) 
Groups       
Statistical 
methods used and 
appropriateness of 
these (e.g. 
adjustment for 
correlation) 
Sample size 
A sample size of 180 participants was required to detect a 
difference of 5 kg weight loss (approximately 5% of body 
weight) or less than 2.5 kg/m2 in BMI between the two 
groups with 80% power, assuming a two-sample t-test, 5% 
significance levels, a standard deviation for weight of 12 kg 
and for BMI of 5.5 kg/m2. An additional 22% of participants 
were recruited to take account of any loss to follow- 
up, giving a recruitment target figure of 220. 
Statistical analysis 
Analyses were performed using Statistical Package for the 
Social Sciences (SPSS for Windows, version 11.5; SPSS, 
Chicago, IL). Independent sample t-tests (or non-
parametric tests where appropriate) and chi-squared tests 
were used to investigate differences in baseline 
characteristics and response rates between the two 
groups. Analysis of covariance (ANCOVA) on weight at 12 
months was used to investigate the difference between the 
two groups. This adjusted for any imbalance in age, sex, 
baseline weight, baseline physical activity score or 
baseline confidence score introduced by losses to follow-
up. Changes in secondary measures were investigated 
using ANCOVA djusting for possible baseline imbalances 
as before. Primary analyses were conducted based on all 
available data. Analyses using LOCF and BOCF were 
performed to assess the robustness of the primary 
analysis for the effect oflosses to follow up and missing 
data. 
      
Reanalysis 
required? (specify) 
   
 No  
            
Reanalysis 
possible? 
   
 No  
            
Reanalysed results 
 
            
Notes:         
 
 
 
Definitions 
 
Assumed risk estimate An estimate of the risk of an event or average score without the 
intervention, used in Cochrane 'Summary of findings tables'. If a study 
provides useful estimates of the risk of average score of different 
subgroups of the population, or an estimate based on a representative 
observational study, you may wish to collect this information. 
Change from baseline A measure for a continuous outcome calculated as the difference 
between the baseline score and the post-intervention score.  
Clusters A group of participants who have been allocated to the same 
intervention arm together, as in a cluster-randomised trial, e.g. a whole 
family, town, school or patients in a clinic may be allocated to the same 
intervention rather than separately allocating each individual to different 
arms. 
Co-morbidities The presence of one or more diseases or conditions other than those of 
primary interest. In a study looking at treatment for one disease or 
condition, some of the individuals may have other diseases or 
conditions that could affect their outcomes. 
Compliance Participant behaviour that abides by the recommendations of a doctor, 
other health care provider or study investigator (also called adherence 
or concordance). 
Contemporaneous data 
collection 
When data is collected at the same point(s) in time or covering the 
same time period for each intervention arm in a study (that is, historical 
data are not used as a comparison). 
Controlled Before and 
After Study 
A non-randomised study design where a control population of similar 
characteristics and performance as the intervention group is identified. 
Data are collected before and after the intervention in both the control 
and intervention groups 
Exclusions Participants who were excluded from the study or the analysis by the 
investigators. 
Imputation Assuming a reasonable value for a measure where the true value is not 
available (e.g. assuming last observation carried forward for missing 
participants). 
Integrity of delivery The degree to which the specified procedures or components of an 
intervention are delivered as originally planned. 
Interrupted Time Series A research design that collects observations at multiple time points 
before and after an intervention (interruption). The design attempts to 
detect whether the intervention has had an effect significantly greater 
than the underlying trend. 
Post-intervention The value of a continuous outcome measured at some time point 
following the beginning of the intervention (may be during or after the 
intervention period). 
Power The probability that a trial will detect, as statistically significant, an 
intervention effect of a specified size. 
Providers The person or people responsible for delivering an intervention and 
related care, who may or may not require specific qualifications (e.g. 
doctors, physiotherapists) or training. 
Quasi-randomised 
controlled trial 
A study in which the method of allocating people to intervention arms 
was not random, but was intended to produce similar groups when used 
to allocate participants. Quasi-random methods include: allocation by 
the person's date of birth, by the day of the week or month of the year, 
by a person's medical record number, or just allocating every alternate 
person. 
Reanalysis Additional analysis of a study's results by a review author (e.g. to 
introduce adjustment for correlation that was not done by the study 
authors). 
Report ID A unique ID code given to a publication or other report of a study by the 
review author (e.g. first author's name and year of publication). If a 
study has more than one report (e.g. multiple publications or additional 
unpublished data) a separate Report ID can be allocated to each to 
help review authors keep track of the source of extracted data. 
Sociodemographics Social and demographic information about a study or its participants, 
including  economic and cultural information, location, age, gender, 
ethnicity, etc. 
Study ID A unique ID code given to an included or excluded study by the review 
author (e.g. first author's name and year of publication from the main 
report of the study). Although a study may have multiple reports or 
references, it should have one single Study ID to help review authors 
keep track of all the different sources of information for a study. 
Theoretical basis The use of a particular theory (such as theories of human behaviour 
change) to design the components and implementation of an 
intervention 
Unit of allocation The unit allocated to an intervention arm. In most studies individual 
participants will be allocated, but in others it may be individual body 
parts (e.g. different teeth or joints may be allocated separately) or 
clusters of multiple people. 
Unit of analysis The unit used to calculate N in an analysis, and for which the result is 
reported. This may be the number of individual people, or the number of 
body parts or clusters of people in the study. 
Unit of measurement  The unit in which an outcome is measured, e.g. height may be 
measured in cm or inches; depression may be measured using points 
on a particular scale. 
Validated A process to test and establish that a particular measurement tool or 
scale is a good measure of that outcome. 
Withdrawals Participants who voluntarily withdrew from participation in a study 
before the completion of outcome measurement. 
 
 
Sources: 
Cochrane Collaboration Glossary, 2010. Available from 
http://www.cochrane.org/training/cochrane-handbook. 
 
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 
Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from 
www.cochrane-handbook.org. 
 
Last JM (editor), A Dictionary of Epidemiology, 4th Ed. New York: Oxford University Press, 
2001. 
 
Schünemann H, Brożek J, Oxman A, editors. GRADE handbook for grading quality of evidence 
and strength of recommendation. Version 3.2 [updated March 2009]. The GRADE Working 
Group, 2009. Available from http://www.cc-ims.net/gradepro. 
  
Data collection form 
Intervention review – RCTs and non-RCTs 
 
 
This form can be used as a guide for developing your own data extraction form. Sections can 
be expanded and added, and irrelevant sections can be removed. It is difficult to design a single 
form that meets the needs of all reviews, so it is important to consider carefully the information 
you need to collect, and design your form accordingly. Information included on this form should 
be comprehensive, and may be used in the text of your review, ‘Characteristics of included 
studies’ table, risk of bias assessment, and statistical analysis. 
 
Notes on using a data extraction form:  
 Be consistent in the order and style you use to describe the information for each report. 
 Record any missing information as unclear or not described, to make it clear that the 
information was not found in the study report(s), not that you forgot to extract it.  
 Include any instructions and decision rules on the data collection form, or in an 
accompanying document. It is important to practice using the form and give training to any 
other authors using the form. 
 
Review title or ID 
The ‘Pounds for Pounds’ weight loss financial incentive scheme: an evaluation of a pilot in NHS 
Eastern and Coastal Kent 
 
Study ID (surname of first author and year first full report of study was published e.g. Smith 2001)  
Relton, Strong & Li (2011) 
 
Report ID (if different to 
Study ID) 
Report IDs of other reports of this study (e.g. duplicate 
publications, follow-up studies) 
            
 
Notes:         
 
General Information 
 
Date form completed 
(dd/mm/yyyy) 
19th July 2011 
Name/ID of person 
extracting data 
Alison Moore 
 
Reference citation 
 
      
 
 
Study author contact 
details 
Relton, 2011 
 
Publication type 
(e.g. full report, abstract, 
letter) 
Full Study - Pilot 
 
Notes:       
 
 
Study eligibility 
 
Study 
Characteristic
s 
Eligibility criteria 
(Insert inclusion criteria for each 
characteristic as defined in the Protocol) 
Eligibility criteria 
met?  
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) Yes  r 
Type of study Randomised Controlled Trial 
 No  
      
Quasi-randomised Controlled Trial 
  
No  
      
Controlled Before and After Study 
 Contemporaneous data collection 
 Comparable control site 
 At least 2 x intervention and 2 x 
control clusters 
 No  
      
Interrupted Time Series 
 At least 3 time points before and 
3 after the intervention 
 Clearly defined intervention point 
 No  
      
Other design (specify): 
 
Pilot Study 
 
Yes   
Measurements 
taken at 
baseline & 
monthly 
thereafter up 
to 12 month 
programme 
completion. 
Participants 
 
402 participants with a mean age of 45.1 
years and a mean baseline weight of 
101.8 kg. Approximately three quarters 
(77.4%) of participants were obese (as 
defined as BMI _30 kg/m2). Despite up-
weighting in the random sample of invited 
participants, 
only 41.5% of those who activated their 
plan were male and only 31.3% were from 
deprived areas.  
Yes   
      
Types of 
intervention 
‘Weight Wins’ commercial programme 
The P4P programme tied rewards directly 
to weight loss results. Plans ranged from 
15 lb (6.8 kg) weight loss over 3 months 
to 50 lb (22.7 kg) weight loss over 7 
months, with optional additional weight 
‘maintenance’ periods. The 
Yes    
      
maximum overall plan length was 13 
months. Rewards ranged from £70 to 
£425 per year according to the P4P 
algorithm. P4P credited participants 
monthly for cumulative weight loss up to a 
maximum target weight loss rate of 
7.1 lb (3.2 kg) per month, and for 
maintenance of weight loss. Participants 
received their accumulated financial 
rewards, plus a bonus equal to 50% of the 
total maximum reward if they had 
achieved their final target weight at plan 
completion. Participants were provided 
with a booklet of weight loss tips. 
 
 
Types of 
outcome 
measures 
 Weight change from baseline to 
final recorded weight at 12 months 
 Weight change at 12 months 
 Estimated weight loss at 12 
months and sensitivity analysis 
 
Yes   
      
 
INCLUDE   
 
 
EXCLUDE   
 
Reason for 
exclusion 
 
      
Notes:  
Weight Wins is a personal financial incentive plan for weight loss. Incentive plans are available 
directly to the public and via organisations such as employers who are concerned about employees 
health. Members are motivated by email and telephone support and online interactive tools 
Weight Wins follows NICE obesity guidelines and rewards gradual long term weight loss and 
maintenance. Weight Wins is a broad base commercial weight loss programme. It is recognised by 
the National Obesity Forum and NHS. 
Participants chose a weight loss plan based on their target weight. Plans ranged from 15 lb (6.8 kg) 
weight loss over 3 months to50 lb (22.7 kg) weight loss over 7 months, with optional additional 
‘maintenance’ periods. Rewards, which were received after successful plan completion, ranged 
from £70 to £425 per year. 
 
DO NOT PROCEED IF STUDY EXCLUDED FROM REVIEW 
Characteristics of included studies 
Methods 
 
 Descriptions as stated in report/paper 
 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Aim of study (e.g. 
efficacy, 
equivalence, 
pragmatic) 
Financial incentive programmes have the potential to 
modify health-related behaviours, including those 
associated with achieving weight loss. This study 
evaluated a pilot NHS commissioned financial incentive 
weight loss programme, based on the commercial Weight 
Wins ‘Pounds for Pounds’ programme. 
      
Design(e.g. parallel, 
crossover, non-
RCT) 
Pilot       
Unit of allocation 
(by individuals, 
cluster/ groups or 
body parts) 
Groups       
Start date 
 
January 2009 
 
“Design & 
Setting” 
End date 
 
March 2010 
 
      
Duration of 
participation 
(from recruitment to 
last follow-up) 
Recruitment January and February 2009 “Results”, 
“Recruitment” 
Ethical approval 
needed/ obtained 
for study 
   
 
 Unclear 
Ethical approval: This paper reports a 
service evaluation conducted on behalf 
of NHS Eastern and Coastal Kent, and 
therefore did not require ethical 
approval. 
      
Notes:         
The P4P Programme itself was provided by a commercial company ‘Weight Wins’ 
 
 
Participants 
 
 Description 
Include comparative information for each intervention or 
comparison group if available 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Population 
description 
(from which study 
participants are 
drawn) 
19% were NHS employees, 27% were 
from males and 32% were from individuals with 
postcodes 
in deprived areas (national IMD2007 score quintiles 4 
and 
5). 
 
Table 1 Baseline characteristics 
Participants (plan starters), n 402 
Age in years, mean (SD) 45.1 (11.7) 
NHS employee, n (%) 171 (42.5) 
Baseline weight (kg), mean (SD) 101.8 (46.1) 
Male, n (%) 167 (41.5) 
Baseline BMI (kg/m2), mean (SD) 34.6 (5.4) 
Proportion BMI _30 kg/m2, n (%) 311 (77.4) 
Proportion BMI _40 kg/m2, n (%) 67 (16.7) 
Plan length (months), mean (SD) 11.6 (2.1), range 3–13 
Target weight loss (kg), mean (SD) 16.7 (12.3) 
Affluent postcodea, n (%) 35 (8.7) 
Intermediate postcodea, n (%) 241 (60.0) 
Deprived postcodea, n (%) 126 (31.3) 
A Using IMD2007 quintiles 1–5: affluent, 1; in 
Results, 
Recruitment 
Setting 
(including location 
and social context) 
Participants were weighed at baseline and monthly 
thereafter until plan completion. Weights were obtained 
at ‘weigh-in’ centres provided at various locations across 
the geographical area covered by NHS Eastern and 
Coastal Kent in GP surgeries, community pharmacies, 
gyms and weight loss clubs. 
Outcome 
Measures & 
Method for 
Follow Up 
Inclusion criteria  
 
 
Adults were eligible for the programme if they lived within 
the NHS Eastern and Coastal Kent area and reported a 
target weight such that, having obtained this, they would 
still 
have a BMI .22.5 kg/m2. Applicants were required to 
report that they had obtained consent from their general 
practitioner if they were under 21, over 65, breast feeding 
a 
baby over 6 weeks old, had a chronic medical condition 
that 
required regular medical checks, were taking prescription 
medication, or had been advised to eat a special diet to 
treat 
a medical condition. 
. 
      
Exclusion criteria 
 
 
Pregnant women and women breastfeeding a baby 
under 6 weeks old were ineligible 
      
Method of 
recruitment of 
participants (e.g. 
phone, mail, clinic 
patients) 
The programme was advertised on the NHS Eastern and 
Coastal Kent website to NHS staff and to the general 
public. Individuals interested in the programme applied 
by 
completing a web form indicating how much weight they 
wished to lose, and for how long they wished to maintain 
their weight loss, along with their age, sex, height and 
postcode. 
      
Informed consent 
obtained  
 
   
Yes No Unclear 
A random sample of 728 applicants 
was sent letters accepting them 
onto the P4P programme. The 
sample was 
stratified by sex, deprivation score 
and whether the participant was an 
NHS employee, with up-weighting 
of the proportion of males in the 
sample to 49%, residents from 
deprived areas to 42% and NHS 
employees to 23% to 
ensure adequate representation of 
these groups. 
A total of 402 of the 728 invited 
(55%) activated their 
individualized P4P plan by 
attending an initial independent 
weigh-in.  
      
Total no. 
randomised  
(or total pop. at start 
of study for NRCTs) 
A random sample of 728 applicants was sent letters 
accepting them onto the P4P programme. The sample 
was 
stratified by sex, deprivation score and whether the 
participant was an NHS employee, with up-weighting of 
the proportion of males in the sample to 49%, residents 
from 
deprived areas to 42% and NHS employees to 23% to 
ensure adequate representation of these groups. 
A total of 402 of the 728 invited (55%) activated their 
individualized P4P plan by attending an initial 
independent 
weigh-in. 
      
Clusters 
(if applicable, no., 
type, no. people per 
cluster) 
N/A       
Baseline 
imbalances 
 
 
N/A       
Withdrawals and 
exclusions 
(if not provided below 
by outcome) 
Plan lengths ranged from 3 to 13 months (mean: 11.6 
months, median: 12 months). At 12 months 101 
participants 
were active on the programme, 53 participants had 
completed a plan and left the programme (‘inactive at 12 
months, plan completed’) and 248 participants had left 
the 
programme without completing a plan (‘inactive at 12 
months, failed to complete plan’). Those who were 
inactive 
at 12 months, but who had completed their plan, had 
been 
active for a mean of 9.2 months, whereas those who 
were 
inactive at 12 months, but who had failed to complete 
their 
plan, had been active for a mean of 3.3 months. 
Plan lengths 
and drop outs 
 
Age 
 
Age in years, mean (SD) 45.1 (11.7)       
Sex 
 
Male, n (%) 167 (41.5)       
Race/Ethnicity 
 
Not provided       
Severity of illness 
 
No detail given       
Co-morbidities 
 
Obesity       
Other relevant 
sociodemographics 
 
Affluent postcodea, n (%) 35 (8.7) 
Intermediate postcodea, n (%) 241 (60.0) 
Deprived postcodea, n (%) 126 (31.3) 
Table 1 
Subgroups 
measured 
 
N/A       
Subgroups reported 
 
N/A       
Notes:         
 
 
 
Intervention groups 
Copy and paste table for each intervention and comparison group  
 
Intervention Group 1 
 Description as stated in report/paper 
The P4P programme tied rewards directly to weight 
loss 
results. Plans ranged from 15 lb (6.8 kg) weight loss 
over 3 
months to 50 lb (22.7 kg) weight loss over 7 months, 
with 
optional additional weight ‘maintenance’ periods. The 
maximum overall plan length was 13 months. 
Rewards 
ranged from £70 to £425 per year according to the 
P4P 
algorithm. P4P credited participants monthly for 
cumulative 
weight loss up to a maximum target weight loss rate of 
7.1 lb (3.2 kg) per month, and for maintenance of 
weight 
loss. Participants received their accumulated financial 
rewards, plus a bonus equal to 50% of the total 
maximum 
reward if they had achieved their final target weight at 
plan 
completion. Participants were provided with a booklet 
of 
weight loss tips. 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Group name 
 
P4P programme       
No. randomised to 
group 
(specify whether no. 
people or clusters) 
728 invited  
402 activated their plan by attending initial weigh in. 
      
Theoretical basis 
(include key references) 
 
N/A       
Description (include 
sufficient detail for 
replication, e.g. content, 
dose, components) 
The P4P programme tied rewards directly to weight 
loss 
results. Plans ranged from 15 lb (6.8 kg) weight loss 
over 3 
months to 50 lb (22.7 kg) weight loss over 7 months, 
with 
optional additional weight ‘maintenance’ periods. The 
maximum overall plan length was 13 months. 
Rewards 
ranged from £70 to £425 per year according to the 
P4P 
algorithm. P4P credited participants monthly for 
cumulative 
weight loss up to a maximum target weight loss rate of 
7.1 lb (3.2 kg) per month, and for maintenance of 
weight 
loss. Participants received their accumulated financial 
rewards, plus a bonus equal to 50% of the total 
maximum 
reward if they had achieved their final target weight at 
plan 
completion. Participants were provided with a booklet 
of 
weight loss tips. 
      
Duration of treatment 
period 
Plans ranged from 15 lb (6.8 kg) weight loss over 3 
months to 50 lb (22.7 kg) weight loss over 7 months, 
with 
optional additional weight ‘maintenance’ periods. The 
maximum overall plan length was 13 months. 
      
Timing (e.g. frequency, 
duration of each 
episode) 
Participants were weighed at baseline and monthly 
thereafter until plan completion. 
      
Delivery (e.g. 
mechanism, medium, 
intensity, fidelity) 
Weights were obtained at ‘weigh-in’ centres provided 
at various locations across the geographical area 
covered by NHS Eastern and Coastal Kent in GP 
surgeries, community pharmacies, gyms and weight 
loss clubs. 
      
Providers 
(e.g. no., profession, 
training, ethnicity etc. if 
relevant) 
Weight Wins trained staff – assuming this but not 
confirmed in paper 
      
Co-interventions 
 
 
N/A       
Economic variables 
(i.e. intervention cost, 
changes in other costs 
as result of intervention) 
Financial incentive       
Resource 
requirements 
(e.g. staff numbers, cold 
chain, equipment) 
Commercial weight management company       
Integrity of delivery 
 
 
Not specified       
Compliance 
 
 
Not specified       
Notes:         
 
 
 
Outcomes 
Copy and paste table for each outcome. 
 
Outcome 1 
 Description as stated in report/paper 
1. Weight Change at 12 Months 
2. Estimated weight loss at 12 months in all 
participants and sensitivity analysis 
Location in 
text or source 
(pg & 
¶/fig/table/othe
r) 
Outcome name 
 
Weight Change at 12 Months       
Time points 
measured 
(specify whether from 
start or end of 
intervention) 
There were 101 participants actively attending a 
weighing-in centre at 12 months, either in an ongoing 
plan of length 
.12 months (n ¼ 63) or completing a 12 month plan (n 
¼ 
38). In addition to this, self-reported 12 month weights 
were obtained via email or telephone interview for 39 
participants. 
Of these, 20 were randomly selected from the 53 
participants who were inactive at 12 months, but who 
had completed a plan (median plan length: 9 months, 
range: 3–11). The remaining 19 were randomly 
selected from the 248 participants who were inactive at 
12 months, but who had failed to complete their plan 
(median plan length: 9 months, range: 4–11). Table 3 
shows mean 12 month weight loss for the active at 12 
months group and for the two groups who were inactive 
at 12 months. 
      
Time points reported 
 
Baseline and 12 months       
Outcome definition 
(with diagnostic criteria 
if relevant) 
Table 3 Weight loss at 12 months 
 
      
Person measuring/ 
reporting 
 
Weight Wins representative       
Unit of measurement  
(if relevant) 
kilogram       
Scales: upper and 
lower limits (indicate 
whether high  or low 
score is good) 
N/A       
Is outcome/tool 
validated? 
   
 Unclear 
            
Imputation of missing 
data 
(e.g. assumptions 
made for ITT analysis) 
No but estimated weight loss at 12 months in all 
participants and sensitivity analysis. 
In the full cohort of participants we calculated mean 
weight 
loss between baseline and final recorded weight, 
proportion 
of participants with weight loss _5% of baseline and 
proportion 
with weight loss _10% of baseline. We explored in a 
logistic regression model the association between 
achievement of _5% weight loss and age, sex, level of 
social deprivation, baseline BMI and target weight loss. 
We calculated mean weight loss and proportion 
achieving _5% weight loss in those participants who 
were active (defined as attending monthly weigh-ins) at 
12 months. We compared this active group with random 
samples from two inactive groups. The first group, 
‘inactive at 12 months( plan completed)’, were those 
who had completed plans of shorter than 12 months 
duration. The second group, ‘inactive at 12 months 
(failed to complete plan)’, were those individuals no 
longer in the programme at 12 months because 
they had dropped out (ceased monthly weigh-ins before 
the 
end of their chosen plan). For both comparisons we 
used 
logistic regression to adjust for baseline covariates 
(age, sex, 
level of social deprivation, baseline BMI and target 
weight 
loss). 
      
Assumed risk 
estimate 
(e.g. baseline or 
population risk noted  
in Background) 
N/A       
Power             
Notes:         
Baseline characteristics in Table 1 but no detail for same characteristics at 12 months 
Statistics: 
We estimated overall 12 month weight loss in all participants under two assumptions. The first 
assumption was that the 12 month weight loss results from the two random samples of those who 
had left the programme were representative of the 12 month weight loss results from all those who 
had left the programme. The second assumption was that those who had left the programme 
without completing their plan had returned to their baseline weight at 12 months. 
Results (abstract) 
Mean baseline weight for the 402 participants was 101.8 kg (SD 46.1 kg), with 77.4% having a BMI 
_30 kg/m2. Clinically significant weight loss (_5%) occurred in 44.8% [95% confidence interval (CI): 
40.0–49.7%] of participants. Estimated mean weight loss at 12 months was 4.0 kg (95% CI: 2.4–
5.6 kg) under the assumption of return-to-baseline weight for those who had left the programme 
before reporting a 12 month weight. 
Estimated weight loss at 12 months in all participants and sensitivity analysis 
Twelve month weight data were not available for 262 of the 301 participants who were inactive at 
12 months (33 plan 
completers and 229 who had failed to complete their plan). 
If we assume, firstly, that the self-reported 12 month weights for the 39 randomly selected inactive 
participants 
were representative of all participants who were inactive at 12 months, then the estimate of the 
mean weight loss at 12 months for all participants in the P4P programme is 5.0 kg (95% CI: 3.4–6.6 
kg). Secondly, if we assume that those 
who failed to complete their plan returned to their baseline weight at 12 months, then the estimated 
overall mean weight loss for all participants in the programme is 4.0 kg (95% CI: 2.4–5.6 kg). 
 
Other 
 
Study funding 
sources 
(including role of 
funders) 
C.R. receives financial support from the University of 
Sheffield. M.S. is supported by a UK Medical Research 
Council Health Services Research/Health of the Public 
research training fellowship [grant number G0601721]. 
      
Possible conflicts 
of interest 
(for study authors) 
Not specified       
Notes:         
‘Active’ is defined as attending monthly weigh in’s (statistical analysis) 
 
 
 
Definitions 
 
Assumed risk estimate An estimate of the risk of an event or average score without the 
intervention, used in Cochrane 'Summary of findings tables'. If a study 
provides useful estimates of the risk of average score of different 
subgroups of the population, or an estimate based on a representative 
observational study, you may wish to collect this information. 
Change from baseline A measure for a continuous outcome calculated as the difference 
between the baseline score and the post-intervention score.  
Clusters A group of participants who have been allocated to the same 
intervention arm together, as in a cluster-randomised trial, e.g. a whole 
family, town, school or patients in a clinic may be allocated to the same 
intervention rather than separately allocating each individual to different 
arms. 
Co-morbidities The presence of one or more diseases or conditions other than those of 
primary interest. In a study looking at treatment for one disease or 
condition, some of the individuals may have other diseases or 
conditions that could affect their outcomes. 
Compliance Participant behaviour that abides by the recommendations of a doctor, 
other health care provider or study investigator (also called adherence 
or concordance). 
Contemporaneous data 
collection 
When data is collected at the same point(s) in time or covering the 
same time period for each intervention arm in a study (that is, historical 
data are not used as a comparison). 
Controlled Before and 
After Study 
A non-randomised study design where a control population of similar 
characteristics and performance as the intervention group is identified. 
Data are collected before and after the intervention in both the control 
and intervention groups 
Exclusions Participants who were excluded from the study or the analysis by the 
investigators. 
Imputation Assuming a reasonable value for a measure where the true value is not 
available (e.g. assuming last observation carried forward for missing 
participants). 
Integrity of delivery The degree to which the specified procedures or components of an 
intervention are delivered as originally planned. 
Interrupted Time Series A research design that collects observations at multiple time points 
before and after an intervention (interruption). The design attempts to 
detect whether the intervention has had an effect significantly greater 
than the underlying trend. 
Post-intervention The value of a continuous outcome measured at some time point 
following the beginning of the intervention (may be during or after the 
intervention period). 
Power The probability that a trial will detect, as statistically significant, an 
intervention effect of a specified size. 
Providers The person or people responsible for delivering an intervention and 
related care, who may or may not require specific qualifications (e.g. 
doctors, physiotherapists) or training. 
Quasi-randomised 
controlled trial 
A study in which the method of allocating people to intervention arms 
was not random, but was intended to produce similar groups when used 
to allocate participants. Quasi-random methods include: allocation by 
the person's date of birth, by the day of the week or month of the year, 
by a person's medical record number, or just allocating every alternate 
person. 
Reanalysis Additional analysis of a study's results by a review author (e.g. to 
introduce adjustment for correlation that was not done by the study 
authors). 
Report ID A unique ID code given to a publication or other report of a study by the 
review author (e.g. first author's name and year of publication). If a 
study has more than one report (e.g. multiple publications or additional 
unpublished data) a separate Report ID can be allocated to each to 
help review authors keep track of the source of extracted data. 
Sociodemographics Social and demographic information about a study or its participants, 
including  economic and cultural information, location, age, gender, 
ethnicity, etc. 
Study ID A unique ID code given to an included or excluded study by the review 
author (e.g. first author's name and year of publication from the main 
report of the study). Although a study may have multiple reports or 
references, it should have one single Study ID to help review authors 
keep track of all the different sources of information for a study. 
Theoretical basis The use of a particular theory (such as theories of human behaviour 
change) to design the components and implementation of an 
intervention 
Unit of allocation The unit allocated to an intervention arm. In most studies individual 
participants will be allocated, but in others it may be individual body 
parts (e.g. different teeth or joints may be allocated separately) or 
clusters of multiple people. 
Unit of analysis The unit used to calculate N in an analysis, and for which the result is 
reported. This may be the number of individual people, or the number of 
body parts or clusters of people in the study. 
Unit of measurement  The unit in which an outcome is measured, e.g. height may be 
measured in cm or inches; depression may be measured using points 
on a particular scale. 
Validated A process to test and establish that a particular measurement tool or 
scale is a good measure of that outcome. 
Withdrawals Participants who voluntarily withdrew from participation in a study 
before the completion of outcome measurement. 
 
 
Sources: 
Cochrane Collaboration Glossary, 2010. Available from 
http://www.cochrane.org/training/cochrane-handbook. 
 
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 
Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from 
www.cochrane-handbook.org. 
 
Last JM (editor), A Dictionary of Epidemiology, 4th Ed. New York: Oxford University Press, 
2001. 
 
Schünemann H, Brożek J, Oxman A, editors. GRADE handbook for grading quality of evidence 
and strength of recommendation. Version 3.2 [updated March 2009]. The GRADE Working 
Group, 2009. Available from http://www.cc-ims.net/gradepro. 
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Quality Assessment – Checklist (Downs & Black, 1998) 
Randomised Controlled Trials 
                     
Questions 1 2 3 4 5 6 7 8 9 
1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
1
7 
1
8 
1
9 
2
0 
2
1 
2
2 
2
3 
2
4 
2
5 
2
6 
2
7 
Summ
ary 
Max 
28 
Percent
age 
Author 
                             Moore et al (2003) 1 1 1 1 2 1 1 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 26 93% 
McConnon et al (2006) 1 1 1 1 2 1 1 0 1 0 1 1 1 0 0 1 0 1 1 1 1 1 1 0 0 1 1 21 75% 
Nanchahal et al ( 2012) 1 1 1 1 2 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 0 1 1 1 26 93% 
Jolly et al ( 2011) 1 1 1 1 2 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 0 1 1 1 26 93% 
Davies et al (2007) 1 1 1 1 2 1 1 1 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 1 1 1 25 89% 
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Non Randomised Controlled Trials 
                   
Author 1 2 3 4 5 6 7 8 9 
1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
1
7 
1
8 
1
9 
2
0 
2
1 
2
2 
2
3 
2
4 
2
5 
2
6 
2
7 
Summ
ary 
Max 
22 
Percent
age 
Ross, Laws, Reckless & Lean 
(2008) 1 1 1 1 2 1 1 1 0 0 1 1 1 0 0 0 1 1 1 1 
    
0 0 0 16 73% 
Relton, Strong & Li (2011) 1 1 1 1 2 1 1 1 1 0 0 1 1 0 0 1 1 1 1 1 
    
0 1 0 18 82% 
 
Question 1-10 = Reporting 
Question 11-13 = External Validity 
Question 14-20 = Internal Validity Bias 
Question 21-26 = Internal Validity Confounding (selection bias) 
Question 27 = Power 
Questions – Quality Assessment Checklist (Downs & Black, 1998) 
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Q1. Clear hypothesis/aim/objective clearly described   
Q2. Main outcomes to be measured clearly described in the Introduction or Methods section  
Q3. Characteristics of the patients included in the study clearly described  
Q4. Interventions of interest clearly described  
Q5. Distributions of principal confounders in each group of subjects to be compared clearly described  
Q6. Main findings of the study clearly described  
Q7. Estimates of the random variability in the data for the main outcomes  
Q8. All important adverse events that may be a consequence of the intervention reported  
Q9. Characteristics of participants lost to follow-up described  
Q10. Actual probability values reported for the main outcomes except where the probability value is less than .001  
Q11. Asked a representative sample of the population to undertake the study  
Q12. Subjects who were prepared to participate who were representative of the entire population from which they were recruited  
Q13. The staff, places, and facilities where the patients were treated, representative of the treatment the majority of participants receive  
Q14. Were identified as attempting to blind study subjects to the intervention they have received  
Q15. Made an attempt to blind those measuring the main outcomes of the intervention  
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Q16. Made clear any results that were based on “data dredging”  
Q17. Adjusted for different lengths of follow-up of participantsts, or in case-control studies the same time period between the intervention and outcome  
Q18. Were identified as using appropriate statistical tests used to assess the main outcomes  
Q19. Reliable compliance with the intervention/s  
Q20. Accurate main outcome measures  
Q21. Participants in different intervention groups (trials and cohort studies), or cases and controls (case-control studies), recruited from the same 
population  
Q22. Study subjects in different intervention groups (trials and cohort studies,) or cases and controls (case-control studies), recruited over the same 
period of time  
Q23. Study subjects randomised to intervention groups  
 Q24. Randomised intervention assignment concealed from both participants and health care staff until recruitment was complete and irrevocable  
Q25. Adequate adjustment for confounding in the analyses from the main findings  
Q26. Losses of patients to follow-up taken into account  
Q27. Sufficient power was described to detect a clinically important effect where the probability value for a difference being due to chance is less than 
5%  
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